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“O INFANTE 
 
Deus quer, o homem sonha, a obra nasce. 
Deus quis que a terra fosse toda uma, 
Que o mar unisse, já não separasse. 
Sagrou-te, e foste desvendando a espuma. 
E a orla branca foi de ilha em continente, 
Clareou, correndo, até ao fim do mundo, 
E viu-se a terra inteira, de repente, 
Surgir, redonda, do azul profundo. 
Quem te sagrou criou-te português. 
Do mar e nós em ti nos deu sinal. 
Cumpriu-se o Mar, e o Império se desfez. 
Senhor, falta cumprir-se Portugal!” 
 
s.d. 
Mensagem. Fernando Pessoa. Lisboa, 1934 (Lisboa: Ática, 10ª ed. 1972).  - 57. 
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SUMÁRIO 
Mobilização de MSC (Células Mesenquimais Estaminais / do Estroma)  durante 
respostas imunes a biomateriais 3D: em direção à regeneração in situ 
A engenharia de tecidos in situ visa intervir terapeuticamente no exíguo processo de 
regeneração endógena através do uso de matrizes biodegradáveis fabricadas para 
instruir, melhorar e acelerar a capacidade de regeneração do hospedeiro. Atualmente, 
biomateriais fabricados com o intuito de modular a inflamação ou de promover a 
mobilização de células progenitoras para o implante biomédico têm sido utilizadas com 
sucesso para potenciar a regeneração endógena. Neste contexto, o avanço da 
regeneração de tecidos in situ exige um conhecimento mais aprofundado sobre como as 
diferentes células do sistema imune interagem com os biomateriais implantados. Tal 
informação irá permitir compreender e modelar esta interação para promover a 
mobilização e recrutamento de células estaminais/progenitoras endógenas em detrimento 
de tipos de células pró-fibróticas para o local do implante por forma a potenciar a 
regeneração da lesão ao invés da sua cicatrização/fibrose. 
Neste contexto, o objetivo global desta tese consiste em fornecer uma análise abrangente 
sobre qual o impacto das respostas imunes primárias humanas no recrutamento de  
células mesenquimais estaminais primárias da medula óssea (BM-MSC) e de fibroblastos 
que são desencadeadas pelo implante de diferentes biomateriais 3D. 
A nossa hipótese explora a mobilização endógena de células de carácter regenerativo 
para os biomateriais implantados. Desta forma foi primeiramente desenvolvida uma nova 
plataforma de imagiologia que possibilitasse a investigação do comportamento dinâmico 
das células estaminais mesenquimais em diferentes microambientes tridimensionais. 
Para tal, BM-MSC humanas foram transfectadas para expressar uma proteína 
fluorescente fotoconversora, designada proteína Dendra2, a qual foi utilizada para 
distinguir e seguir o mesmo grupo de células de forma estável ao longo de mais de sete 
dias, mesmo com a remoção da amostra do microscópio para a incubadora. Esta técnica 
imagiológica, baseada na proteína Dendra2, permitiu a análise da morfologia celular 
acoplada com quantificação da migração celular em tempo real numa variedade de 
matrizes biomédicas, com propriedades distintas, de origem natural ou sintética. De 
especial interesse, através desta técnica de imagiologia foram revelados perfis de 
migração celulares específicos para cada uma mas matrizes tridimensionais testadas ao 
longo de sete dias.          
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Tendo em conta o foco principal, procedeu-se à caracterização das respostas imunes 
desencadeadas pela interação das células imunes com distintos biomateriais e foi 
estabelecido qual o seu impacto no recrutamento de MSC e/ou de fibroblastos para o 
implante. Especificamente, foi determinado que os biomateriais modelo de Ácido Poli-
Láctico (PLA) e de quitosano levam a um aumento da atividade metabólica dos 
macrófagos mas não das células mononucleares do sangue periférico (PBMC), das 
células exterminadoras naturais (NK) ou dos monócitos. As PBMC e as células NK 
aumentam o seu número quando interagem com matrizes de PLA, e expressam um perfil 
de secreção que não promove o recrutamento de MSC ou de fibroblastos. Por outro lado, 
os monócitos secretam mais IL-8 quando em matrizes de PLA que é acompanhada por 
uma tendência para promover um maior recrutamento de fibroblastos mas não de MSC. 
A interação com quitosano aumentou a secreção de IL-8, MIP-1, MCP-1 e de RANTES 
por parte dos macrófagos diferenciados enquanto a interação com PLA estimulou a 
produção de IL-6, IL-8 e MCP-1, todas elas quimiocinas que podem conduzir ao 
recrutamento de MSC e/ou de fibroblastos. De especial importância, este perfil de 
secreção de macrófagos em contacto com os biomateriais foi correlacionado com a 
indução preferencial da invasão por parte de determinadas células do estroma em função 
do material. Desta forma, os macrófagos foram as células imunes que em contacto com 
os biomateriais tornam-se ativados para secretar moléculas bioativas capazes de 
estimular o recrutamento de MSC e de fibroblastos. Subsequentemente, investigámos se 
os macrófagos poderiam também regular a velocidade de colonização das matrizes 
implantadas pelas MSC recrutadas. Para tal, utilizou-se a plataforma de imagiologia, 
baseada na proteína Dendra2, previamente desenvolvida. Surpreendentemente, 
verificou-se que apesar da motilidade das células estaminais no interior das matrizes 3D 
de PLA e de quitosano ser semelhante na ausência de células imunes, a sua motilidade 
foi significativamente aumentada na presença de macrófagos diferenciados em 
quitosano. 
Foi desenvolvido um ensaio de competição fisiologicamente relevante que combina a 
câmara de Boyden com a tripla co-cultura celular. Surpreendentemente, este ensaio 
revelou que quando as MSC e os fibroblastos co-habitam no mesmo ambiente (câmara 
superior) existem diferenças no recrutamento preferencial de cada tipo de célula do 
estroma em função do tipo de biomaterial com que os macrófagos interagem. Neste 
contexto, tem sido sugerido que as MSC diminuem a fibrose e melhoram a integração 
dos implantes biomédicos. Desta forma, foi investigado se a suposta chegada das MSC e 
interação com os macrófagos na interface do implante poderia influenciar a dinâmica de 
recrutamento de fibroblastos. Verificou-se que esta interação reprime o recrutamento de 
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fibroblastos para o biomaterial. Este resultado sugere um mecanismo de regulação das 
MSC sobre a mobilização de fibroblastos para implante que não depende do tipo de 
biomaterial.  
Na sua globalidade, os resultados desta tese proporcionam uma expansão do 
conhecimento sobre a resposta imune despoletada por distintos biomateriais e 
estabelece qual a sua consequência funcional na indução de recrutamento de células do 
estroma com potencial regenerador ou fibrótico para o local do implante. Mais 
especificamente, os nossos resultados destacam um novo conceito integrador na 
engenharia de tecidos in situ fornecendo um dos primeiros passos na definição de regras 
de design para o desenvolvimento de biomateriais imunomoduladores com um carácter 
regenerativo mais eficaz.  
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SUMMARY 
MSC (Mesenchymal Stem / Stromal Cell) mobilization following immune responses 
to 3D biomaterials: a road towards in situ regeneration 
In situ tissue engineering strategies aim to therapeutically target our rather limited 
endogenous regenerative process through the use of off-the-shelf biodegradable scaffolds 
specifically designed to instruct, enhance and accelerate the hosts self-healing ability. 
Until now independent approaches that modulate inflammation or promote mobilization of 
progenitor cells towards the implanted scaffold have been successfully used to achieve 
endogenous regeneration. Predictably, advances in this field require deep insights on how 
different immune cell populations interact with biomaterials and how this can be 
modulated to promote mobilization of endogenous stem/progenitor cells in detriment of 
pro-fibrotic cell types towards the implant site. 
In this framework, the overall thesis objective is to provide a comprehensive analysis on 
the impact of primary human immune responses, triggered by distinct 3D scaffold models, 
on the recruitment of primary human bone marrow MSC and fibroblasts.   
Since our hypothesis focuses on exploiting mobilization of regenerative cells towards 
implanted materials, an imaging platform was developed to interrogate MSC dynamical 
behaviour within distinct 3D microenvironments. For that, human MSC were transfected to 
express a fluorescent photoconvertible protein, Dendra2, which was used to stably 
highlight and follow the same group of cells for more than seven days, even if removed 
from the microscope to the incubator. Dendra2 imaging allowed to couple an analysis of 
the cells morphology with quantification of cell migration in real-time, in a range of natural 
and bioengineered matrices with distinct properties. Interestingly, specific cell migration 
profiles throughout seven days were revealed for each of the tested matrices with this 
imaging technique. 
The immune cell responses triggered by distinct scaffolds were characterized and their 
impact on MSC and/or fibroblast recruitment towards the implant established. It was found 
that Poly-Lactic Acid (PLA) and chitosan scaffold models lead to increased metabolic 
activity of macrophages but not of peripheral blood mononuclear cells (PBMC), natural 
killer (NK) cells or monocytes. PBMC and NK cells increased their cell number in PLA 
scaffolds and expressed a secretion profile that did not promote MSC or fibroblast 
recruitment. On the other hand, monocytes secreted more IL-8 when in PLA, which was 
followed by a trend to increase fibroblast recruitment but not MSC. Importantly, chitosan 
lead to increased IL-8, MIP-1, MCP-1 and RANTES secretion by monocyte derived-
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macrophages while PLA stimulated IL-6, IL-8 and MCP-1 production, all of which are 
chemokines that can lead to MSC and/or fibroblast recruitment. This secretion profile of 
macrophages in contact with biomaterials correlated with the highest stromal cell invasion, 
which was biomaterial-dependent. Thus, macrophages were the cells that in contact with 
engineered biomaterials become activated to secrete bioactive molecules capable of 
stimulating MSC and fibroblast recruitment. Subsequently, we have investigated whether 
macrophages could also modulate the MSC colonization rate of implanted scaffolds using 
the Dendra2 imaging platform previously developed. Strikingly, it was found that although 
stem cell motility within PLA and chitosan 3D matrices was similar in the absence of 
immune cells, MSC motility significantly increased in the presence of macrophages 
differentiated in chitosan.  
Interestingly, using a physiologically relevant triple co-culture competitive Boyden 
chamber assay it was revealed that when MSC and fibroblasts co-habited within the same 
environment (upper chamber) there were biomaterial-dependent differences on 
preferential stromal cell type recruitment induced by macrophages. In line with this, MSC 
have been recently suggested to decrease fibrosis and improve scaffold integration. 
Therefore, it was investigated whether a putative MSC arrival and interaction with 
macrophages at the implant interface could influence the dynamics of fibroblast 
recruitment. It was found that MSC interaction with the scaffolds interface repressed 
macrophage-mediated fibroblast recruitment. This suggests a biomaterial-independent 
MSC regulatory mechanism over macrophage-mediated fibroblast mobilization. 
Taken together, the results of this thesis provide new knowledge on the scaffold-evoked 
immune responses and established their functional consequence on recruitment of 
stromal cells with regenerative or reparative potential. More specifically, our findings 
highlight a novel integrative concept for in situ tissue engineering providing one of the first 
steps towards defining design rules for a more effective development of 
immunomodulatory scaffold.  
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1.1 The physiology of tissue repair and/or regeneration 
The human body has the ability to regenerate certain organs over time as part of natural 
tissue turnover(1). For instance, organs as bone, intestinal epithelia and skin can self-
renewal at distinct rates with new cells replacing the exhausted/damaged ones to maintain 
the original tissue structure and function during life-time. Hence regeneration is defined as 
the biological process that leads to the restitution of native tissue architecture and 
function. Unfortunately, this regenerative potential is largely hindered in a severe injury 
scenario(2). When an emergency response is required the body rushes to repair the 
damaged tissue. Upon injury, healing occurs mostly by laying down a fibrotic connective 
tissue “patch” to seal the lesion/wound rather than fully restoring the native tissue 
structure and function. Thus, while tissue regeneration leads to the restitution of native 
tissue architecture and function, tissue repair is defined as the replacement of native 
parenchyma tissue for a relative acellular and fibrotic deposit of extracellular matrix (ECM) 
with consequent loss of function(3). Importantly, the recognition of tissue injury and 
recruitment of inflammatory cells to the lesion site is a key pre-requisite to clear out debris 
and initiate the healing mechanisms either by regeneration or fibrotic repair(4,5). The local 
release of “danger signals” by damaged cells triggers an inflammatory response. This sets 
in motion a sequence of events that signal the innate immune system to rush into the 
injury site, eliminate the injurious agents, contain damage and orchestrate the repair or 
regeneration of the lost tissue(6,7). Importantly, the amount of regeneration versus repair is 
highly dependent on the integrity of the connective-tissue framework (tissue that supports 
the parenchyma), on the recruitment of progenitor cells, and on the duration and extent of 
the inflammatory process (Figure 1).    
 
Following tissue injury, there is disruption of the blood hemodynamics at the damaged 
area. Blood contact with interstitial collagen matrix at the injury site triggers blood platelets 
to degranulate several inflammatory mediators including adenosine diphosphate (ADP), 
serotonin and tromboxane A2 (TXA2)(8). This instals a strong positive feedback for further 
platelet aggregation and degranulation at the injured area(9). These series of events leads 
to a fibrin clot formation that stops blood extravasation to the extravascular space. The 
formed fibrin clot provides a provisional matrix, rich in growth factors and chemokines that 
establish the foundations to support and initiate immune cell influx to the injured site which 
later gives rise to granulation tissue(10). Notably, the activated platelets also release a 
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range of chemokines that can promote mobilization, adhesion and proliferation of different 
progenitor cells with regenerative potential in this early phase(11-13).     
 
The aforementioned sequence of events initiates the inflammatory phase. Acute 
inflammation is a pivotal response to tissue damage that signals the injury to the immune 
system, neutralizes the injurious agents, removes necrotic cells and initiates healing 
mechanisms(14). The innate immune system senses the presence of an injury stimuli 
through pattern recognition receptors that detect either exogenous pathogen-associated 
molecular patterns (PAMPs) or endogenous damage-associated molecular patterns 
(DAMPs)(15). These “danger signals” may comprise damaged/degraded extracellular 
matrix (ECM) proteins(16-18), cell stress-induced proteins(19) and chemicals or cytokines 
released by necrotic/damaged cells(20,21). Simultaneously, the newly formed fibrin clot at 
the injury site releases inflammatory mediators that increase blood flow, haemostasis and 
vessel permeabilization to synergistically promote immune cell influx and initiate the 
healing process(22).  
The local release of inflammatory mediators such as tumour necrosis factor alpha (TNF-α) 
and interleukin-1 beta (IL-1β) at the injury site mediates expression of adhesion molecules 
on the plasma membrane of leukocytes(23). Their expression is essential to bind to their 
complementary integrin and selectin receptors on the inflamed endothelial wall(24,25). 
Altered blood flow dynamics force  incoming leukocytes to position near the margins of 
blood vessels, promoting their slowly roll over the endothelium and subsequent firm 
adhesion to activated endothelial cells(26). Leukocyte rolling is mediated mostly by low 
affinity interactions between L-, P-, and E-selectin (CD62-L,-P,-E) with P-selectin 
glycoprotein ligand 1 (PSGL1)(27,28). Then, leukocytes firmly adhere to the inflamed 
endothelium under sheer stress through vascular cell adhesion molecule (V-CAM) and 
intercellular adhesion molecule 1 (ICAM-1) integrins(29). Noteworthy, PSGL1-L-selectin 
can also mediate additional leukocyte-leukocyte interactions by which the adhered 
leukocytes may facilitate secondary leukocyte tethering and thus increase immune cell 
influx to injury site(30,31).   
Before crossing the endothelial wall, leukocytes spread and crawl inside blood vessels in 
a macrophage adhesion molecule 1- (MAC-1) and ICAM-1-dependent manner seeking a 
site to transmigrate to the extravascular space either by paracellular(32) or transcellular 
routes(26,33). Once the endothelial-cell barrier is crossed, leukocytes then migrate through 
the endothelial basement membrane and pericyte sheath to reach the injury site in a 
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chemotactic gradient-dependent manner(34). The type of expressed receptor at the 
endothelium and chemotactic signal gradient regulates the recruitment of distinct immune 
cells to the injury site in a timely fashion(35). Hence, the profile of infiltrated immune cells 
and their interaction with local tissue cells influences many aspects of the healing process, 
facilitating or not tissue regeneration. 
This acute inflammatory process is relatively short in time, ranging from hours to a few 
days, and it is tightly regulated by the immune system to avoid excessive tissue damage 
and spill over to normal tissue(14). However, depending on the severity of tissue injury and 
on the ability of progenitor cells to be mobilized towards the damaged tissue, proliferate 
and replace the damaged cells through differentiation, acute inflammation can progress to 
one of three outcomes: tissue regeneration, repair by fibrosis and/or chronic inflammation 
(Figure 1). 
 
Figure 1 - Framework of healing mechanisms upon tissue injury largely depends on 
the integrity of the connective-tissue, on the duration and extent of the 
inflammatory process, and on the type of mobilized stromal cells. (a) Tissue injury 
triggers local release of danger signals that mediates recruitment and activation of 
immune cells to the damaged site. The mobilized immune cells phagocyte cell debris and 
secrete inflammatory cytokines and chemokines that drive the inflammatory process 
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required to initiate the healing mechanisms. (b) In minor lesions the immune response is 
fine-tuned and has the ability to mobilize progenitor cells to replace the lost cells. 
Inflammation is timely resolved and the native tissue function and architecture is restored. 
(c) Larger necrotic debris areas require a more intense inflammatory response and the 
body rushes to patch the defect with connective tissue. Fibroblast mobilization and 
proliferation drives the fibrotic repair of the injury. Although the structural integrity of the 
affected area is restored the native parenchymal tissue function is irreversibly lost. (d) 
Interference with the normal process of healing, caused for example by the persistence of 
a foreign material within the wound, perpetuates inflammation which might drive further 
tissue damage and exacerbate concurrent fibrotic repair.    
 
Regeneration involves complete restitution of the native tissue architecture and function. 
However, in humans it is usually restricted to natural tissue turnover of some tissues and 
to minor tissue injuries(36). Certain tissues of the body are more capable of self-renewing 
(and hence regenerating) than others and can be broadly divided into three main types: 
continuously dividing (e.g. skin and gut), quiescent (e.g. liver and bone) and non-dividing 
tissues (e.g. heart and brain). The regenerative potential of these tissues lies not in the 
parenchymal cells (which are terminally differentiated and with limited proliferative 
potential) but in the progenitor cells located in the stem cell niches(37). Therefore in an 
injury scenario, regeneration can only occur if the connective-tissue framework is 
relatively intact and/or the tissue maintains the ability to mobilize progenitor cells to 
replace the lost tissue-specific cells(14). Extensive destruction of connective tissue in 
severe wounds limits the structural support to the regenerative process. In such scenario, 
the tissue-specific stem cell niches were probably obliterated, and a more prominent 
immune/inflammatory response for a longer time period is required to fully 
remove/remodel the damaged tissue. In the lack of the proper structural support, provided 
by the connective tissue, healing often occurs by remodelling the exudates/blood clot at 
the injury site into granulation tissue and ultimately in a fibrotic scar with limited blood 
supply. In opposition, in a well-approximated surgical incision the healing is usually fast as 
the defect is relatively small(38). Moreover, the fine-tuned inflammatory response triggered 
by the minor tissue damage might initiate mobilization of stem cells and subsequent injury 
resolution and regeneration with minimal scarring (Figure 1b).  
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Few types of tissue injury can result in complete restoration of native tissue and the 
majority of our body’s healing takes place via fibrotic scarring with very little regeneration. 
This type of repair occurs when there is substantial damage to the stromal tissue 
framework (as occurs in most injuries) and/or the inflammatory process lacks the ability to 
mobilize progenitor cell to replace the lost specialized cells(14,39). In these instances, the 
margins of the damaged area are not easily approximated, such as in infractions, ulcers 
and large tissue resections (e.g. upon tumour excision). Since larger necrotic debris areas 
require a more intense inflammatory response to resolve, an abundant layer of fibrotic 
tissue is deposited to fill in the defect(40). Despite the loss of some specialised cells and 
architectural distortion by fibrous scar, structural integrity is re-established at the expenses 
of tissue function (Figure 1c). This repair by connective tissue requires a massive influx of 
immune cells that remove all the damaged tissue and mediate the mobilization and 
activation of fibroblasts. In turn, recruited fibroblasts remodel the granulation tissue into a 
fibrotic scar to fill in the defect(41). Although this type of repair rapidly seals the wound, it 
leads to a major loss of tissue function which can be potentially life threatening depending 
on the site and extent of injury(42).   
 
Acute to chronic transition occurs when the acute inflammatory response cannot be 
resolved. This can occur owing either to the persistence of the injurious agent, foreign 
material or to some interference with the normal process of healing, such as infection(14). 
Although inflammation has a pivotal role in orchestrating the healing process after injury, 
the perpetuation of the inflammatory component can also severely compromise the 
healing outcome(43). 
In chronic inflammation the prolonged presence of inflammatory macrophages at the 
injury site directly contributes to maintenance of a pro-inflammatory environment. These 
macrophages can secrete an array of bioactive molecules that continuously promote 
tissue damage spill-over, as well as proliferation and activation of recruited fibroblasts. 
The originated tissue destruction/reconstruction cycles often result in excessive fibrosis(44) 
in a wound that often fails to heal spontaneously (Figure 1d).        
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1.2 Regenerative medicine and tissue engineering approaches 
The ability of human tissues to regenerate following severe injuries is rather limited during 
adulthood. Within this framework, regenerative medicine and tissue engineering seek to 
develop therapeutic strategies that restore the structure and function of the native tissue  
upon injury, by providing the required microenvironment to direct tissue regeneration(45). 
To this end, a number of approaches have been proposed in the last decades and can be 
broadly divided into (i) stem cell transplantation(46), (ii) implantation of ex-vivo tissue 
constructs (which comprises biodegradable materials that provide a temporary template 
for tissue formation seeded with stem cells and growth factors)(47) or (iii) the use of 
scaffolds alone or in combination with chemotactic agents to assist and enhance the hosts 
endogenous regenerative potential(48). We will briefly overview the last two tissue 
engineering strategies, proposed to address deficits in repair of serious injuries by relying 
on the use of instructive biomaterials. The idea is to implant artificial matrix (scaffold) to 
fill/replace the lesion volume and temporarily provide the mechanical and biochemical 
support for cell ingrown and tissue regeneration. For successful regeneration the 
implanted scaffold should (i) be biocompatible, (ii) be timely reabsorbed /degraded by the 
organism over the regenerative process, (iii) be porous, with an interconnected network to 
enable rapid tissue ingrowth and diffusion of nutrients, oxygen and metabolites, (iii) have 
surface properties (chemistry, roughness and stiffness) that support cell adhesion, 
proliferation and differentiation and (iv) should also provide adequate mechanical support 
accordingly to organ demands(49,50).      
 
The traditional tissue engineering paradigm to regenerate damaged tissues relies on 
harnessing autologous bone marrow mesenchymal stem/stromal cells (BM-MSC) from 
patients, expanding the cells in vitro and subsequently seeding these cells into a 
biodegradable scaffold. Then, the cell-scaffold constructs can be further conditioned or not 
in bioreactors to promote additional cell growth, differentiation and extracellular matrix 
formation, before implantation(47,51). Although this approach can lead to an autologous 
tissue substitute, the in vitro process is a very costly, time consuming procedure, and it 
has safety issues related with excessive ex-vivo stem cell manipulation(52). 
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Therefore, a novel approach emerged from this, in which the in vitro phase is obliterated, 
the so-called in situ tissue engineering, or scaffold-guided endogenous regeneration(53). 
The endeavour of in situ tissue engineering is to develop scaffolds that can therapeutically 
interfere with our otherwise limited regenerative potential by creating a regenerative 
microenvironment capable of accelerating and enhancing our self-healing ability(54,55). And 
this might be achieved by modulating inflammation or by promoting the mobilization of the 
endogenous mesenchymal stem/stromal cells (MSC) towards the implanted 
scaffold(48,56,57). The development of such immunomodulatory materials have been 
recently reviewed elsewhere(58).  
1.3 Inflammation, foreign body response and regeneration 
One of the main challenges for tissue engineering is to stimulate native tissue formation 
while avoiding fibrosis. Nevertheless, implantation of the so called “regenerative 
biomaterials” triggers two opposing types of host response: activation of regenerative 
mechanisms at the injured area but also an immune reaction against the implanted foreign 
material(59,60). Although these biological responses are very distinct they share 
inflammation as a common denominator. While the beneficial aspects of this immune 
reaction, such as debris clearance and progenitor cell recruitment must occur to initiate 
healing, their damaging effects as chronic inflammation, fibroblast mobilization, activation 
and subsequent fibrotic encapsulation of the biomaterial should be minimized for scaffold-
guided regeneration to succeed.  
 
Biomaterial implantation triggers a foreign body reaction (FBR) that consists of five crucial 
steps: (i) adsorption of blood proteins at materials surface, (ii) recruitment of immune cells, 
(iii) acute and (iv) chronic inflammation and, finally, (v) fibrotic encapsulation(59,61). This 
alternative healing response is sustained by chronic inflammation and characterized by 
formation of foreign body giant cells (FBGCs), which ultimately leads to encapsulation of 
the foreign object(62) (Figure 2). Typically, 2-4 weeks upon implantation, the foreign 
material is encapsulated within an almost avascular and acellular fibrous connective 
tissue which impairs the scaffolds regenerative function. Fibrotic thickness largely 
depends on the extent of the inflammatory response which is intrinsically related to 
biomaterial properties(63,64).  
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The inflammatory response is mainly driven by colonization of the scaffold by blood-
derived immune cells. Immune cell activation upon interaction with a biomaterial can occur 
by two means: (i) binding of adhesion receptors (e.g. integrins) to the pre-adsorbed 
fibrinogen, Immunoglobulin G (IgG), fibronectin and vitronectin proteins at the surface of 
materials or (ii) through activation of Toll Like Receptors (TLRs) by local PAMPs and 
DAMPs related to scaffold implantation(64). The nature of the infiltrating immune cells and 
their activation state were demonstrated to be pivotal in the delicate balance between 
fibrotic or functional ECM formation(65,66). Table 1 illustrates the immune cell populations 
present in human peripheral blood that can be recruited to the implant site. Activation of 
immune cells leads to production of inflammatory cytokines and chemokine-mediated 
recruitment of more immune cells but also of circulating BM-MSC and fibroblasts to the 
site of implantation. Importantly, the type of recruited cells can shift the healing outcome. 
Nevertheless, the specific contribution to stem cell or fibroblast recruitment by each 
immune cell population upon biomaterial interaction remains largely unknown.  
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Table 1 – Frequencies of immune cell types present in human peripheral blood (67,68). 
+percentage relative to number of peripheral blood leukocytes. *percentage relative 
to number of peripheral blood mononuclear cells. 
 
Cell type  Morphology  
Size 
(μm)  
Frequencies in 
human blood 
(x10
6 
cells/mL)  
Life-
span  
Primary function  
 
Erythrocytes   6-8  
93-96% 
(3800 – 6200) 
100-120 
days  
O2 and CO2 
transportation  
L
e
u
k
o
c
y
te
s
 (
0
.1
-0
.2
%
 o
f 
b
lo
o
d
 c
e
lls
) 
Granulocytes  
  
35-80%+ 
(2.13 – 6.35)    
Neutrophils 
 
10-14  
30-80%+ 
(2.09 – 5.97)  
6-48 
hours  To phagocyte bacteria 
and fungi 
Basophils  
 
10-14  
0-7%+ 
(0.01 – 0.08)  
8-12 
days  To kill parasites; 
allergic response  
Eosinophils  
 
10-12  
0-2%+ 
(0.03 – 0.30)  
hours-
days  
To release histamine  
Mononuclear 
cells (PBMC)    
20-65%+  
  
 Monocytes 
 
12-14  
10 – 30%* 
(0.20-0.90) 
hours- 
days  
Angiogenesis; 
phagocytosis  
Macrophages  
    
Phagocytosis; to 
mediate inflammation  
Dendritic cells  
 
 
1-2%* 
(0.02-0.06)   
To recognize and 
present antigens; T cell 
activation  
 Lymphocytes  
 
5-17  
70-90%* 
(1.1 – 3.5)  
weeks-
years   
NK cells  
  
10-15%* 
(0.08 – 0.43)   
Lysis of tumour or 
virally-infected cells; 
production of IFN-α 
and TNF- 
T cells  
  
45 – 70%* 
(0.54 – 1.79)   
To mediate adaptive 
immunity  
B cells  
  
15%* 
(0.07 – 0.53)   
Antibody production  
 
Platelets   2-4  
4-7% 
(140 – 450)  
5-10 
days  
Blood clotting; 
release of factors  
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1.3.2.1 Neutrophils 
Following biomaterial implantation, cells of the innate immune system are the first to 
respond yielding a classical FBR. The early immune cell influx is characterized by 
polymorphonuclear neutrophils (PMNs). Neutrophils are CD15+/CD68+ phagocytic 
leukocytes containing granules and are activated by pro-inflammatory cytokines such as 
IL-1β, TNF-α and Interferon gamma (IFN-γ). Despite their relatively short life span of 24-
48 hrs these cells display a rather destructive role(64). Neutrophils destroy the foreign 
particles by phagocytosis and their activation triggers their degranulation of proteolytic 
enzymes and reactive oxygen species (ROS). Additionally, formation of neutrophils 
extracellular traps (NETs) on implant surfaces renders an inhospitable environment for 
nearby foreign entities preventing the spread of a potential biomaterial-derived 
infection(69).  
1.3.2.2 NK cells 
Even though Natural killer (NK) cells are one of the first immune cell populations to arrive 
at an injury site, their role in biomaterial-mediated immune reaction is considerably less 
studied(70). NK cells are CD56+/CD3- granular cytotoxic lymphocyte effector cells involved 
in wound healing processes and in uterine tissue remodelling during pregnancy(71,72). 
These cells play a major role in both innate and adaptive immune responses and could 
mediate cytotoxicity against implanted allografts and tissue-constructs due to their ability 
to distinguish between self and non-self. This ability could be crucial to kill potential 
pathogens associated with implanted biomaterials through degranulation of lytic granules 
on target cells. NK cells can also secrete several cytokines including TNF-α, interleukin-10 
(IL-10), IFN-γ, transforming growth factor beta (TGF-β) and neutrophil-activating protein-2 
(NAP-2), known to impact other immune cells and/or mediate MSC recruitment(73-75).  
1.3.2.3 Monocytes 
Sequentially to neutrophil and NK cell engraftment, circulating monocytes are recruited 
from the blood to the implant site in response to monocyte chemotactic protein 1 (MCP-
1)(76) produced by recruited neutrophils(77) and tissue-derived macrophages(78). Monocytes 
are CD14+/CD3- phagocytic cells that replace the short-lived neutrophils and reach 
maximum numbers 24-36 hrs after injury(79). Upon arrival, monocytes became activated by 
local DAMPs and binding to the fibrinogen layer on the biomaterials surface. These cells 
also phagocyte cell debris resulting from the initial immune cell response and secrete 
chemokines such as IL-8 and MCP-1 to foster invasion of additional inflammatory cells(59).  
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1.3.2.4 Macrophages 
Eventually, monocytes gradually differentiate into long-lived macrophages that became 
the predominant cell type at the tissue-implant interface. Macrophages are phagocytes 
with a remarkable plasticity that enables them to assume diverse and context-dependent 
polarization states(80). These are broadly categorized by their functional properties and 
patterns of cytokine secretion into M1 and M2 types. Although this classification provides 
an important framework to study their roles during many processes including tissue 
repair/regeneration it is simplistic. In vivo, macrophages adopt continuum phenotypes with 
overlapping functions in which classically activated (M1), wound-healing (M2wound-healing), 
and regulatory macrophages (M2regulatory) occupy different points of the spectrum
(81).  
Upon injury, macrophage exposure to pro-inflammatory cytokines as IFN-γ and TNF-α 
and/or necrotic cellular or bacterial debris drives cells into a pro-inflammatory (M1) 
phenotype. Macrophages activated by biomaterials are typically M1 and secrete high 
levels of IL-1β, IL-6, IL-8, MCP-1 and macrophage inflammatory protein-1β (MIP-1β) 
which can recruit more inflammatory cells and exacerbate inflammation. Although this M1 
state is essential to mount the inflammatory response to injury and initiate healing their 
prolonged activation is detrimental and leads to further tissue damage and chronic 
inflammation(82,83). 
A prominent acute inflammatory response is required to cleanse the wound and to 
mobilize progenitor cells and other stromal cell types as fibroblasts to assist in tissue 
regeneration and/or repair, respectively (Figure 2). This phase is followed by a M1 to M2 
phenotype transition of macrophages. Wound healing macrophages (M2wound-healing) are 
induced by IL-4 and IL-13 secreted into the inflammatory milieu by mast cells, 
granulocytes and T helper cells that were recruited during the previous acute inflammatory 
phase. M2wound-healing macrophages assists in tissue repair through secretion of TGF-β, 
basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), vascular 
endothelial growth factor (VEGF) to  promote angiogenesis, pro-fibrotic activity by 
fibroblasts and the secretion of a myriad of proteolytic enzymes to remodel the damaged 
ECM(84). As the inflammatory process progresses, the cytokine environment gradually 
changes and accumulates increased levels of anti-inflammatory signals such as IL-10, 
prostaglandin E2 (PGE2), and TGF-β produced by regulatory T cells (Tregs), B cells and 
recruited MSC. This combined with TLR4 activation on macrophages, by apoptotic bodies, 
drives regulatory macrophage (M2regulatory) polarization
(85). Subsequently, M2regulatory 
macrophages can themselves secrete high amounts of these anti-inflammatory cytokines. 
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Their main task is to dampen the immune response, resolve inflammation and promote 
regeneration while limiting development of fibrosis(86).  
Despite the sequential role of macrophages M1, M2wound-healing and M2regulatory during the 
physiologic healing process, persistence of a foreign material (e.g. a regenerative 
scaffold) at the injury site often disrupts this sequence of events and prolongs the 
presence of pro-inflammatory (M1) and M2wound-healing macrophages
(64,87). In this scenario, 
biomaterial-adherent M1 macrophages attempt to phagocyte the material or degrade it 
through secretion of reactive oxygen species (ROS). Since solid biomaterials are typically 
larger than a cell this results in “frustrated phagocytosis”. This promotes macrophage 
fusion into FBGCs which display enhanced ability to degrade the material surface and to 
orchestrate the fibrotic encapsulation of the implant in close interaction with fibroblasts(59).  
1.3.2.5 T and B lymphocytes 
The immune system employs tissue-resident antigen presenting cells (APC: dendritic 
cells, macrophages, B cells) to identify and present antigens/epitopes to B and T cells for 
development of an adaptive immune response. These epitopes are usually peptide 
sequences, which can be incorporated into biomaterials or can arise in situ as APCs 
process larger antigens, proteins, cells, or debris associated with the biomaterial. 
Noteworthy, accumulation of T lymphocytes (CD3+) is associated with the expression of 
MCP-1 a few days after injury and coincides with macrophage predominance in a FBR. 
These cells are part of cell-mediated adaptive immune responses and can display effector 
(CD8+ cytotoxic T cells) or regulatory (CD4+ helper T cell or CD4+/CD25+ Treg cell) 
roles. Activated T cells will undergo proliferation during injury and upon interaction with 
antigen presenting cells (APCs) will secrete the pro-inflammatory cytokines IL-1β, IL-6, IL-
8, TNF-α, MCP-1 and MIP-1β(88). However their specific role in regeneration remains 
controversial. During healing, it has been reported that increased T lymphocytes correlate 
with delayed bone regeneration(89). However, Saddler et al.(90) recently showed that 
regeneration upon implantation of decellularized tissue-derived scaffolds requires an 
mTOR/Rictor-dependent T helper 2 pathway to guide an IL-4-dependent M2 macrophage 
polarization. Moreover, this IL-4 up-regulation is driven by an early adaptive response (at 
week 1) which is then maintained by an innate response (at week 3) later in the wound-
healing and regenerative processes. Together, this unveils the potential role of CD4+ Th2 
T cells to induce a pro-regenerative transcriptome on scaffold-associated macrophages(90-
92). Nevertheless, it remains the question whether this putative CD4+ T cell role is 
maintained upon implantation of artificial/engineered scaffolds.  
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B cells are lymphocytes that are responsible for the humoral immune response. 
Interestingly, in biomaterials that trigger Th2 type responses, B cells are rarely observed 
in the implant site which suggests limited antibody production(93). Despite their potential 
involvement in mediating an adaptive response towards implanted materials their specific 
role and interplay with other cells in FBR is considerable less studied. 
1.4 Cell recruitment in regeneration 
Mobilization and recruitment of specific stromal cell types towards implanted biomaterials 
is a crucial step for the regenerative outcome. This is justified by the need to recruit a 
sufficient number of pro-regenerative stem cells in the best time frame in order to have 
accelerated recovery. In this regard, several chemoattractant molecules released by 
immune cells upon biomaterial interaction may have an important role in mediating a 
preferential recruitment of stem cells, which ultimately may impact on the healing outcome 
(Figure 2).  
 
Figure 2 – Overview of the chemokines, growth factors and cell players involved in 
acute inflammation, chronic inflammation, and/or tissue regeneration triggered 
upon scaffold implantation. Upon implantation, the scaffold surface is immediately 
coated by blood proteins. The surgical implantation of the biomaterial injuries the tissue 
and initiates an inflammatory process mediated by the local production of IL-1β and IL-8 
inflammatory signals. Local inflammation triggers the influx of neutrophils and NK cells to 
the implant site to remove cell debris and other injurious agents. Increased IL-6 and MCP-
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1 expression promotes recruitment of monocytes which gradually differentiate into 
macrophages replacing the short-lived neutrophils. Pro-inflammatory macrophages (M1) 
secrete chemokines as RANTES and MIP-1α/β that recruit additional immune and/or 
stromal cells to initiate healing mechanisms. Excessive fibroblasts mobilization and 
activation and/or the persistence of foreign material stimuli prolong the presence of pro-
inflammatory and wound-healing macrophages and perpetuate the inflammatory cytokine 
environment. The inability of macrophages to phagocyte the scaffold drives formation of 
FBGCs which ultimately orchestrate fibrotic encapsulation of the scaffold and impair 
scaffold colonization. On the other hand, MSC recruitment can assist tissue regeneration 
through secretion of SDF-1 to attract additional progenitor cells and PGE2, IDO, TSG-6 
and IL-10 to polarize macrophages and other immune cells such as T cells towards a 
regulatory phenotype. This ameliorates inflammation and creates a feed-back loop to 
resolve inflammation allowing scaffold-guided regeneration to succeed. This pathway is 
facilitated by the synchronized biodegradation of the implanted scaffold over the 
regenerative process. Abbreviations: FBGCs, foreign body giant cells. 
 
1.4.1.1 SDF-1  
Stromal cell-derived factor 1 (SDF-1), also known as CXCL12, is a chemokine produced 
by resident endothelial cells and stromal fibroblasts and it is specially up-regulated 
following tissue injury and/or hypoxia(94). SDF-1, recognized by the CXCR4 receptor, is 
involved in mobilization and recruitment of MSC and endothelial progenitor cells from the 
bone marrow to the injury site but also of other immune cells including B lymphocytes(95). 
Hence, a number of in situ tissue engineering SDF-1 delivery strategies have been shown 
to promote MSC migration towards implanted scaffolds and improve tissue 
regeneration(96,97). Depending on the local concentration of SDF-1, this chemokine can act 
as chemoattractant as well as repellent for leukocytes(98,99). 
1.4.1.2 IL-6 
Interleukin 6 (IL-6) is promptly and transiently produced in response to tissue injuries and 
is an important mediator of acute inflammatory phase(100). IL-6 binds to the IL6R receptor 
and can be produced by several cell types including endothelial cells, fibroblasts, 
monocytes and macrophages(101). Depending on the environment, IL-6 production may act 
as pro-inflammatory or pro-regenerative cytokine. For instance, IL-6 secreted by 
fibroblasts in an autocrine fashion has a central role in pathologic fibrosis which drives 
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fibroblast proliferation and collagen synthesis while perpetuating inflammation(102,103). On 
the other hand, proteolytic processing of the IL-6R from invading neutrophils subsequently 
drives IL-6 trans-signaling in resident tissue cells, leading to a switch from neutrophil to 
monocyte recruitment by suppressing neutrophil-attracting (CXCL1/Gro-α, CXCL8/IL-8, 
CX3CL1/fractalkine) and enhancing monocyte-attracting chemokines (CCL2/MCP-1, 
CCL8/MCP-2, CXCL5/ENA-78, CXCL6/GCP-2), a instrumental event for the progression 
of the inflammatory process(104,105).  
1.4.1.3  IL-8 
Interleukin 8 (IL-8), or CXCL8, is a chemokine primarily involved in neutrophil 
accumulation during the inflammatory response that also primes phagocytosis and 
respiratory burst at the injury site(106). IL-8 can be recognized by the receptors CXCR1 and 
CXCR2 and is transiently expressed upon tissue damage or ischemia by several cells 
including endothelial cells, fibroblasts, NK cells, monocytes and macrophages(107,108). 
Interestingly, BM-MSC show a dose-dependent chemotactic response to IL-8(109,110). 
1.4.1.4 MCP-1 
Monocyte chemotactic protein 1 (MCP1), also known as CCL2, signals by binding to the 
CCR2 receptor. This chemokine that can be secreted upon tissue damage or stress by 
many cell types including endothelial cells, fibroblasts, smooth muscle cells and 
monocytes/macrophages(111,112). Although MCP-1 is primarily involved in 
monocyte/macrophage recruitment to sites of inflammation, it also promotes chemotaxis 
of BM-MSC, dendritic cells, NK cells and memory T cells(112-115).   
1.4.1.5  MIP-1α/β 
Macrophage inflammatory protein 1α (MIP-1α), also known as CCL3, and MIP-1β (CCL4) 
play critical roles in recruitment of leukocytes to the site of inflammation and signal 
through CCR1, CCR4, and CCR5. Their expression is induced by inflammatory stimuli, 
mainly in macrophages, lymphocytes and dendritic cells but also in other cells, including 
fibroblasts and smooth muscle cells(116). While CCL3 and CCL4 are both chemoattractant 
for monocytes, macrophages, and dendritic cells, they differ in their responses with T 
cells. While MIP-1α preferentially attracts CD8+ T cells, CD4+ T cells are more responsive 
to MIP-1β. In addition to its chemotactic and co-activator functions, MIP-1α also induces 
inflammatory cytokine secretion, mast cell degranulation, and NK cell activation. MIP-1α 
has been shown to encourage BM-MSC migration. Therefore it has been proposed as one 
of the mechanisms for stem cell recruitment to the injury site(117-119). 
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1.4.1.6 RANTES 
Regulated upon Activation Normal T cell Expressed and Secreted (RANTES), also known 
as CCL5, is produced by synovial fibroblasts, NK cells, monocytes, macrophages, T 
lymphocytes, mast cells, and platelets. RANTES signals through the receptors CCR1, 
CCR3, CCR4 and CCR5 and plays an important role in the immune response by initiating 
the recruitment of leukocytes and other cells to the injury site. RANTES is chemoattractant 
for monocytes, NK cells, dendritic cells and T cells but also for non-inflammatory cells 
such as BM-MSC(120). Interestingly, BM-MSC chemotaxis towards RANTES was found to 
be greatly increased in inflammatory environments(121). The activity of RANTES is not 
restricted to chemotaxis, since it is also involved in proliferation and activation of certain 
immune cells(122).  
1.4.1.7 PDGF-BB  
Platelet-derived growth factor BB (PDGF-BB) is a growth factor, recognized by PDGF-R, 
and can be produced upon tissue injury by a plethora of cells including activated platelets, 
macrophages, mast cells and endothelial cells. The secreted PDGF-BB promotes 
neutrophil and macrophage infiltration, triggers fibroblasts migration, proliferation and 
fibrotic activity and has a key role in angiogenesis. PDGF also mediates recruitment of 
BM-MSC, which express high levels of PDGFRs. Nevertheless, while other chemokines 
(as SDF-1 and MCP-1) greatly increase their ability to promote MSC recruitment under 
inflammatory stimuli the same does not seem to occur with growth factors, including 
PDGF-BB(121).    
1.5 The stromal compartment: MSC and fibroblasts 
The type of healing adopted upon injury is intrinsically related with the stromal 
compartment. Stroma refers to the tissue that provides the structural support for the 
parenchyma/functional tissue of the organs. Since the parenchyma is avascular, it largely 
depends on the integrity of the underlying stromal tissue to access to oxygen, nutrients, 
waste disposal and eventually to the immune system for surveillance. Thus, upon tissue 
injury two key stromal cell types, MSC and fibroblasts (Table 2), can be mobilized to 
participate in wound healing and most likely determine the healing outcome.  
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Table 2 – Overview MSC and fibroblasts features. Phenotypic markers are denoted as 
(–) absent or (+) present. Chemokine receptor expression is graded from + to ++++.  
 
MSC  Fibroblasts  Refs. 
Morphology  
 
 
 
Distribution 
Bone-marrow 
Throughout vascularised 
tissues, possibly as pericytes  
Ubiquitous  
(123-125)
 
Frequency 
Rare 
(0.001-0.08% in bone-marrow; 
Lower frequencies in other 
tissues)  
Common in stromal 
compartments  
(123,126)
  
Primary function 
Support haematopoiesis 
Tissue turn-over and 
regeneration  
ECM production 
Wound healing/fibrosis  
(127-129)
 
    
 
Phenotype 
CD14 -  -  
(130)
 
CD19  -  -  
(131)
 
CD34 -  -  
(130)
 
CD45 -  -  
(130)
 
CD73 +  +  
(125,132)
 
CD90 +  +  
(125)
 
CD105 +  +  
(125,132)
 
CD106 + -  
(125)
 
CD146 +  -  
(125)
 
HLA-DR -  -  
(133)
 
    
 
Chemokine 
receptors 
CCR1 - +++ 
(117,121,134)
 
CCR2 ++++ +++ 
(121,134,135)
 
CCR3 +++ + 
(121,135)
 
CCR4 ++ ++ 
(109,121,136,137)
 
CCR5 +++ +++ 
(109,121,135)
 
CXCR1 ++++ + 
(109,138)
 
CXCR2 ++++ + 
(109)
 
CXCR4 ++++ + 
(117,121,139)
 
IL-6R - + 
(140-142)
 
PDGF-R +++ +++ 
(121,143)
 
    
 
Immumodulatory 
ability  
Immunoenhancing  (MSC1) or 
Immunosupressive (MSC2)
 
 
Pro-inflammatory  
(144,145)
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In 1961 Freidenstein et al.(146) experimentally demonstrated that a bone marrow transplant 
into a heterotypic site could give rise to a functional bone organoid. MSC characterized by 
their fibroblastic morphology were then identified as the bone marrow stem cell 
component responsible for the in vivo regeneration and support of ectopic bone, stroma 
and hematopoietic tissues upon transplantation(147-149). These stromal cells isolated by 
plastic adherence, were characterized by their colony forming capacity (CFU) at low 
densities and by their ability to differentiate and form bone, cartilage and adipose tissues 
upon single stem cell transplantation(127). In the following decades, MSC were also 
identified, isolated and expanded by in vitro culture from a myriad of other tissues 
including adipose tissue, umbilical cord blood, skin, tendon, muscle and dental pulp. The 
widespread research on MSC became plagued by the lack of uniform criteria to define 
these cells which hampered the possibility to compare the results obtained by the different 
research groups(150). This major obstacle, lead the International Society for Cellular 
Therapy (ISCT) in 2006 to formulate the minimal standard criteria to define MSC(151) as: (i) 
plastic-adherence cells under standard culture conditions, (ii) with positive expression of 
CD73, CD90 and CD105 and lack of hematopoietic cell surface marker expression, 
namely CD14, CD19, CD34, CD45 and human leukocyte antigen (HLA-DR) and (iii) ability 
for in vitro differentiation into osteoblasts adipocytes and chondrocytes when chemically 
stimulated. Although the characterization of this broad population of MSC is still under 
debate(127,152), these cells seem to exhibit stem cell function in vivo, and were hence 
named Mesenchymal Stromal/Stem cells (MSC)(153). Although not included in the ISCT 
minimal criteria for defining these cells, MSC have been increasingly recognized to 
participate in tissue regeneration not only as building blocks through differentiation but 
more importantly by their role in immune modulation, recruitment of tissue-specific 
progenitor cells and release of trophic factors in response to injury(128,154,155).    
The gradual understanding of stem cell biology has lead to a notorious MSC paradigm 
evolution over the last decades, with direct implications on their therapeutic application. 
Indeed, within the first decades upon their discovery MSC were explored as feeder cells 
that provided the niche for culture of hematopoietic stem cell (HSC). The experimental 
demonstration, in 1999 by Pittenger and colleagues(123), that MSC could be cultured ex-
vivo and chemically induced to differentiate into other tissue-specific lineages as 
osteoblasts, adipocytes and chondrocytes has led to a novel paradigm: MSC as a 
regenerative medicine workhorse which could be used to replace the damaged 
cells/organs. However, as the knowledge on stem cell biology increases it is now apparent 
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that only a small fraction of MSC actually differentiates into tissue-specific cells upon 
recruitment to assist regeneration. In fact, MSC seem to act also as a transient first aid 
responder in injured tissues.  Their ability to (a) modulate excessive inflammation and 
immune reactions, (b) secrete bioactive factors that lead to diminished fibrosis and 
apoptosis of damaged cells, and (c) that promote proliferation and differentiation of tissue-
specific progenitor cells seems instrumental to minimize tissue damage and orchestrate 
tissue regeneration(156). Within the current paradigm, in-depth understanding on how 
endogenous MSC function upon tissue injury is crucial to develop novel and more efficient 
in situ tissue engineering strategies to improve tissue regeneration.    
1.5.1.1 MSC: a first aid responder 
MSC can differentiate into multiples tissue-specific cell types. Since their differentiated 
progeny is not limited to one specific anatomical position it has been suggested that these 
cells can participate in the regeneration of multiple tissues throughout the body(124,126,157). 
Conceptually, this implies that MSC are localized (i) within an anatomical site or “niche” 
with access to systemic danger signals and (ii) have the ability to reach the damaged 
tissues throughout the body. 
In an effort to regenerate damaged tissue, it is thus essential to efficiently recruit sufficient 
number of endogenous MSC to the implanted scaffold(116). This recruitment is a multistep 
process and involves complex inflammatory signals from the injury site causing the 
release of MSC from their storage niche into circulation (mobilization), which may then 
migrate towards the injury site (homing), colonize the implanted scaffold, secrete bioactive 
molecules to support the regenerative process and eventually some will directly replace 
the damaged tissue through differentiation (Figure 3a). 
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Figure 3 - Model of the dynamical behavior of MSC upon biomaterial implantation. 
(a) Overall view of MSC mobilization, homing, interstitial migration, scaffold colonization 
and immunomodulation upon scaffold implantation. Colonization of an implanted scaffold 
by immune cells drives the inflammatory process through secretion of chemokines and 
inflammatory mediators. (b) The release of inflammatory signals from the injury site is 
sensed in the bone marrow and mediates mobilization of MSC from their niche into the 
blood stream. The presence of activated immune cells within the bone marrow niche 
together with SDF-1 and other inflammatory mediators released from the injury site 
decreases the adhesion of MSC to the niche and facilitate their migration towards the 
blood stream into the injury site. (c) The continuous release of inflammatory mediators 
and chemokines from the injury site activate the endothelium to express P- and E-
selectins and incoming MSC to express CD44, CD105 and V-CAM, which mediates the 
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slow rolling of MSC and subsequently the firm adhesion and transmigration through the 
inflamed endothelial cells into the interstitial space. (d) Upon transmigration MSC need to 
overcome the physical constrains imposed by the basement membrane and interstitial 
ECM before reaching the implanted scaffold. Here, MSC motility modes include 
mesenchymal motility, or various forms of amoeboid motility characterized by blebs, 
pseudopods, or stable blebs. Additionally, cells can degrade/cleave ECM proteins through 
secretion of MMPs. The adopted motility mode is influenced by environmental factors, 
including the strength of adhesion to the substrate, or the extent of physical confinement 
and contractility. (e) Biomaterial colonization rate by recruited MSC and their fate is 
influenced by the physical-chemical features of the scaffold, by the inflammatory 
microenvironment and cell-cell interactions. (f) Upon arrival to the implanted scaffold MSC 
interaction with the surrounding environment can trigger their polarization into a pro-
inflammatory (MSC1) or anti-Inflammatory (MSC2) phenotype. In the onset of 
inflammation (low levels of TNF-α and IFN-γ), recruited MSC may adopt a pro-
inflammatory phenotype (MSC1) and enhance immune cell responses by secreting 
chemokines that recruit lymphocytes to the implanted biomaterial (e.g. MIP-1α and MIP-
1β, RANTES and IP-10). In the presence of an inflammatory environment (high levels of 
TNF-α and IFN-γ), MSC become activated to adopt an immune-suppressive phenotype 
(MSC2) by secreting high levels of soluble factors such as IDO, PGE2, TSG-6 and MCP-1, 
which suppress inflammatory immune cell responses and drive their polarization into a 
regulatory phenotype. The switch toward MSC1 or MSC2 type may also depend on MSC 
stimulation through TLRs expressed on their surface. 
1.5.1.2 MSC niches 
MSC reside primarily in bone marrow niche, comprising approximately 0.001-0.08% of 
bone marrow cells, but were identified in almost every vascularised tissues throughout the 
body(123,157). The close association of many stem cells types with vasculature and the fact 
that MSC and CD146+ pericytes, that reside in close proximity with the vascular wall, 
share the same phenotypic profile and multipotency lead to the hypothesis of vascular 
pericytes as a possible in vivo source of MSC(158,159).  
The stem cell “niche” hypothesis was first proposed by R. Schofield for hematopoetic stem 
cells (HSC) (160). Niche was then defined as a specialized environment within tissues that 
can preserve the adult stem cells proliferative potential and block maturation. Removal of 
stem cells from the niche results in loss of stem cell identity, self-renewal capacity and the 
onset of differentiation(161). Every stem cell niche represents a dynamic entity with different 
cells interacting to modulate MSC function(162) (Figure 3b). Within this microenvironment 
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there are two types of niche cells: resident and transitory cells. The permanent cells 
include endothelial cells, nerve cells and connective-tissue fibroblasts while immune cells 
and MSC itself account for the transitory component, especially during host response to 
tissue damage(163,164). Importantly the close proximity of MSC niches with blood vessels 
ensures their responsiveness to systemic signals and provides a conduit for recruitment of 
stem cells into and from the niche(165-167). 
The stem cell pool within the niches are maintained by two cell division mechanisms: (i) 
asymmetric self-renewal into which a stem cell divides into one stem and one 
differentiated cell to maintain tissue homeostasis and/or (ii) symmetric self-renewal in 
which a stem cell gives rise to two daughter stem cells leading to the re-establishment of 
the stem cells pool, a condition required upon tissue injury(168). 
Although distinct tissue-specific stem cell niches can be identified they share common 
features. These niches are physical entities with specific ECM proteins and environmental 
properties as hypoxia. Stem cell niches are typically governed by heterotypic cell-cell 
interactions, where secreted and membrane-bound factors as chemokines gradients 
regulate stem cell fate: quiescence or mobilization into blood stream/injury site. 
Interestingly, immune cells seem to provide the needed dynamic regulation of the niche 
during inflammation and tissue damage, which in turn can transiently modify the specific 
local environmental properties and chemokine gradients of the niche setting off the 
release of MSC(163). 
1.5.1.3 MSC mobilization from niches 
The release of MSC from their niche into circulation is defined as mobilization(169). The 
bone marrow acts as a major reservoir for multiple stem cell populations including MSC, 
which are mobilized at different extents to the peripheral circulation following tissue 
injury(170-172). However, the nature of signals released from the injured tissue and the 
molecular mechanism that sets off MSC mobilization from the niche are poorly 
understood. Under physiologic conditions, bone marrow MSC are maintained within their 
niche through tightly controlled interactions of chemokines, cytokines and growth factors 
as well the presence of specific adhesion molecules. SDF-1/CXCR4 axis seems to be 
pivotal for MSC maintenance within the niche. Moreover, their maintenance in discrete 
hypoxic regions of bone marrow promotes cell adhesion to the niche possibly through 
local increase in SDF-1 due to stabilization of hypoxia related hypoxia-inducible factor 1-
alpha (HIF-1α) transcription factor(173).  
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However, injury leads to upregulation of inflammatory cytokines and chemokines that are 
released into circulation from remote damaged tissues, thus creating a transient 
imbalance on niche gradients. This stimulates the downregulation of adhesion molecules 
in MSC and ultimately sets off their mobilization from the niche (Figure 3b). For instance, 
blood vessel disruption upon injury leads to tissue hypoxia with stabilization of HIF-1α. 
Consequently there is SDF-1 expression and its release from the damaged tissue to the 
circulation triggers a spike on SDF-1 systemic levels(174). This is sensed in bone marrow 
MSC niches, inducing CXCR4 receptor desensitization on resting MSC and increases in 
matrix metalloproteinase 9 (MMP-9) protease activity on the stromal component of the 
niche, hence triggering the release of stem cells from the bone marrow reservoir(175). 
Additionally it is also possible that MSC participating in tissue regeneration following injury 
can originate from local tissues or nearby vasculature (pericytes) as these cells only need 
to travel short distances to arrive to the site of injury avoiding the need for circulation(176) 
(Figure 3c). 
1.5.1.4 MSC homing 
Upon release from their niches into circulation, MSC then need to home and engraft at the 
injury site(177). Homing mechanisms of circulating MSC to the site of injury involve a 
cascade of events, including rolling of MSC along the blood vessels, adhesion onto 
inflamed endothelial cell surface, transendothelial migration and finally, migration and 
invasion through ECM towards the target tissue(178). Although the exact mechanism used 
by MSC remains largely unknown it seems to rely on a complex interplay between 
inflammatory cytokines, chemokines, adhesion molecules and ECM-degrading 
proteases(179,180). This process is thought to be similar to the one used by leukocytes 
homing to sites of inflammation since many of the molecules involved are also expressed 
by MSC. Importantly, maximal engraftment of stem cells was correlated with peak 
production of inflammatory cytokines, such as IL-6, which supports the notion that the 
intensity of inflammation is an important modulator for enhanced homing and migration of 
stem cells to damaged tissues(181).      
Several studies implicated P- and E-selectin in endothelial cells to be involved on MSC 
rolling over the inflamed endothelial wall. The specific P-selectin ligand used by human 
MSC seems to be a modified CD44 isoform since these cells do not express neither 
PSGL-1 (CD162) nor CD24 on their surface(182,183). For subsequent firm adhesion, MSC 
seem to use several protein-integrin interactions as VCAM-1/ very late antigen-4 (VLA-4), 
ICAM-1-β2 integrin(179,184). This could be facilitated by local production of pro-inflammatory 
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cytokines such as IFN-γ, TNF-α and IL-1β in response to injury, all of which upregulate 
expression of ICAM-1 and VCAM-1 on the surface of MSC(185,186) (Figure 3c). Moreover, a 
myriad of other cell adhesion molecules (CAM) such as a1, a2, a3, a4, a5, av, b1, b3, b4, 
ICAM-3, activated leukocyte cell adhesion molecule  (ALCAM), and endoglin/CD105 have 
also been implicated in mediating  MSC-endothelial cell adhesion(187,188). Interestingly, the 
integrin-dependent adhesion of several progenitor cells can be regulated by several 
chemokines including SDF-1(189). Nevertheless, further studies are required to understand 
whether bone marrow-derived circulating MSC and tissue-derived MSC operate through 
identical trafficking mechanisms.  
1.5.1.5 MSC interstitial migration 
Regardless of MSC origin from circulation or local tissues, their ability to migrate and 
invade is critical for their functional integration within the inflamed tissue. In two-
dimensional (2D) surfaces the matrix stiffness directly modulates the velocity of cells(190). 
However, for navigation in three-dimensional (3D) substrates cells interpret not only 
adhesive and mechanical features of increased complexity from their environment but 
also the steric hindrances created by the ECM itself. And to navigate effectively MSC can 
either migrate directly through the matrix pores, use cell-mediated degradation of the 
matrix or a combination of both(191,192). Direct migration of MSC in 3D depends on 
deformability of cells and cell sub-structures with cell nucleus being the rate-limiting 
organelle in 3D migration(193). For direct migration, single MSC can adopt two broadly 
defined motility modes: mesenchymal or amoeboid(194). MSC in the mesenchymal mode 
exhibit elongated, spindle-like shape morphology and their movement relies on strong 
cell-substrate adhesions to exert traction via focal adhesions, with actin rich leading edge 
structures including lamellipodia or filopodia protrusions. On the other hand, cells 
undergoing amoeboid migration adopt round or irregular shapes and undergo cycles of 
expansion and contraction to squeeze through gaps in the ECM, a process that does not 
rely so heavily on cell-substrate adhesions(191) (Figure 3d). The cells velocity in amoeboid 
mode is higher than that of cells in mesenchymal one and it appears to involve a range of 
different sub-modes, depending if cells use a bleb-, pseudopod- or stable bleb-based 
motility(195). Mesenchymal and amoeboid migration modes are not mutually exclusive, and 
the ECM features seem to influence which mode predominates. This plasticity in the 
motility mode is an important aspect of immune cells and MSC migration, as the cells 
mobilized by acute inflammation have to navigate through a range of extracellular matrix 
geometries to escape their niche and engraft at the injury site. The degree of cell 
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confinement that cells encounter in the different tissues seems to be one of the most 
important factors for cells to use a given motility mode(195)(Figure 3d).  
The transendothelial and thereafter interstitial migration of MSC requires degradation of 
the basement membrane that underlies all epithelia and endothelia surrounding muscle 
and fat tissues. This process largely depends on the production of matrix-degrading 
enzymes(196). This thin, yet dense and highly cross-linked ECM is composed mainly by 
laminin and collagen type IV but also contains nidogen/enactin and proteoglycans(197). 
Notably, all cell types that migrate through endothelial walls, including leukocytes, tumor 
cells, HSC and MSC, express matrix metalloproteinases (MMPs) -2 and MMP-9, which 
degrade the two major basement membrane components - collagen type IV and 
laminin(198,199). 
The majority of MMP activity exhibited by MSC is associated with the 
membrane/pericellular vicinity rather than on the secreted proteolytic factors(200). 
Importantly, MSC proteolytic activity experiences a complex regulation by the 
inflammatory cytokines present at the injury site that can further encourage their ability to 
invade into the damaged tissue. For instance, TGF-β1, IL-1β and TNF-α promote BM-
MSC recruitment through up-regulation of MMP-2, -9 MT1-MMP and TIMP 
metallopeptidase inhibitor (TIMP) -1 and -2. Similarly, IL-6 seems to do the same by 
increased expression of MMP-13 alone(180,200,201) while PDGF-BB modulates MSC 
migration by inducing a decrease on TIMP secretion, counterbalanced with an increased 
expression of MMP-2(200). Besides their MMP and TIMP secretion these cells were also 
found to activate proMMP-2 inactive form already present within the inflammatory milieu in 
a process that appears to involve TIMP-2 and MT1-MMP(180). Although SDF-1 can play an 
important role on MSC mobilization several studies suggest that this chemokine does not 
influence MMP/TIMP production by MSC and therefore their ability to degrade the 
basement membrane(201). 
1.5.1.6 Scaffold colonization by recruited MSC  
Upon arrival, MSC and other cells attracted by local inflammation should colonize the 
implanted engineered ECM that gaps the wound limits. It is important to notice that 
without cellular colonization of the implanted scaffold, little if any new tissue could be 
formed. Cell migration within such scaffolds is a critical process governing tissue 
integration. Thus, improved understanding on how matrix physico-chemical cues affect 
MSC behaviour led to the design of dynamic and multifunctional scaffolds with fine-tuned 
features to facilitate cell ingrown and to instruct MSC fate decisions upon scaffold 
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colonization. The colonization rate of the engineered matrix by endogenous MSC is highly 
dependent on the 3D architectural features of the porous scaffold, stiffness and cell-
material interactions(50) (Figure 3e).  
Implantation of highly porous scaffolds is desirable since it provides high surface area for 
cell-matrix interactions, which combined with increased pore interconnectivity facilitates 
cell adhesion, deposition of ECM elements and uniform cell migration within the implanted 
matrix(49). Importantly, the matrix pore size not only plays a major role in immune 
responses triggered but also on cell migration. Although the “optimal pore size range” may 
vary depending on the cell type and application, several reports state that pores within the 
range of 100-150 µm are adequate to support most mature cell ingrown(202-204). Surface 
chemistry and roughness are other features that can impact migration of cells. Differences 
in expression of focal adhesion components and Rho GTPases were found to be 
modulated by different surface chemistry which in turn enhanced endothelial cell migration 
in the order CH3>NH2>OH>COOH
(205). Similarly, MSC expression of cell-substrate and 
cell-cell adhesion proteins has been shown to be regulated by substrate roughness with 
consequences on cell spreading and migration (206,207). The understanding that most cells 
interact with the Arginine-Glycine-Aspartic acid (RGD) binding domains present in many of 
ECM proteins prompted the manufacture of biomaterials tailored with these small RGD 
peptide sequences to improve cell adhesion, proliferation and migration(208,209).     
Additionally, matrix stiffness and viscoelasticity can also have an important role on 
scaffold colonization since MSC can actively deform and re-arrange more compliant 
matrices to move directly through the ECM while in more resistive matrices degradation of 
the ECM components may be necessary for cell movement(50). These physical properties 
of the matrix not only influence cell migration but also MSC proliferation and 
differentiation. Human MSC have been shown to increase their proliferation rate with 
increasing substrate stiffness(210-212). Moreover, MSC tend to differentiate into the cell type 
relevant to the substrate stiffness on the long run(213). For instance, soft matrices that 
resemble soft brain tissue induce MSC differentiation into neuronal lineages, a 10 fold 
stiffer matrices promote myoblast differentiation while harder substrates that match 
cortical bone stiffness triggers osteogenic differentiation(214-218). Interestingly, in the 
absence of regenerative intervention, formed scar tissue stiffness following injury is 
usually 2 to 3 times higher than the native tissue where it is paved-down(219,220). Notably, 
fibrotic ECM properties have been shown to hinder MSC differentiation into the native 
tissue-specific cell type and thus contributing for poor healing outcomes (221,222).         
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Therefore, it is the biophysical properties of the material scaffold and how the cells interact 
that will influence the MSC phenotypic decisions and thus the healing outcome. 
1.5.1.6.1  Imaging MSC ability to integrate 3D bioengineered matrices 
Multiple features such as matrix porosity, pore size, surface chemistry and stiffness 
impact cells dynamical behaviour within engineered 3D matrices. Therefore, scaffold 
properties should be carefully optimized to facilitate MSC ingrowth upon recruitment. In 
this regard 3D cell-based tissue models have been increasingly useful(223,224). While the 
use and complexity of 3D models have advanced, there has been an increasing demand 
for methods to monitor and compare the MSC dynamical behaviour within distinct 
engineered matrices/models. Surprisingly, histology of fixed samples remains the “gold 
standard” technique for imaging tissue constructs to access cells ability to integrate the 
implanted matrix(225). Unfortunately, this requires destruction of the samples which limits 
longitudinal 3D assessment. Thus, non-destructive imaging technologies for live 3D 
analysis have been identified as a strategic priority in tissue engineering research, 
required to accelerate progress this field(226). To this end a number of live cell imaging 
techniques were developed for tissue engineering and regenerative medicine purposes, 
namely, Ultrasound (US), Resonance imaging (MRI), X-ray Imaging, Nuclear Imaging, 
Photoacoustic microscopy (PAM) and Optical imaging. Imaging techniques often display 
an intrinsic trade-off between spatial resolution and imaging depth/sensibility (Table 3). 
These features make US, MRI, X-ray and nuclear imaging techniques more suitable for in 
vivo applications and optical microscopy more promising for detailed in vitro monitoring of 
3D cell-scaffold interactions. To access advanced tissue-engineered constructs, versatile 
3D live cell imaging methods to monitor morphological and, more importantly, functional 
and molecular information are needed. Importantly each imaging method has a specific 
range of applications and provides distinct types of information. For in vitro 3D models, 
confocal imaging techniques are the most promising due to their high spatial resolution 
which enables visualization of sub-cellular features. The fact that a plethora of fluorescent 
probes are commercially available makes the ability to target specific sub-cellular 
structures/processes a powerful ally to interrogate cell morphology and function within 
engineered microenvironments. Moreover, since materials can exhibit inherent auto-
fluorescence this can be further exploited to image 3D structure of the matrix(227). Several 
studies illustrate confocal ability to track cell movement within engineered matrices and 
potential to interrogate how specific ECM features can be optimized to facilitate cell 
motility(228-231). However, such imaging platforms do not allow to follow MSC dynamical 
behaviour in these matrices for more than a couple of days due to photo-bleaching 
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constrains. Therefore, imaging methods with improved longitudinal perspective of MSC 
movement are required and will greatly benefit advances in biomaterial design. 
Although scaffold properties can have an important role in regeneration, other key 
environmental features must be considered for improving the healing outcome. These 
include the type of cells recruited to colonize the implanted scaffold and the inflammatory 
state encountered at the biomaterial-tissue interface. Importantly, each of these factors 
can be modulated by MSC mostly through secretion of an array of key chemokines and 
cytokines with tremendous impact on the regenerative microenvironment.  
  
 32 
Table 3 – Properties of imaging modalities for tissue engineering applications(225,226). 
Abbreviations: PLDL: poly(l-lactide-co-dl-lactide); PEG: poly(ethylene glycol); PLLA: 
poly(L-lactic acid); ECM: extracellular matrix; PEO: poly(ethylene oxide); PGA: 
polyglycolic acid; PLGA: poly(lactic-co-glycolic acid); POC: poly(1,8-octanediol-co-citrate); 
CG: collagen; HA: hyaluronic acid; CT: computed tomography; PET: positron emission 
tomography; SPECT: single-photon emission computed tomography.  
 
Imaging 
technique 
Endpoint 3D Scaffold 
Imaging 
resolution/
depth 
Real-
time? 
Markers 
(molecular 
imaging) 
Cost Refs. 
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/ 
P
re
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n
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a
l 
X-ray imaging 
(μ-CT) 
Changes in 
mineralization; 
Scaffold structure  
PLDL; 
Bioceramic 
scaffolds; 
PEG hydrogels 
5 μm / Full 
body 
No Poor Medium 
(232-
234)
 
Nuclear imaging 
(μ-PET; μ-
SPECT) 
Cell adhesion, 
metabolism; 
MSC tracking 
Bioceramic, chitosan 
and PLLA scaffolds; 
Decellularized ECM 
1-2 mm / Full 
body 
No Excellent High 
(235-
239)
 
μ-MRI 
Changes in ECM, 
MSC tracking  
PEO hydrogel; 
PGA/PLLA 
scaffolds; Cartilage 
tissue-constructs; 
pullulan/dextran 
scaffolds 
100-200 μm / 
Full body 
Yes Good High 
(240-
244)
 
μ-Ultrasound 
Changes in ECM 
content and 
stiffness 
PLGA scaffolds; 
Cartilage constructs; 
PEG hydrogels; 
POC scaffolds. 
20-100 μm / 
10 mm 
Yes Good Low 
(245-
248)
 
O
rg
a
n
s
 
O
p
ti
c
a
l 
m
ic
ro
s
c
o
p
y
 
Bioluminesce
nce 
Cell 
proliferation/surviv
al, hypoxia, 
MSC 
differentiation, 
tracking 
Matrigel; 
Decellularized 
matrix; bioceramic, 
chitosan and PLLA 
scaffolds; 
2-3 mm / 10 
mm 
Yes Excellent  Low 
(239,249-
253)
 
T
is
s
u
e
s
 
Photoacoustic 
microscopy 
Vascularisation; 
Cell distribution, 
invasion, tracking 
and proliferation; 
Scaffold structure  
Matrigel, Gelatin and 
PEGylated fibrin 
gels; PLGA scaffolds  
50-150 μm / 
20 mm  
Yes Good Medium 
(254-
258)
 
C
e
ll
s
 
Optical 
Coherence 
Tomography  
Cell metabolism, 
migration, 
proliferation and 
distribution; 
Scaffold structure 
PLLA, PLGA, 
calcium phosphate 
scaffolds; Matrigel 
and agarose 
hydrogels 
15 μm / 2-3 
mm 
Yes Good Low 
(259-
262)
 
M
o
le
c
u
le
s
 
Confocal 
microscopy 
(Fluorescence) 
Cell tracking and 
motility dynamics; 
Cell viability, 
invasion; 
Cytoskeleton 
dynamics; 
Molecule diffusion  
Matrigel; CG, PLGA, 
PEG, silk-fibroin, 
chitosan, scaffolds; 
Alginate- and HA- 
RGD hydrogels, 
Tissue engineered 
models 
0.2-1 μm / 
100-500 μm 
Yes Excellent Low 
(208,228-
231,263-
265)
 
  
 33 
1.5.1.7 MSC immunomodulatory and paracrine properties 
Upon arrival at the injury site, MSC encounter a rather hypoxic, pro-inflammatory 
microenvironment with extensive immune cell infiltration. Stimulation of MSC with pro-
inflammatory cytokines up-regulates the expression of a subset of toll-like receptors 
(TLRs) to grant MSC increased sensitivity to the damage/danger signals following 
injury(266). Moreover, during inflammation many DAMPs are released from necrotic cells 
which will trigger TLRs not just on immune cells but also on MSC at the injury site(267).  
MSC ability to sense and integrate many of these inflammatory signals allows them to 
adopt a pro-inflammatory (MSC1) or anti-inflammatory (MSC2) phenotype accordingly 
shaping their responses(268) (Figure 3f). Human BM-MSC have been reported to express 
all TLR1-10 with TLR3 and TLR4 having the highest expression(269). And recently, 
MSC1/MSC2 polarization based on TLR4/TLR3 priming has been proposed(145). This 
putative dual MSC phenotype relies on the presence of inflammatory cytokines together 
with specific danger signals that activate these cells TLRs at the injury site(270).  
During onset of acute inflammation, tissue-specific stem cells and early recruited MSC 
can actually help to mount and enhance the inflammatory response to boost host defence. 
In fact, low levels of IFN-γ, TNF-α together with activation of TLR4 signalling by 
exogenous bacterial LPS or endogenous HSP released from necrotic cells and fibronectin 
fragments from damaged ECM promotes a pro-inflammatory MSC1 phenotype. This 
triggers secretion of low levels of indoleamine (IDO), oxide nitric (NO) and PGE2 and high 
levels of pro-inflammatory cytokines as IFN-gamma-inducible protein 10 (IP-10), MIP-1α, 
MIP-1β and RANTES by MSC that can exacerbate inflammation through the recruitment 
of additional leukocytes to clear the injured area(268). Interestingly, several of these 
cytokines have also been reported as powerful inducers of MSC recruitment(121).   
When high levels of these pro-inflammatory cytokines are achieved and there is activation 
of TLR3 signalling, then MSC adopt an anti-inflammatory MSC2 profile. This renders MSC 
to secrete high levels of anti-inflammatory cytokines as IDO, IL-10, MCP-1 chemokine, 
TGF-β, tumor necrosis factor-inducible gene 6 protein (TSG6) and PGE2 that suppress 
immune cell responses counteracting the excessive inflammation. These paracrine factors 
can ameliorate the immune response by preventing the proliferation and function of a 
myriad of inflammatory cells including T cells, B cells, dendritic cells, NK cells, monocytes 
and macrophages(271,272). MSC2 can also induce IL-10 expression by monocytes and 
macrophages which in turn prevents neutrophils migration into the damaged tissue, 
avoiding further oxidative damage(273,274). Notably, prolonged stimulation with TLR ligands 
induces down-regulation of TLR2 and TLR4 on MSC, which constitutes another self-
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regulatory mechanism to prevent chronic inflammation and thus impaired healing(268,275). 
Importantly, the balance between these opposing pathways can therefore encourage host 
defence mechanisms at the beginning of acute inflammation while at the same time it 
creates a loop that prevents excessive inflammation later on to initiate tissue 
regeneration/repair mechanisms.  
Apart from shaping the immune responses and inflammation MSC-secreted bioactive 
molecules also play an important role in limiting damage and re-establishing the native 
tissue architecture following injury. For instance, many of the MSC-secreted molecules 
can rescue apoptotic cells due to traumatic hypoxia, acidic environments and mechanical 
injury. IGF-1 and IL-6 secretion by MSC increases protein kinase B (AKT), Wnt and factor 
nuclear kappa B (NF-κB) signalling in damaged cells which in turn can regulate the 
expression of B-cell lymphoma 2 (Bcl-2), B-cell lymphoma-extra large (Bcl-xL) and heat-
shock proteins that revert and limit cell apoptosis upon injury(276,277). Moreover, VEGF, 
hepatocyte growth factor (HGF) and TGF-β1 cytokines secreted by MSC can also revert 
hypoxia-related apoptosis of endothelial cells while at the same time these molecules are 
instrumental to promote angiogenesis and support tissue regeneration later on(278,279). 
A persistent and exacerbated inflammatory state is a pre-requisite for healing through 
fibrotic repair/scaring. Notably, it was found that MSC in implanted tissue constructs 
decrease the fibrous capsule thickness that circumvents the biomaterial(280,281). Therefore, 
MSC secreted molecules can inhibit excessive fibrosis both indirectly - by suppressing 
immune responses and damping the inflammatory state - and directly through modulation 
of myofibroblasts ECM protein deposition rate. Indeed, MSC can secrete molecules as IL-
10, TNF-α, HGF and PGE2 that have been shown to inhibit collagen synthesis and 
proliferation of fibroblast like cells(282-285).  
 
Fibroblasts are a heterogeneous population of stromal cells characterized by their spindle 
shape morphology and plastic adherence. Although no universal fibroblast marker exists 
to identify this population they are reported to lack hematopoietic and endothelial lineage 
markers(125) (Table 2). Fibroblasts have an important role in the structural maintenance of 
ECM through production and secretion of all ECM components including structural 
proteins (fibrous collagens and elastin), adhesive proteins (laminin and fibronectin) and 
ground substance (glycosaminoglycans)(129). This property combined with their ability to 
remodel the ECM, respond and secrete a broad range of pro-inflammatory cytokines, 
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chemokines and growth factors during injury makes them a key player on tissue repair, 
pathological fibrosis and foreign body reactions(286).  
1.5.2.1 Fibroblast recruitment and activation during inflammation 
The array of inflammatory cytokines and chemokines produced upon injury by immune 
cells promotes recruitment of many cell types to the injury site to initiate healing, including 
fibroblasts. Fibroblasts main role upon recruitment is to replace and remodel the blood clot 
provisional matrix with collagen and other ECM components(287). Despite the fact that 
resident stromal fibroblasts seem to be the most significant cell source for the fibrotic 
response, they can originate from a variety of precursor cells and are not terminally 
differentiated cells. Following injury, TGF-β1, TNF-α, IL-1β, IL-6, IL-8 and PDGF are 
among the cytokines that are normally encountered within the inflammatory milieu that 
can drive the development of a fibrotic response(287) (Figure 4). Fibroblast activation by 
these inflammatory signals promotes their migration, proliferation and differentiation into 
myofibroblasts(288). Fibroblast differentiation renders increased responsiveness to 
inflammatory stimuli, exaggerated ECM component synthesis and a constitutive pro-
inflammatory cytokine secretion. Among these cytokines are MCP-1, MIP-1α, MIP-1β, 
RANTES and IP-10 which can have an important role in the recruitment of more 
inflammatory cells(289). Together, these features endow them the ability to assist on 
biomaterials fibrotic encapsulation and simultaneously promote the recruitment and 
activation of more immune cells towards the implant site, exacerbating inflammation(59).  
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Figure 4 - Overview of the factors involved in profibrotic myofibroblast phenotype 
that mediate the fibrotic encapsulation of implanted scaffold (green mesh). 
Macrophage polarization into pro-inflammatory (M1) or wound-healing (M2wound) 
phenotypes impacts secretion of IL-1β, IL6 and PDGF and production of ROS, which 
drives fibroblast activation and differentiation into myofibroblasts. This, in turn perpetuates 
the inflammatory environment and mediates fibrotic encapsulation of the implant. On the 
other hand, mobilized MSC secrete HGF, PGE2 and IL-10 that drive macrophage 
polarization into the M2 regulatory phenotype to synergistically resolve inflammation and 
inhibit excessive deposition of ECM components by fibroblasts. 
1.5.2.2 Chronic inflammation and fibrotic encapsulation 
Continuous activation of recruited immune cells due to prolonged presence of a foreign 
body (regenerative scaffold) leads to a chronic inflammation state which deregulates the 
normal course of healing. This pro-inflammatory environment maintains a positive 
feedback loop that perpetuates inflammation and consequently drives fibrotic 
encapsulation of the implanted scaffold. In turn, activated fibroblasts secrete molecules as 
IL-1β, IL-6, TGF-β that sustain inflammation and can act in an autocrine fashion to further 
enhance their own fibrotic activity(287,290). 
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Although fibrotic tissue production immediately after injury can limit the damage it is an 
inappropriate environment for regeneration over the long term. Excessive deposition of 
ECM components at the biomaterial-tissue interface results in a thick and dense fibrotic 
capsule circumventing the biomaterial. This rather hypo -cellular and -vascular fibrotic 
region composed by highly crosslinked collagen type I and III fibbers isolates the 
regenerative scaffold from host’s cells, severely compromising their colonization by 
endogenous MSC and consequently scaffold-guided tissue regeneration.   
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Rationale & thesis aims 
In situ tissue engineering approaches rely on the use of scaffolds designed to stimulate 
endogenous healing mechanisms, which intimately involves the immune system. While 
the beneficial aspects of the immune response, namely debris clearance and progenitor 
cell recruitment, initiate healing, their potentially damaging effects, due to excessive 
inflammation followed by fibrotic encapsulation of a biomaterial should be minimized for a 
successful regeneration. Consequently, two independent research lines are currently 
being pursued with significant effects on scaffold integration and remodelling. These are 
based on the implantation of scaffolds designed to (i) enhance the recruitment of 
endogenous MSC or to (ii) ameliorate the foreign body reaction and fibrotic encapsulation.  
As an alternative, I propose that scaffolds should be designed to modulate inflammation 
as a mean of controlling the type of regenerative/fibrotic cells mobilized towards the 
implanted material. However, the potential of the immune cell populations to promote 
stem cell and/or fibroblast recruitment, upon interaction with distinct 3D biomaterials, 
remains largely uncharacterized.  
Hypothesis and goal 
Here I explore the idea that biomaterials can modulate the immune response to control 
the recruitment and motility of specific stromal cell types, pivotal to determine the 
likelihood of tissue regeneration/fibrosis.  
To test the aforementioned hypothesis, experiments were conducted in a 3D model with 
multiple scaffolds and cell types. Within this framework, the main objective of this work is 
to provide a comprehensive analysis on the impact of primary human immune responses, 
triggered by distinct 3D scaffold models, on primary human bone-marrow MSC and 
fibroblasts recruitment. The specific aims of this thesis are as follows: 
Specific aims 
1. Develop a bioimaging platform to characterize MSC dynamical behaviour 
within 3D engineered matrices.   
Upon scaffold implantation, mobilized MSC need to move through distinct 3D 
environments to colonize the engineered scaffold. Nevertheless, there is a scarcity of 
imaging tools to access and longitudinally monitor MSC dynamical behaviour within such 
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3D microenvironments. This has been identified as a strategic priority to accelerate 
progress in the tissue engineering and regenerative medicine field(291).  
Therefore, in Chapter 2 I describe the development and characterization of a novel 
imaging tool that takes advantage of the photoswitchable Dendra2 protein to directly 
compare MSC migration within distinct 3D engineered matrices over long periods of time. 
2. Profile which immune cell populations promote MSC recruitment upon 
interaction with distinct 3D biomaterial models. 
Once developed the needed technology to monitor MSC motility within 3D engineered 
matrices, I sought to establish a link between the immune responses triggered by different 
3D biomaterial models and their predisposition to mobilize endogenous MSC towards the 
implanted material.  
Accordingly, in Chapter 3, the responses elicited by interactions of PBMCs, NK cells, 
monocytes and macrophages with 3D scaffolds were first characterized. Then, the ability 
of those responses to promote bone-marrow MSC invasion towards the implanted 
scaffolds was directly compared. Additionally, this characterization made use of the 
Dendra2 imaging platform, developed in Chapter 2, in order to analyse whether the 
immune responses could also modulate the scaffolds colonization rate by the recruited 
MSC. 
3. Map which immune cell populations induce fibroblast mobilization upon 
interaction with distinct 3D scaffold models. 
Recently, the extent of fibrocytic cell recruitment towards the implant site was correlated 
with a poor healing outcome(292). Indeed fibroblasts are one of the major contributors for 
the biomaterials fibrotic encapsulation observed following foreign body response to 
implanted materials.  
Thus, in Chapter 4, I sought to clarify which type of immune responses and which 
biomaterials promoted the highest fibroblast mobilization. 
4. Develop a 3-cell platform to screen how the immune responses triggered 
by model 3D biomaterials regulate the recruitment of stromal cells. 
In a physiologic environment, several cell types will reciprocally influence each other 
behaviour. For example, recruited MSC and fibroblasts compete for the chemokines 
and/or growth factors produced by the immune cells reacting to the implanted 
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biomaterials. Thus in Chapter 4, a 3-cell platform was developed to investigate whether 
those biomaterial-evoked immune responses promoted the competitive recruitment of one 
specific stromal cell type in detriment of another. Also, MSC at the implant site have been 
suggested to decrease biomaterials fibrotic encapsulation and improve the regenerative 
outcome(280). Thus, I sought to investigate the consequence of endogenous MSC arrival 
and interaction with immune cells at the implant site on the recruitment of fibroblasts.  
Finally, this thesis closes with a general discussion on the data gathered (Chapter 5), 
integrating the knowledge from preceding chapters, and highlights the challenges that 
should be addressed for the development of next generation immunomodulatory 
scaffolds.  
It is expected that this work provides one of the first steps towards defining rules for the 
creation of biomaterials that trigger the desired immunological pathways for enhanced 
stem cell recruitment in detriment of pro-fibrotic cell types.  
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“DA NOSSA SEMELHANÇA COM OS DEUSES 
 
Da nossa semelhança com os deuses 
Por nosso bem tiremos 
Julgarmo-nos deidades exiladas 
E possuindo a Vida 
Por uma autoridade primitiva 
E coeva de Jove. 
 
Altivamente donos de nós-mesmos, 
Usemos a existência 
Como a vila que os deuses nos concedem 
Para esquecer o Estio. 
 
Não de outra forma mais apoquentada 
Nos vale o esforço usarmos 
A existência indecisa e afluente 
Fatal do rio escuro. 
 
Como acima dos deuses o Destino 
É calmo e inexorável, 
Acima de nós-mesmos construamos 
Um fado voluntário 
Que quando nos oprima nós sejamos 
Esse que nos oprime, 
E quando entremos pela noite dentro 
Por nosso pé entremos.” 
 
30-7-1914 
Odes de Ricardo Reis . Fernando Pessoa. Lisboa: Ática, 1946 (imp.1994).  - 40.  
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2.1 Abstract 
Mesenchymal Stem/Stromal Cells (MSC) are a promising cell type for cell-based 
therapies - from tissue regeneration to treatment of autoimmune diseases - due to their 
capacity to migrate to damaged tissues, to differentiate in different lineages and to their 
immunomodulatory and paracrine properties. Here, a simple and reliable imaging 
technique was developed to study MSC dynamical behaviour in natural and 
bioengineered 3D matrices. Human MSC were transfected to express a fluorescent 
photoswitchable protein, Dendra2, which was used to stably highlight and follow the same 
group of cells for more than seven days, even if removed from the microscope to the 
incubator. This strategy provided reliable tracking in 3D microenvironments with different 
properties, including the hydrogels Matrigel and alginate as well as chitosan porous 
scaffolds. Comparison of cells motility within matrices with tuned physicochemical 
properties revealed that MSC embedded in Matrigel migrated 64% more with 5.2 mg 
protein/mL than with 9.6 mg/mL and that MSC embedded in RGD-alginate migrated 51% 
faster with 1% polymer concentration than in 2% RGD-alginate. This platform thus 
provides a straightforward approach to characterize MSC dynamics in 3D and has 
applications in the field of stem cell biology and for the development of biomaterials for 
tissue regeneration. 
Keywords: Matrigel; RGD-Alginate; Chitosan; Dendra2; 3D imaging; Human MSC  
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2.2 Introduction 
MSC are an attractive cell source for regenerative cell-based therapies due to its well 
established multipotency, immunomodulatory and paracrine properties, combined with 
their ability to migrate into damaged tissues. Most strategies being currently explored 
involve either stem cell transplantation to patients(1), implantation of the triad 
scaffolds/stem cells/growth factors(2,3), or the use of materials that stimulate endogenous 
stem cell recruitment(4). Regardless of the approach, to improve the effectiveness of such 
applications it is critical to understand the determinants of stem cell migration in 3D 
microenvironments.  
Despite the worldwide effort to modulate and direct stem cell fate for tissue regeneration, 
the influence of 3D extracellular matrix (ECM) features on MSC motility still remains 
largely unknown. A tool to longitudinally follow MSC in 3D is essential to better understand 
cell migration and organization in 3D microenvironments. To this end, a number of cell 
labelling techniques have been developed. Some studies have suggested that cell 
transfection with fluorescent proteins(5-7) will be required for long term cell tracking and 
others are pursuing magnetic nanoparticles(8), bioluminescent probes(9-11), quantum 
dots(12,13) and radioactive isotope alternatives(14) for stem cell labelling.  
Most of these bioimaging techniques are well established but are more oriented to localize 
the final homing site of transplanted cells or to roughly quantify cell survival after 
implantation, being rather limited for studying the effect of cell-ECM interactions on MSC 
dynamical behaviour. There are some reports on the use of fluorescent proteins or dyes to 
track stem cells, but most use labelling in order to find the cells at one fixed time point and 
not to follow them by time-lapse analysis(6,15). As MSC are slowly moving cells when in 3D, 
tracing the same cells through time requires imaging performed for several days and it is 
usually not feasible to keep the cells under the microscope for long periods. Apart from 
unpractical to perform continuous 3D live cell imaging for more than a day, the increased 
probability of photo-damaging cells or photobleach the fluorophore over time is often the 
limiting factor. When imaging cells at discrete daily intervals, it is extremely difficult to find 
exactly the same cells that were being imaged(16). Thus, studies aiming to compare the 
dynamic MSC behaviour within distinct 3D microenvironments would benefit from new 
bioimaging tools that allow finding and tracing the same cells over long periods of time.  
A class of fluorescent proteins that can change irreversibly the emission fluorescence 
spectrum upon laser excitation offers a promising and flexible opportunity for solving this 
problem(17,18). With these fluorescent photoconvertible proteins, it is possible to create a 
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reference by selecting and photo-marking cells of interest in precisely defined positions, 
which will then be easier to track with no mistaken identity issues. It has been shown that 
photoswitchable or photoconvertible proteins can indeed be applied to accurately track a 
discrete sub-population of tumor cells even with imaging sessions spaced over days(19,20). 
Dendra2 is such a photoswitchable protein, with a fluorescence spectrum similar to Green 
Fluorescent Protein (GFP), but that upon exposure to blue light (e.g., 405 nm) suffers an 
irreversible shift to red (>150 nm). Dendra2 is highly photostable after switching to its red 
form, and some of the advantages compared with other photoswitchable proteins are: its 
predominant monomeric form (generating less aggregates than tetrameric proteins); the 
fact that it forms a completely functional chromophore at 37ºC, and its great brightness in 
relation to other photoconvertible proteins(21,22). 
Here, Dendra2+ human bone marrow MSC were generated and characterized, and the 
influence of optimized photoconversion on MSC properties was analyzed. Finally, the 
feasibility and flexibility of Dendra2 imaging to quantify MSC dynamics in distinct 3D 
environments was verified. A tool to investigate and compare the dynamical behaviour of 
MSC in bioengineered materials was thus developed.  
2.3 Results 
2.3.1 Transfection of human MSC to express the photoswitchable protein Dendra2 
To follow living MSC in 3D for long periods of time it is vital to develop a strategy that 
allows imaging of the same cells at different time-points. Here, human bone marrow MSC 
were transfected to express a photoswitchable fluorescent protein, Dendra2, which 
enables green-to-red photo-conversion of labelled MSC, and subsequently highlighting 
and tracking the same group of cells over long time periods. Transfection of MSC by 
electroporation yielded more than 80% of cells expressing Dendra2 protein, with most 
cells expressing high levels of this fluorescent protein (Figure 1a, b). Transfection with the 
pDendra2 plasmid did not affect cell number or metabolic activity of MSC, which remained 
constant for up to eight days, when comparing with cells electroporated in the absence of 
a plasmid. However, electroporation in itself affected the kinetics of both the cell number 
and metabolism (Figure 1c, d). Importantly, almost 70% of the transfected cell population 
still expressed Dendra2 ten days after transfection (Figure 1e, f). Additionally, MSC 
morphology was not affected by transfection; transfected MSC started to exhibit an 
elongated spindle shape after ten days due to extended cell culture time (Figure 1f). 
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Figure 1. Transfection of human MSC to express Dendra2. (a) Flow cytometry 
histogram showing the fluorescence intensity of control (grey, filled) and transfected 
(open) MSC two days after electroporation. Data is representative of 3 experiments. (b) 
The percentage of Dendra2+ MSC upon electroporation was measured by flow cytometry. 
Graphs show mean ± SEM of three experiments.*, p > 0.05 by Mann-Whitney test. (c) 
Growth curve of MSC over a period of 8 days after an initial seeding of 6,000 cells/cm2. 
Number of cells was determined by trypan blue exclusion. Graph shows mean ± SEM of 
three experiments. **, p > 0.01 and ***, p > 0.001 by two-way ANOVA with Bonferroni 
post-test for comparison with control group. (d) Relative fluorescence unit (RFU) as a 
measure of metabolic activity determined by resazurin assays. Graph shows mean ± SEM 
of four experiments. Differences are not statistically significant, two-way ANOVA with 
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Bonferroni post-test for comparison with control group. (e) The percentage of Dendra2+ 
cells was determined 10 days after transfection by flow cytometry. Graphs show mean ± 
SEM of three experiments.*, p > 0.05 by Mann-Whitney test. (f) Fluorescence microscopy 
images of transfected cells 4, 6 and 10 days after electroporation. Scale bar, 250 µm. 
2.3.2 Characterization of Dendra2+ MSC  
In order to analyze whether Dendra2 expression affected MSC properties, we firstly 
analyzed the expression profile of MSC-related cell surface antigens. MSC were 
electroporated to obtain a mixed population with Dendra2 positive and negative cells, to 
correlate with expression of the surface markers. Importantly, neither electroporation nor 
Dendra2 expression influenced surface marker expression, with more than 90-95% of 
cells being positive for CD73, CD90 and CD105 and negative for CD14, CD19, CD34, 
CD45, HLA-DR  (Figure 2a). 
To test whether Dendra2 transfection affects MSC differentiation capacity, control and 
transfected cells were induced into osteogenic and adipogenic differentiation. Both 
transfected and control cells were able to differentiate when cultured under osteogenic or 
adipogenic stimuli but not under basal condition, as detected by Alkaline Phosphatase 
activity (ALP), von Kossa and oil red O stainings (Supplementary Figure S1a, b). 
Furthermore, both Dendra2+ and Dendra2- MSC could be visualized by fluorescence 
microscopy to express ALP and stain with oil red O under the appropriate stimuli 
(Supplementary Figure S1c). Moreover, the percentage of ALP+ MSC increased after 
culture with osteogenic stimuli for 7 days both on Dendra2+ and Dendra2- cells (Figure 
2b, c). Thus, Dendra2 expression did not interfere with either MSC surface marker 
expression nor MSC differentiation capacity.  
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Figure 2. Dendra2 expression does not interfere with MSC properties. (a) Flow 
cytometry histograms showing expression of CD14, CD19, CD34, CD45, HLA-DR, CD73, 
CD90 and CD105 by control (grey filled) and transfected (Dendra2+, solid line; Dendra2-, 
dashed line). Isotype control is displayed as the grey line. Numbers indicate the 
percentage of cells in each gate for the Dendra2+ cells. Figure is representative of three 
experiments. (b) Representative flow cytometry dot plots showing ALP surface staining on 
control or transfected MSC cultured under basal or osteogenic medium for 7 days (n=3). 
(c) Fold increase of the percentage of ALP+ cells in Dendra2+ and Dendra2- MSC 
cultured in osteogenic conditions for 7 days, in relation to cells cultured in basal medium 
(n=3). Each dot represents data from one experiment and bars represent the mean. 
Differences are not statistically significant, Friedman test with Dunns post-test 
comparison.   
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2.3.3 Efficient Photoswitching of Dendra2 protein expressed by MSC 
Maximized photoconversion efficiency should result in enhanced signal-to-noise ratio of 
photo-marked MSC and therefore in improved imaging quality and extended tracking time. 
Excitation at 488 nm with high power could lead to photoconversion but using a 405 nm 
laser was much more efficient. Hence, parameters were optimized for efficient 
photoconversion with a 405 nm laser in a region of interest (ROI), without complete 
fluorescence bleaching and without photoconverting nearby cells (Figure 3a, b). To 
determine the optimal conditions for Dendra2 green-to-red photoconversion, we 
incrementally increased laser power and tested different numbers of iterations (Figure 3c). 
Laser power below 15% was insufficient for noticeable photoconversion. Efficient 
photoconversion was achieved using 60-70% of laser power with 60 iterations, which 
allowed obtaining an intense red signal to track MSC for an extended time (Figure 3d). UV 
irradiation with these optimized settings did not affect cells metabolic activity, indicating 
that it was not cytotoxic (Figure 3e). Photoconversion could also be achieved at the 
subcellular level (Supplementary Figure S2). 
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Figure 3. Photoswitching Dendra2 protein expressed by MSC. (a) Confocal 
microscopy images in green, red and merged channels of Dendra2+ MSC taken before 
(top) and after (bottom) irradiation with a 405 nm laser. Photoconversion was achieved by 
laser irradiation of a square region of interest (ROI) targeting a selected cell population 
(dashed line). Scale bar, 250 µm. (b) Green-to-red conversion did not induce 
photoconversion of cells located outside the defined ROI. Fluorescence intensity in each 
channel was measured and normalized relatively to the fluorescence intensity in the green 
channel before conversion. (c) The laser power and number of iterations affected 
photoconversion efficiency of Dendra2 on MSC. (b) and (c) Mean ± SEM of normalized 
fluorescence units (n=3 experiments, 3 cells analyzed in each). (d) Confocal microscopy 
images (merged green and red channels) of Dendra2 expressing MSC taken after 
irradiation. Green-to-red conversion for a selected group of cells was achieved at time-
point zero and used to track this group of cells for 7 days after conversion. Scale bar, 250 
µm. (e) Relative fluorescence units (RFU) as a measure of metabolic activity of Dendra2 
Green and Dendra2 Red MSC, determined 2, 4 and 8 days after an initial seeding of 
6,000 cells/cm2. Photoconversion was performed at day 2. Each dot represents data of 
one individual experiment, lines represent the mean. Differences are not statistically 
significant, two-way ANOVA with Bonferroni post-test. 
2.3.4 Migration of Dendra2+ MSC in 2D  
To examine the ability of Dendra2+ MSC to migrate, time-lapse microscopy of an in vitro 
wound healing assay was performed (Figure 4). MSC migrated using lamellipodia mode 
with visible cell extensions and rear body retraction. Cells motility was oriented towards 
the centre of the wound with a similar directness index for all groups (Figure 4b). 
However, the velocity of MSC showed some differences: control cells migrated at 0.33 ± 
0.15 µm/min, electroporated cells without pDNA at 0.35 ± 0.16 µm/min, transfected green 
cells at 0.23 ± 0.09 µm/min and photoswitched red cells at 0.20 ± 0.07 µm/min (Figure 4c). 
Therefore, even though transfected cells moved slightly slower than control cells, 
photoswitching did not interfere with the cells velocity. 
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Figure 4. Migration of Dendra2+ MSC in 2D. (a) Representative images of in vitro 
wound healing time-lapse microscopy at time-points 0 (top) and 16.5 hrs (bottom) post 
wound. Dashed lines represent the migrating front and arrows show Dendra2-, Dendra2+ 
Green and Dendra2+ Red cells. Scale bar, 250 µm. (b) Directness index and (c) migration 
velocity were determined for Control, Electroporated (without plasmid), Dendra2 Green 
and Red single cells (n=4). Only cells initially at the migrating front were analyzed. ***, p > 
0.001, linear mixed model.  
2.3.5 Tracking Migration of MSC in different 3D matrices 
To assess the feasibility of this tool to analyze MSC dynamics in 3D, experiments were 
performed in microenvironments with distinct properties, including the hydrogels Matrigel 
and alginate as well as chitosan porous scaffolds. Transfected MSC were embedded in 
the hydrogels or seeded on top of chitosan scaffolds and tracked for up to seven days. It 
was possible to photoconvert cells, enabling finding and imaging the same cells at 
discrete daily intervals, after placing them in the 37ºC/CO2 incubator instead of leaving 
them for 7 days under the microscope. Thus it was possible to trace photoconverted cells 
over extended periods of cell culture, and to compare MSC motility in different matrices 
(Figure 5). Labelling cells with a fluorescent protein such as GFP would not allow tracing 
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the same cells over these long periods of time, as evident when cells were imaged only at 
the green channel (Supplementary Figure S3). Approximately 400-500 µm in depth were 
effectively imaged for Matrigel and RGD-alginate hydrogels and approximately 100 µm for 
chitosan scaffolds due to lower light penetration properties of the later. To avoid any 
inaccuracy related with photoconversion in stiffer/opaque materials, which may derive 
from laser scattering, data was normalized to the photoconverted area at time-point zero. 
Unwanted photoconversion due to routine imaging with low power 488 / 561 nm lasers 
was not observed over the time points imaged. 
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Figure 5. MSC motility in 3D microenvironments. (a) Representative maximum 
projection images of cells in Matrigel, RGD-alginate and Chitosan matrices obtained over 
a period of 7 days (first four columns in xy; right column in xz). Cell migration can be 
determined by the increasing infiltration area over time in maximum projection images. 
White dotted square line represents the photoconverted area at time-point zero. Scale 
bar, 250 µm. The infiltration area at time-points 1, 4 and 7 days was normalized to time-
point zero, for cells in (b) Matrigel (5.2 or 9.6 mg/mL), (c) RGD-alginate (1% or 2%) 
hydrogels or in (d) Chitosan scaffolds. **, p > 0.01 and ***, p > 0.001 by linear mixed 
model. 
 
This approach could be used to discriminate differences in MSC dynamics in 3D matrices 
with tuned physicochemical properties. Dendra2+ MSC were embedded in Matrigel with a 
protein content of 5.2 mg/mL and 9.6 mg/mL or in RGD-alginate at 1% and 2% (wt) 
polymer concentration. Then, a square region was photoswitched and the population was 
traced over a period of seven days. In Matrigel, MSC were able to migrate 64% more at 
5.2 mg/mL than at 9.6 mg/mL (Figure 5). Moreover, Matrigel 5.2 mg/mL favoured a more 
elongated morphology than cells embedded in Matrigel 9.6 mg/mL (Figure 6a,d). In RGD-
alginate, MSC embedded in a 1% polymer concentration migrated 51% more than in 2% 
concentration after seven days of incubation (Figure 5c), with more elongated and 
clustered cells in 1% RGD-alginate (Figure 6b,e). Interestingly, cells seeded in the much 
different chitosan scaffolds showed an infiltration area similar to Matrigel 5.2 mg/mL and 
RGD-alginate 1% hydrogels at day 7, even though the increase in infiltration area was 
higher for early time points. MSC in chitosan scaffolds were the most elongated for all 
time-points (Figure 6c,f). MSC embedded in Matrigel 9.6 mg/mL, 1% and 2% RGD-
alginate but not in Matrigel 5.2 mg/mL or chitosan matrices displayed a statistically 
significant trend to decrease cell sphericity over time. In summary, Dendra2 
photoswitching in MSC allowed analysis of the cells morphology and quantification of 
MSC motility in different 3D microenvironments. 
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Figure 6. Dendra2+ MSC morphology in 3D microenvironments. Representative 
merged bright-field and fluorescence images of cells when embedded in (a) Matrigel (5.2 
or 9.6 mg/mL), (b) RGD-alginate (1% or 2%) hydrogels or seeded in (c) Chitosan scaffolds 
at day eight. Scale bar, 100 µm. Cells sphericity for (d) Matrigel, (e) RGD-alginate and (f) 
Chitosan was determined throughout 7 days. Data are mean ± SEM of more than 150 
cells per time point (3 experiments). *, p > 0.05 and ***, p > 0.001 by linear mixed model. 
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2.4 Discussion 
Here we describe an imaging tool to follow the dynamical behavior of human MSC in 
complex 3D microenvironments. The idea behind this method is to photo-mark Dendra2+ 
MSC in precisely defined positions, being then able to follow the same group of cells for 
long periods of time.   
High transfection efficiency with minimal loss of Dendra2 expression after ten days was 
achieved by electroporation. Analysis of cell number suggests that there is equilibrium 
between proliferation and cell death in electroporated cells, an effect that was not affected 
by Dendra2 protein expression. Electroporation in itself (without any plasmid) affected the 
proliferation of these slowly dividing cells, whose number remained constant over time. 
However, the metabolic activity of the cells does not show statistically significant 
differences, indicating that the cells are alive and probably recovering from the 
electroporation. These data highlights the need that future studies involving Dendra2 
transfection, which may be used to study the role of other proteins, also perform these 
controls. A diminished cell proliferation rate due to electroporation is a limitation of this 
technology, but at the same time it avoids the problem of signal loss due to fluorescence 
signal dilution to daughter cells which could limit cell tracking to a couple of days or less 
depending on the cells proliferation rate(23,24).  
Nevertheless, others report that electroporation does not influence cell proliferation, and 
therefore this effect could be related to MSC donor used. Photo-marked red cells could be 
clearly distinguished from the green non-converted cells and exhibited a 3-fold increase in 
red fluorescence. This increase in red fluorescence intensity was coupled with a decrease 
in green fluorescence intensity, consistent with conversion of both the green and neutral 
forms of Dendra2 into the red form(21,22,25). Photoswitching did not lead to diminished 
metabolic activity, suggesting that it was not cytotoxic. Also, cells could be tracked for at 
least seven days, indicating that the degradation rate of Dendra2 red form is low. 
Importantly, photoconversion only targeted cells inside a pre-defined ROI, with minimal 
photoconversion occurring outside the ROI. Photoswitching did not adversely affect MSC 
properties, nor the cells migration directionality and velocity. As transfection affected MSC 
motility, this tool does not allow quantification of the cells speed but it allows the 
comparison of the dynamic behaviour when cells are subjected to different treatments or 
microenvironments. 
To analyze whether Dendra2 imaging allows detection of changes in MSC dynamics in 
3D, we compared MSC migration in Matrigel, RGD-alginate hydrogels and in porous 
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chitosan scaffolds. Matrigel is a reconstituted basement membrane widely used to study 
cellular invasion and interactions with the basement membrane. Cells embedded in 
diluted Matrigel 5.2 mg/mL migrated more than in Matrigel 9.6 mg/mL matrices. Also, cells 
in diluted Matrigel adopted a more elongated shape, which is usually associated with 
increased cell migration. The slower migration in denser Matrigel matrix could be 
explained by the tighter mesh size, the increased gel stiffness, the lower diffusion of 
soluble factors from culture medium and/or sub-optimal adhesion ligand density(26). 
Alginate is a natural hydrogel forming polysaccharide that can be tailored with specific 
biofunctional moieties to modulate cell behaviour and thus is currently being widely 
explored for tissue engineering(27,28). A higher motility in 1% as compared with RGD-
alginate 2% was seen after seven days of culture. Here, cell motility probably depends 
more on gel stiffness than on pore size, as cells are embedded and need to rearrange the 
mesh to create the physical space to move inside this matrix. Furthermore, mechano-
sensing molecules can modulate cytoskeleton organization, which affects migration mode 
and speed(29-32).          
To further demonstrate the usefulness of this method in biomaterials where cells are 
seeded on top instead of embedded inside, MSC dynamical behaviour was analyzed in 
porous chitosan scaffolds. Chitosan is a natural biodegradable polysaccharide obtained 
by N-deacetylation of chitin, currently being explored for many applications, from bone 
repair to gene therapy, amongst others. In chitosan scaffolds cells exhibited an elongated 
morphology through seven days of imaging possibly due to the high porosity and large 
pore size (larger pores and smaller interconnecting pores measure on average 147 µm 
and 58 µm in diameter(33,34)). On the other hand, the lack of physical constrain can impact 
negatively on cells migration velocity, as less adhesion sites could be available to support 
an efficient cell movement. Cells could be seen to migrate, with an infiltrated area similar 
to the values obtained for Matrigel 5.2 mg/mL and RGD-alginate 1% after seven days of 
incubation.  
 Applying this tool to access the behaviour of the cells in different materials revealed some 
of the issues that may arise when dealing with matrices with varied optical properties. 
Indeed, the more opaque chitosan allowed imaging a smaller depth and led to some light 
scattering when photoswitching was performed. In was possible to overcome this by 
normalizing data to the photoconverted area at time-point zero. Table 1 compares some 
characteristics of the analysed scaffolds, as well as differences in the imaging strategies 
and the cellular behaviour in the 3D matrices.  
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In summary, a tool that takes advantage of the photoswitchable Dendra2 was developed 
to characterize and compare MSC migration in distinct 3D microenvironments. Applying 
photoconvertible proteins has clear advantages to trace cells in 3D when comparing with 
fluorescent dyes or proteins such as GFP (Table 2).  Importantly, this method allowed 
quantification of differences in cell migration in bioengineered matrices with fine-tuned 
physicochemical modifications. Furthermore, it also allowed coupling cell morphology 
analysis with quantification of cell migration in real-time, to study cell-ECM interactions. 
This method provides reliable tracking over at least seven days with an easy and 
straightforward analysis of cell migration using open source software. Thus, this novel 
platform to characterize MSC dynamics in matrices will likely have an important role in the 
development of biomaterials with improved characteristics for stem cell recruitment and 
migration or even for the study of stem cell biology in 3D microenvironments. 
Table 1 - Comparison of scaffold characteristics, imaging strategies and MSC 
behaviour in 3D Matrigel. 
 
 
 
 
 
 
 
 
 
 
 
 
 83 
Table 2 - Key characteristics of using photoconvertible or fluorescent proteins to 
label and quantify cell motility in 3D matrices over long periods of time *Brightness 
is calculated as a product of molar extinction coefficient (EC) and fluorescence quantum 
yield (QY) in mM•cm−1. 
 
2.5 Materials & Methods 
2.5.1 Cells 
Human bone marrow MSC (purchased from Lonza) were cultured in MSC growth medium 
(DMEM with low glucose and Glutamax plus 10% selected inactivated FBS and 1% 
penicillin/streptomycin (all from Invitrogen)). Cells were incubated at 37ºC/5% (V/V) CO2 
and medium was changed twice per week until cells reached approximately 80% 
confluence. For expansion, cells were detached by treatment with 0.05% trypsin/EDTA 
(Invitrogen) and replaced in 150 cm2 tissue culture flasks (BD Falcon). Cells were used at 
passages 6-10.  
2.5.2 MSC transfection 
MSC were ressuspended in OptiMEM (Invitrogen) at 1.25 x106 cells/mL. Then, 200 µl of 
cell suspension were transferred to a 4 mm electroporation cuvette (BioRad), mixed with 
60 µg Dendra2 plasmid DNA (pDendra2, Clontech) per 1x106 cells and electroporated 
using a X-Cell Gene Pulser (BioRad). For optimal cell electroporation, an exponential 
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pulse protocol was used with 250V, 950 uF and 200 Ω(35). After electroporation, cells were 
cultured in MSC growth medium at 37ºC/5%CO2. After 16-18 hrs, medium was changed 
to remove debris and dead cells. Cells were incubated for 48 hrs to allow Dendra2 
expression. Electroporation was performed with 200 µl of cell suspension for all 
experiments except for surface marker expression and 2D motility analysis, where 500 µl 
were used to obtained an evenly proportion of Dendra2+ and Dendra2- cells.  
To determine transfection efficiency, the percentage of Dendra2+ cells was determined 48 
hrs after electroporation by flow cytometry (FACSCalibur, Becton Dickinson) and analysis 
with FlowJo software. 
2.5.3 Cell number, metabolic activity, and morphology 
Cells were seeded in triplicate at 6,000 cells/cm2 in 24 well plates and metabolic activity 
was assessed as described(36). To analyze the effects of photoconversion on cells 
metabolic activity, photoswitching was performed 2 days after transfection. To estimate 
cell number, three wells for each condition were analyzed by trypan blue exclusion. 
Morphology was visualized by confocal microscopy (Leica TCS SP5 II, Leica 
Microsystems, Wetzlar, Germany, model DMI6000B-CS).   
2.5.4 Surface marker expression 
Cells were harvested 72 hrs after electroporating 500 µl cell suspension per cuvette. 
Surface staining was performed in 96-well plates by incubating for 30 min on ice with all 
antibodies diluted at 1.25:50, except for anti-CD73, at 2.5:50, in staining buffer (PBS, 
0.5% BSA, 0.01% sodium azide), as determined after an initial titration. The antibodies 
used were: PerCP eFluor® 710 conjugated anti-human CD73 (clone AD2), APC 
conjugated anti-human CD90 (clone 5E10), eFluor® 450 conjugated anti-human CD45 
(clone HI30), PE conjugated anti-human CD105 (clone SN6), eFluor® 450 conjugated 
anti-human HLA-DR (clone L243, eBioscience) and eFluor® 450 conjugated anti-human 
CD34 (clone 4H11), all from eBioscience, and PE conjugated anti-human CD14 (clone 
MEM-15), APC conjugated anti-human CD19 (clone LT19), from Immunotools. 
Appropriate isotype controls were used. Samples were washed four times in staining 
buffer before acquisition in a flow cytometer (FACSCanto II, Becton Dickinson). Data were 
analyzed with FlowJo software. Only samples resulting in more than 10,000 events were 
analyzed.  
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2.5.5 Measuring ALP expression by flow cytometry  
MSC were plated at 30,000 cells/well in 24 well plates with basal or osteogenic medium. 
Cell surface staining for flow cytometry was performed using anti-human ALP antibody 
Alexa Fluor 700 (Clone B4-78, R&D Systems) as(37).  
2.5.6 Photoswitching Dendra2 
Photoswitching was optimized in a Leica TCS SP5 II laser scanning confocal microscope 
(Leica Microsystems) by using the Leica LAS AF software FRAP Wizard application 
(version 2.6.0.7266, Leica Microsystems) and applying a ROI (region of interest) scan, 
with a 10x HCX PL APO CS dry objective (0.4 N.A.) with the pinhole set to Airy1 (53.07 
μm), image size 1024x1024 pixels with 16 bits and bidirectional scanning at 400 Hz. Cells 
were firstly imaged by sequentially acquiring green and red images with a 488 nm and 
561 nm laser lines in low power. Dendra2 was converted to its red form by exposure to 
405 nm laser using distinct iteration number (defined as one complete pass with the 405 
nm laser, 1.303 s/frame, laser power at 2.466 mW) for a ROI with 470,000 μm2. Finally, 
cells were imaged again in the green and red channels to quantify photoconversion 
efficiency. For 3D cell tracking 3 to 6 spots were photoswitched for each material in each 
individual experiment.  
2.5.7 Wound healing assay combined with time-lapse microscopy 
MSC were plated at 25,000 cells/well in 24-well plates in MSC growth medium. When 
cells reached 100% confluence a scratch was made using a 200 μL pipette tip. Cell 
monolayer was washed twice with PBS, MSC growth medium was added and cells were 
imaged in a confocal microscope (Leica TCS SP5 II, Leica Microsystems, Wetzlar, 
Germany), at 37°C/5% CO2 (incubator from OKO lab).  Bright-field and fluorescence 
images were collected using the Live Data Mode application, with 10x dry objective. 
Images were captured every 15 min for 16-24 hrs. Each experiment was run in triplicate 
and repeated 4 times. For each replicate 3 distinct positions were imaged. Photoswitching 
of transfected MSC located at the edges of the wound was performed immediately after 
the scratch. Single cell trajectories in time-lapse movies were analyzed using Gradientech 
Tracking Tool™ v1.07 software (Gradientech). Only cells initially at the migrating front 
were considered for analysis. The directness index is a measure of the cell directionality 
and is calculated by comparing euclidean and accumulated distances. This value can 
range from 0 to 1, with a value closer to 1 indicating oriented cell migration. 
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2.5.8 Preparation of 3D matrices 
Matrigel: Matrigel Matrix Phenol Red-free (BD Biosciences) was mixed with cells following 
manufacturer’s instructions and allowed to gel at 37ºC. 
RGD-alginate disks: PRONOVA ultrapure sodium alginate (FMC Biopolymers, 70% 
guluronic acid) was covalently modified with cell-adhesion peptide sequence 
GGGGRGDSP (abbreviated as RGD, custom-made at GenScript (U.S.A.)) using aqueous 
carbodiimide chemistry, as previously described(36,38,39). Solutions composed of a 1:1 
mixture of high (HMW, 1.5 ×105 Da) and low molecular weight (LMW, 2.5 ×104 Da) 
alginate (both RGD-modified) were prepared in 0.9 wt-% sodium chloride (NaCl, Sigma) 
and combined with crosslinking agents (CaCO3 and δ-gluconolactone (GDL)) to trigger 
hydrogel formation by internal gelation(40,41).  
Chitosan scaffolds: Chitosan (France-Chitine) was purified as described(42). Chitosan 
sponges were prepared by freeze-drying using a 2% solution of chitosan (degree of 
acetylation: 12.00 ± 2.35%, molecular weight: 324 ± 27 x 103) and disinfected as 
previously described(42,43). Scaffolds were cut in parallelepiped shape with a dimension of 
4x4 mm and a height of 2 mm (1 ± 0.2 mg average weight).  
2.5.9 MSC seeding in 3D matrices 
Matrigel: 1.8 x 105 transfected cells were mixed with Matrigel solution pre-cooled at 4ºC at 
5.2 or 9.6 mg/mL of protein content. Solution was cast into a 0.8 cm2 Lab-Tek II chamber 
and incubated at 37ºC/5%CO2 for 30 min, until gelling was complete.  
RGD-alginate: transfected MSC were homogeneously mixed with gel precursor solutions, 
prepared as described above, for a final concentration of 8x106 cells/mL and 1 or 2% (wt) 
alginate (both with RGD at 100 μM). Crosslinking of hydrogel disks was promoted in teflon 
plates by placing 15 μL of the solution into the plate surface. Small and uniform hydrogel 
disks (1.5 mm height, 3 mm diameter) were obtained by mechanical pressing during the 
gelling process using 3 mm spacers. Samples were incubated at 37ºC/5%CO2 for 1hrs, 
until crosslinking was completed.  
Chitosan: 2.5x105 cells in 10 μL of MSC growth medium were added to each side (top and 
bottom) of a scaffold in non-treated 24 well tissue culture plates. Cells were allowed to 
adhere to the scaffold for 4 hrs and 400 µL of MSC growth medium was added.  
Prior to imaging, chitosan and RGD-alginate matrices were transferred to a 10 cm2 dish 
with a bottom coverslip and to a 0.8 cm2 Lab-Tek II chamber, respectively. After 24 hrs of 
 87 
incubation cells were photoswitched and imaged. The cell-loaded matrices were cultured 
during seven days and medium was changed every 48 hrs. 
2.5.10 Tracking Photoswitched MSC  
The reference red cell population (3-6 spots per scaffolds in each individual experiment) 
was centred and imaged 0, 1, 4 and 7 days after conversion. Each spot was imaged by 
sequentially acquiring green and red images with 3% power of the 488 nm laser and with 
a 30% power of the 561 nm laser using a 10x dry objective, pinhole set to Airy1, image 
size 512x512 pixels with 8 bits, bidirectional scanning at 400 Hz, using xyz mode with a Z-
stack of 50 frames, each with 9.99 µm thickness, building a Z-stack with 499.5 µm. After 
imaging, cells were returned to the incubator and cultured at 37ºC/5%CO2, until the next 
imaging time-point. 
2.5.11 Data processing 
2.5.12 Photoconversion efficiency  
Fluorescence intensity of both green and red forms of the Dendra2 protein were 
measured in 16 bits images using ImageJ software. The increase in fluorescence of 
Green and Red Signal Post-Conversion (relative fluorescence intensity, RFU) was 
normalized to take into account the initial number of Dendra2 green fluorescence 
molecules by calculating: 
(1) 
;  red
bc
bcac
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redred
RFU


   
(2) 
bc
ac
green
green
green
RFU 
;   
where redac = red fluorescence intensity after conversion; redbc = red fluorescence 
intensity before conversion; greenac = green fluorescence intensity after conversion; 
greenbc = green fluorescence intensity before conversion.  
2.5.13 Cell tracking and shape analysis 
To quantify the cells infiltration area, 2D maximum projection images of Z-stacks for both 
green and red channels were generated using Leica LAS AF software for each 
photoswitched spot. The same manual threshold (threshold value ≥ 30; scale 0 - 255) was 
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applied to all images using ImageJ software. The area occupied by red cells was 
quantified by drawing a manual ROI around this area (Supplementary Figure S3). The 
infiltration area was then normalized to the area measured at time-point 0.  
For shape analysis, ICY software was used(44). Images were threshold by the Otsu 
method with the Best Threshold plugin (developed by Thomas Provoost)(45).  Then, Spot 
Detector plugin (developed by Fabrice de Chaumont)(46) was used for detection of the 3D 
objects followed by 3D Analysis (developed by Thomas Boudier)(47) to calculate object 
sphericity. 
2.5.14 Statistical analysis 
Statistical analysis was performed using Prism5 software, v5.01 for data on MSC 
characterization (Figure 1-3). One tailed Mann-Whitney test was used to compare two 
samples, whereas comparison between more than two samples was performed using the 
Friedman-matched paired test followed by Dunns comparison test. For grouped samples, 
two-way ANOVA test was used followed by Bonferroni post-test. 
R software (v2.14.1) was used for statistical analysis of cells motility and shape (Figure 4–
6). To test cell velocity, directness index, relative infiltration area and cell sphericity for 
significant differences between groups we used a linear mixed model(48), as detailed in 
Supplementary Methods. For 2D migration experiments, groups were treated as fixed 
effects and individual cells nested within each experiment were treated as random factors. 
For infiltration area and cell sphericity, spots and cells, respectively, were considered 
nested, with days nested within each experiment, which was treated as a random effect to 
take into account possible variability. The detailed results of this statistical analysis are in 
Supplementary Tables 1-5. 
Data are mean ± Standard Error of the Mean (SEM) unless stated otherwise. Confidence 
intervals (CIs) for the desired comparisons were computed as(49). 
Parameters were estimated by computing the maximum likelihood estimators using R 
software (www.R-project.org, R Development Core Team) and the lme and multcomp 
package. Values of p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***) were considered 
statistically significant.(50) 
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2.9 Supplementary Data 
2.9.1.1 Oil Red O / ALP / Von Kossa Stainings 
For adipogenesis or osteogenesis, hMSCs were plated in 24 well plates until reaching 
confluence and were stimulated with DMEM with low glucose and glutamax plus 10% FBS 
(PAA) and penicillin/streptomycin and with or without the adipogenic or osteogenic 
supplements as previously described1. Cells were washed with distilled water twice and 
analyzed both under an inverted microscope (Olympus CKX Inverted Microscope) and in 
a confocal microscope (Leica TCS SP5 II) for co-localization of Oil Red O stained lipid 
droplets or ALP with cells Dendra2 fluorescence. 
2.9.1.2 Statistical analysis: Linear Mixed Model Analysis 
For 2D migration experiments, groups were treated as fixed effects and individual cells 
nested within each experiment were treated as random factors. For infiltration area and 
cell sphericity, spots and cells, respectively, were considered nested, with days nested 
within each experiment, which was treated as a random effect to take into account 
possible variability. The fixed effect materials and days interaction was tested for 
significance. The random factor experiment described the between-experiment variability 
of infiltration area and sphericity from one experiment to another, the days described the 
between-days-within-experiment variability from one day to another one, and the random 
factor cells described the between-cells-within-days-within-experiment variability of 
infiltration area and sphericity. This random effect was assumed to follow a normal 
distribution centred on 0 with standard deviations for experiment, days and cells. 
To assess the importance of random factors in our model, we tested their significance by 
removing terms one at a days and comparing the difference between the log likelihoods of 
the reduced and complete models using a qui-square test. In each model random terms 
were retained if they significantly improved likelihood.  
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Supplementary Figure S1. Transfected MSC are capable of multilineage 
differentiation when appropriately stimulated but not in basal condition. (a) Control 
and transfected MSC differentiate into osteoblasts as determined by staining for ALP 
activity (left: ALP staining) and late calcium-containing mineral deposits in extracellular 
matrix (right: von Kossa staining). (b) Lipid vacuoles accumulation stained with Oil Red O 
solution at 21 days indicates differentiating adipocytes on both control and transfected 
MSC. Scale bar, 250 µm. (c) Both Dendra2+ (asterisk) and Dendra2- MSC (arrowhead) 
were able to differentiate into osteogenic or adipogenic lineages when appropriately 
stimulated as denoted by expression of ALP showed as black staining (left) or oil droplets 
illustrated as black droplets (right), respectively. Scale bar, 75 µm. Pictures are 
representative of 3 individual experiments in duplicate.  
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Supplementary Figure S2. Photoconversion at sub-cellular resolution. Confocal 
microscopy images in Green (top) and Red (bottom) channels of Dendra2+ MSC. 
Photoconversion was achieved with 405nm laser in the circular region of Interest indicated 
(dashed line). Photoswitched red Dendra2 redistributed throughout the cell cytoplasm 
within 99.9 ms after conversion. 
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Supplementary Figure S3. Using Dendra2 photoconversion to track MSC. (top) It is 
difficult to quantify cell motility in 3D when MSC are all labelled with the same fluorescent 
protein (GFP-like approach, cells were imaged in the green channel only). In this scenario, 
it is extremely hard to find the same cells when imaging sessions have to be performed at 
discrete daily intervals and samples cannot be kept under a microscope. (middle) 
Dendra2 photoconversion of a group of cells creates a fixed reference with defined 
geometric shapes that allows repositioning the same cells over the different imaging 
sessions. (bottom) Infiltration area quantified in xy maximum projection images by manual 
drawing a ROI. Scale bar, 250 µm. 
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Supplementary Table 1 - Contrast comparison using mixed effect model fit to test 
differences in mean directness index between groups. Group1: Control ; Group2: 
Electroporated without plasmid ; Group3: Dendra2+ Green ; Group4: Dendra2+ Red. 
Materials Estimate Std. Error 95%CI z value Pr(>|z|)   
Group2 vs. Group1 -0.017 0.015 (-0.055; 0.020) -1.179 0.637 
 
Group3 vs. Group1 -0.001 0.015 (-0.041; 0.039) -0.056 1.000 
 
Group4 vs. Group1 -0.047 0.019 (-0.096; 0.002) -2.452 0.066 
 
Group3 vs. Group2 0.017 0.014 (-0.020; 0.053) 1.176 0.639 
 
Group4 vs. Group2 -0.029 0.018 (-0.075; 0.017) -1.630 0.358 
 
Group4 vs. Group3 -0.046 0.019 (-0.094; 0.002) -2.476 0.062 
 
Variance Component                                   StdDev     
Between-experiment 
   
0.000002 
  Between-cells-within-experiments 
  
0.000009 
  Residuals       0.1335     
 
Supplementary Table 2 - Contrast comparison using mixed effect model fit to test 
differences in mean velocity between groups. Group1: Control ; Group2: 
Electroporated without plasmid ; Group3: Dendra2+ Green ; Group4: Dendra2+ Red. 
  Estimate Std. Error 95%CI z value Pr(>|z|)   
Group2 vs. Group1 0.030216 0.013872 (-0.005; 0.066) 2.178 0.128 
 
Group3 vs. Group1 -0.10191 0.014061 (-0.138; -0.066) -7.248 p<0.001 *** 
Group4 vs. Group1 -0.11584 0.01737 (-0.160; -0.071) -6.669 p<0.001 *** 
Group3 vs. Group2 -0.13212 0.013375 (-0.166; -0.098) -9.879 p<0.001 *** 
Group4 vs. Group2 -0.14605 0.016651 (-0.189; -0.103) -8.772 p<0.001 *** 
Group4 vs. Group3 -0.01393 0.016884 (-0.057; 0.029) -0.825 0.841 
 
Variance Component                                   StdDev     
between-experiment 
   
0.0585 
  between-cell-within-experiment 
  
0.0043 
  Residual       0.1209     
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Supplementary Table 3 - Contrast comparison using mixed effect model fit to test 
differences in the mean % infiltration area between material in each time point and 
within material in each time point. Group1: Matrigel 5.2 mg/mL ; Group2: Matrigel 
9.6 mg/mL ; Group3: 1% RGD-alginate ; Group4: 2% RGD-alginate ; Group5: 
Chitosan. 
Material Estimate Std. Error IC95% z value Pr(>|z|) 
 
TimePoint1: Group2 vs. Group1 -22.866 9.959 (-50.019; 4.287) -2.296 0.146 
 
TimePoint1: Group3 vs. Group1 -24.884 9.651 (-51.195; 1.428) -2.578 0.074 
 
TimePoint1: Group4 vs. Group1 -19.920 9.658 (-46.252; 6.413) -2.062 0.236 
 
TimePoint1: Group5 vs. Group1 29.815 10.629 (0.835; 58.795) 2.805 0.040 * 
TimePoint1: Group3 vs. Group2 -2.017 9.651 (-28.329; 24.294) -0.209 1.000 
 
TimePoint1: Group4 vs. Group2 2.946 9.658 (-23.386; 29.279) 0.305 0.998 
 
TimePoint1: Group5 vs. Group2 52.681 10.629 (23.701; 81.661) 4.956 0.000 *** 
TimePoint1: Group4 vs. Group3 4.964 9.330 (-20.474; 30.402) 0.532 0.984 
 
TimePoint1: Group5 vs. Group3 54.699 10.341 (26.506; 82.892) 5.290 0.000 *** 
TimePoint1: Group5 vs. Group4 49.735 10.341 (21.540; 77.930) 4.809 0.000 *** 
TimePoint4: Group2 vs. Group1 -37.789 9.959 (-64.938; -10.64) -3.794 0.001 ** 
TimePoint4: Group3 vs. Group1 -9.145 9.651 (-35.454; 17.163) -0.948 0.878 
 
TimePoint4: Group4 vs. Group1 -9.075 9.658 (-35.404; 17.254) -0.940 0.881 
 
TimePoint4: Group5 vs. Group1 32.153 10.629 (3.178; 61.129) 3.025 0.021 * 
TimePoint4: Group3 vs. Group2 28.644 9.651 (2.336; 54.952) 2.968 0.025 * 
TimePoint4: Group4 vs. Group2 28.715 9.658 (2.386; 55.044) 2.973 0.024 * 
TimePoint4: Group5 vs. Group2 69.943 10.629 (40.967; 98.918) 6.580 0.000 *** 
TimePoint4: Group4 vs. Group3 0.071 9.330 (-25.364; 25.506) 0.008 1.000 
 
TimePoint4: Group5 vs. Group3 41.299 10.341 (13.110; 69.488) 3.994 0.001 *** 
TimePoint4: Group5 vs. Group4 41.228 10.341 (13.037; 69.419) 3.987 0.001 *** 
TimePoint7: Group2 vs. Group1 -64.232 9.959 (-91.389; -37.074) -6.450 0.000 *** 
TimePoint7: Group3 vs. Group1 3.796 9.651 (-22.520; 30.113) 0.393 0.995 
 TimePoint7: Group4 vs. Group1 -47.273 9.658 (-73.610; -20.935) -4.895 0.000 *** 
TimePoint7: Group5 vs. Group1 6.079 10.629 (-22.906; 35.063) 0.572 0.979 
 TimePoint7: Group3 vs. Group2 68.028 9.651 (41.711; 94.344) 7.049 0.000 *** 
TimePoint7: Group4 vs. Group2 16.959 9.658 (-9.378; 43.297) 1.756 0.399 
 TimePoint7: Group5 vs. Group2 70.310 10.629 (41.326; 99.295) 6.615 0.000 *** 
TimePoint7: Group4 vs. Group3 -51.069 9.330 (-76.512; -25.626) -5.474 0.000 *** 
TimePoint7: Group5 vs. Group3 2.282 10.341 (-25.916; 30.480) 0.221 0.999 
 TimePoint7: Group5 vs. Group4 53.351 10.341 (25.151; 81.551) 5.159 0.000 *** 
Material Estimate Std. Error IC95% z value Pr(>|z|) 
 
Group1: Time1 vs. Time0 35.634 9.959 (10.054; 61.213) 3.578 0.002 ** 
Group1: Time4 vs. Time0 87.683 9.959 (62.103; 113.262) 8.804 0.000 *** 
Group1: Time7 vs. Time0 160.315 9.959 (134.736; 185.895) 16.097 0.000 *** 
Group1: Time4 vs. Time1 52.049 9.959 (26.470; 77.628) 5.226 0.000 *** 
Group1: Time7 vs. Time1 124.682 9.959 (99.102; 150.261) 12.519 0.000 *** 
Group1: Time7 vs. Time4 72.633 9.959 (47.053; 98.212) 7.293 0.000 *** 
Group2: Time1 vs. Time0 12.767 9.959 (-12.741; 38.276) 1.282 0.601 
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Group2: Time4 vs. Time0 64.817 14.084 (28.742; 100.891) 4.602 0.000 *** 
Group2: Time7 vs. Time0 137.449 14.084 (101.375; 173.523) 9.759 0.000 *** 
Group2: Time4 vs. Time1 37.126 9.959 (11.617; 62.634) 3.728 0.001 ** 
Group2: Time7 vs. Time1 83.316 9.959 (57.808; 108.824) 8.366 0.000 *** 
Group2: Time7 vs. Time4 46.190 9.959 (20.682; 71.699) 4.638 0.000 *** 
Group3: Time1 vs. Time0 10.627 9.316 (-13.649; 34.903) 1.141 0.768 
 
Group3: Time4 vs. Time0 67.472 13.637 (31.935; 103.008) 4.948 0.000 *** 
Group3: Time7 vs. Time0 189.605 15.014 (150.481; 228.729) 12.629 0.000 *** 
Group3: Time4 vs. Time1 67.787 9.316 (43.511; 92.063) 7.277 0.000 *** 
Group3: Time7 vs. Time1 153.362 9.316 (129.085; 177.638) 16.462 0.000 *** 
Group3: Time7 vs. Time4 85.574 9.316 (61.298; 109.850) 9.186 0.000 *** 
Group4: Time1 vs. Time0 15.422 9.316 (-8.475; 39.320) 1.656 0.359 
 
Group4: Time4 vs. Time0 67.472 13.637 (32.489; 102.455) 4.948 0.000 *** 
Group4: Time7 vs. Time0 140.104 13.637 (105.121; 175.087) 10.274 0.000 *** 
Group4: Time4 vs. Time1 62.894 9.316 (38.996; 86.792) 6.751 0.000 *** 
Group4: Time7 vs. Time1 97.329 9.316 (73.431; 121.227) 10.448 0.000 *** 
Group4: Time7 vs. Time4 34.435 9.316 (10.537; 58.333) 3.696 0.001 ** 
Group5: Time1 vs. Time0 64.923 11.235 (36.216; 93.631) 5.778 0.000 *** 
Group5: Time4 vs. Time0 116.972 15.014 (78.610; 155.335) 7.791 0.000 *** 
Group5: Time7 vs. Time0 189.605 15.014 (151.243; 227.967) 12.629 0.000 *** 
Group5: Time4 vs. Time1 54.387 11.235 (25.680; 83.095) 4.841 0.000 *** 
Group5: Time7 vs. Time1 100.945 11.235 (72.238; 129.653) 8.985 0.000 *** 
Group5: Time7 vs. Time4 46.558 11.235 (17.850; 75.265) 4.144 0.000 *** 
Variance Component 
   
StdDev 
  
between-experiment 
 
0.0027 
  between-spot-within-experiment 
 
4.4 
  between-days-within-spot-within-experiment 
 
0.0002 
  Residual 
 
26.349 
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Supplementary Table 4 - Contrast comparison using mixed effect model fit to test 
differences in cell sphericity between material in each time point and within 
material over time. Group1: Matrigel 5.2 mg/mL ; Group2: Matrigel 9.6 mg/mL ; 
Group3: 1% RGD-alginate ; Group4: 2% RGD-alginate ; Group5: Chitosan. 
 
Material Estimate Std. Error IC95% z value Pr(>|z|) 
 
TimePoint0: Group2 vs. Group1 0.046 0.007 (0.027; 0.065) 6.500 0.000 *** 
TimePoint0: Group3 vs. Group1 0.007 0.007 (-0.011; 0.025) 1.085 0.814 
 
TimePoint0: Group4 vs. Group1 0.016 0.007 (-0.003; 0.035) 2.263 0.157 
 
TimePoint0: Group5 vs. Group1 -0.069 0.007 (-0.09; -0.049) -9.319 0.000 *** 
TimePoint0: Group3 vs. Group2 -0.039 0.006 (-0.056; -0.021) -5.936 0.000 *** 
TimePoint0: Group4 vs. Group2 -0.030 0.007 (-0.049; -0.011) -4.275 0.000 *** 
TimePoint0: Group5 vs. Group2 -0.115 0.007 (-0.135; -0.095) -15.658 0.000 *** 
TimePoint0: Group4 vs. Group3 0.009 0.006 (-0.009; 0.026) 1.367 0.648 
 
TimePoint0: Group5 vs. Group3 -0.077 0.007 (-0.095; -0.058) -11.131 0.000 *** 
TimePoint0: Group5 vs. Group4 -0.085 0.007 (-0.105; -0.066) -11.698 0.000 *** 
TimePoint1: Group2 vs. Group1  0.029 0.007 (0.029; 0.011) 4.269 0.000 *** 
TimePoint1: Group3 vs. Group1 0.005 0.007 (0.005; -0.013) 0.772 0.939  
TimePoint1: Group5 vs. Group1 -0.087 0.007 (-0.087; -0.106) -12.157 0.000 *** 
TimePoint1: Group4 vs. Group1 0.019 0.007 (0.019; 0.000) 2.682 0.056  
TimePoint1: Group3 vs. Group2 -0.024 0.007 (-0.024; -0.042) -3.62 0.003 ** 
TimePoint1: Group4 vs. Group2 -0.011 0.007 (-0.011; -0.029) -1.546 0.532  
TimePoint1: Group5 vs. Group2 -0.116 0.007 (-0.116; -0.135) -16.375 0.000 *** 
TimePoint1: Group4 vs. Group3 0.013 0.007 (0.013; -0.005) 2.016 0.258  
TimePoint1: Group5 vs. Group3 -0.092 0.007 (-0.092; -0.111) -13.43 0.000 *** 
TimePoint1: Group5 vs. Group4 -0.106 0.007 (-0.106; -0.125) -14.971 0.000 *** 
TimePoint4: Group2 vs. Group1 0.016 0.006 (0.016; 0.000) 2.777 0.043 * 
TimePoint4: Group3 vs. Group1 -0.027 0.005 (-0.027; -0.042) -4.983 0.000 *** 
TimePoint4: Group4 vs. Group1 -0.021 0.006 (-0.021; -0.037) -3.721 0.002 ** 
TimePoint4: Group5 vs. Group1 -0.078 0.007 (-0.078; -0.096) -11.946 0.000 *** 
TimePoint4: Group3 vs. Group2 -0.043 0.005 (-0.043; -0.057) -8.017 0.000 *** 
TimePoint4: Group4 vs. Group2 -0.037 0.006 (-0.037; -0.053) -6.58 0.000 *** 
TimePoint4: Group5 vs. Group2 -0.094 0.006 (-0.094; -0.111) -14.575 0.000 *** 
TimePoint4: Group4 vs. Group3 0.006 0.005 (0.006; -0.009) 1.053 0.829  
TimePoint4: Group5 vs. Group3 -0.051 0.006 (-0.051; -0.068) -8.258 0.000 *** 
TimePoint4: Group5 vs. Group4 -0.057 0.006 (-0.057; -0.074) -8.771 0.000 *** 
TimePoint7: Group2 vs. Group1 0.046 0.007 (0.046; 0.026) 6.5 0.000 *** 
TimePoint7: Group3 vs. Group1 0.007 0.007 (0.007; -0.011) 1.085 0.892  
TimePoint7: Group4 vs. Group1 0.016 0.007 (0.016; -0.003) 2.263 0.175  
TimePoint7: Group5 vs. Group1 -0.069 0.007 (-0.069; -0.090) -9.319 0.000 *** 
TimePoint7: Group3 vs. Group2 -0.046 0.007 (-0.046; -0.066) -6.51 0.000 *** 
TimePoint7: Group4 vs. Group2 -0.027 0.008 (-0.027; -0.048) -3.525 0.004 ** 
TimePoint7: Group5 vs. Group2 -0.093 0.007 (-0.093; -0.113) -12.811 0.000 *** 
TimePoint7: Group4 vs. Group3 0.020 0.006 (0.020; 0.002) 3.131 0.016 * 
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TimePoint7: Group5 vs. Group3 -0.047 0.006 (-0.047; -0.064) -7.671 0.000 *** 
TimePoint7: Group5 vs. Group4 -0.066 0.007 (-0.066; -0.084) -10.099 0.000 *** 
Material Estimate Std. Error IC95% z value Pr(>|z|) 
 
Group1: Time1 vs. Time0 0.007 0.009 (0.007; -0.017) 0.784 0.862   
Group1: Time4 vs. Time0 0.007 0.009 (0.007; -0.016) 0.817 0.846 
 
Group1: Time7 vs. Time0 -0.012 0.009 (-0.012; -0.036) -1.282 0.574 
 
Group1: Time4 vs. Time1 0.000 0.009 (0.000; -0.023) -0.001 1.000 
 
Group1: Time7 vs. Time1 -0.019 0.009 (-0.019; -0.043) -2.090 0.156 
 
Group1: Time7 vs. Time4 -0.019 0.009 (-0.019; -0.042) -2.182 0.128 
 
Group2: Time1 vs. Time0 -0.009 0.009 (-0.009; -0.033) -1.000 0.797 
 
Group2: Time4 vs. Time0 -0.009 0.011 (-0.009; -0.038) -0.825 0.889 
 
Group2: Time7 vs. Time0 -0.028 0.011 (-0.028; -0.058) -2.476 0.065 
 
Group2: Time4 vs. Time1 -0.013 0.009 (-0.013; -0.036) -1.520 0.451 
 
Group2: Time7 vs. Time1 -0.025 0.010 (-0.025; -0.050) -2.610 0.045 * 
Group2: Time7 vs. Time4 -0.012 0.009 (-0.012; -0.036) -1.299 0.601 
 
Group3: Time1 vs. Time0 0.005 0.009 (0.005; -0.017) 0.608 0.976 
 
Group3: Time4 vs. Time0 0.010 0.011 (0.010; -0.019) 0.878 0.896 
 
Group3: Time7 vs. Time0 -0.029 0.012 (-0.029; -0.060) -2.481 0.069 
 
Group3: Time4 vs. Time1 -0.032 0.008 (-0.032; -0.054) -3.837 0.001 *** 
Group3: Time7 vs. Time1 -0.048 0.009 (-0.048; -0.070) -5.608 0.000 *** 
Group3: Time7 vs. Time4 -0.016 0.008 (-0.016; -0.037) -1.961 0.230 
 
Group4: Time1 vs. Time0 0.010 0.009 (0.010; -0.014) 1.073 0.751 
 
Group4: Time4 vs. Time0 0.010 0.011 (0.010; -0.019) 0.878 0.863 
 
Group4: Time7 vs. Time0 -0.009 0.012 (-0.009; -0.039) -0.817 0.892 
 
Group4: Time4 vs. Time1 -0.040 0.009 (-0.040; -0.062) -4.573 0.000 *** 
Group4: Time7 vs. Time1 -0.042 0.009 (-0.042; -0.065) -4.544 0.000 *** 
Group4: Time7 vs. Time4 -0.002 0.009 (-0.002; -0.024) -0.200 1.000 
 
Group5: Time1 vs. Time0 -0.010 0.010 (-0.010; -0.035) -1.067 0.752 
 
Group5: Time4 vs. Time0 -0.010 0.012 (-0.010; -0.040) -0.884 0.858 
 
Group5: Time7 vs. Time0 -0.029 0.012 (-0.029; -0.060) -2.481 0.063 
 
Group5: Time4 vs. Time1 0.009 0.009 (0.009; -0.015) 0.968 0.812 
 
Group5: Time7 vs. Time1 -0.002 0.009 (-0.002; -0.026) -0.266 0.999 
 
Group5: Time7 vs. Time4 -0.011 0.009 (-0.011; -0.035) -1.274 0.614   
 Variance Component  StdDev 
  
between-experiment 0.005     
between-days-within-experiment 0.007 
  
between-cells-within-days-within-experiment 0.000002 
  
Residual  0.0796     
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Supplementary Table 5 - Contrast comparison using mixed effect model fit to test 
differences in mean cell sphericity within material over time (consider time 
continuous). 
Trend per Material Estimate Std. Error IC95% z value Pr(>|z|) 
 
Trend in Matrigel 5.2 mg/mL -0.002 0.001 (-0.005; 0.001) -1.486 0.459 
 
Trend in Matrigel 9.6 mg/mL -0.005 0.001 (-0.008; -0.002) -3.929 0.000 *** 
Trend in 1% RGD-alginate -0.007 0.001 (-0.010; -0.004) -6.613 0.000 *** 
Trend in 2% RGD-alginate -0.006 0.001 (-0.009; -0.003) -5.288 0.000 *** 
Trend in Chitosan -0.001 0.001 (-0.004; 0.002) -0.935 0.840 
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“O QUE HÁ EM MIM É SOBRETUDO CANSAÇO  
 
(…) 
Há sem dúvida quem ame o infinito, 
Há sem dúvida quem deseje o impossível, 
Há sem dúvida quem não queira nada 
Três tipos de idealistas, e eu nenhum deles: 
Porque eu amo infinitamente o finito, 
Porque eu desejo impossivelmente o possível, 
Porque eu quero tudo, ou um pouco mais, se puder ser, 
Ou até se não puder ser... 
(…)” 
 
9-10-1934 
Poesias de Álvaro de Campos. Fernando Pessoa. Lisboa: Ática, 1944 (imp. 1993) - 64. 
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3.1 Abstract 
Despite the importance of immune cell - biomaterial interactions for the regenerative 
outcome, few studies have investigated how distinct 3D biomaterials modulate the 
immune cell-mediated MSC recruitment and function. Thus, this work compares the 
response of varied primary human immune cell populations triggered by different model 
scaffolds and describes its functional consequence on recruitment and motility of bone 
marrow MSC. It was found that Poly-Lactic Acid (PLA) and chitosan scaffolds lead to an 
increase in the metabolic activity of macrophages but not of peripheral blood mononuclear 
cells (PBMC), NK cells or monocytes. PBMC and NK cells increase their cell number in 
PLA scaffolds and express a secretion profile that does not promote MSC recruitment. 
Importantly, chitosan increases IL-8, MIP-1, MCP-1 and RANTES secretion by 
macrophages while PLA stimulates IL-6, IL-8 and MCP-1 production, all chemokines that 
can lead to MSC recruitment. This secretion profile of macrophages in contact with 
biomaterials correlates with the highest MSC invasion. Furthermore, macrophages 
enhance stem cell motility within chitosan scaffolds by 44% but not in PLA scaffolds. 
Thus, macrophages are the cells that in contact with engineered biomaterials become 
activated to secrete bioactive molecules that stimulate MSC recruitment. 
KEYWORDS: Biomaterials; Inflammation; regeneration; Mesenchymal stem cell; 
Recruitment; human 
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3.2 Introduction 
Implantation of tissue engineered scaffolds triggers simultaneously two types of host 
response: an immune reaction against the foreign material and activation of tissue repair 
mechanisms at the injured area. Although the nature of these biological processes is very 
distinct they share inflammation as a common denominator. If perpetuated, inflammation 
can be detrimental, leading to tissue damage and fibrotic encapsulation of the biomaterial, 
but at the same time inflammation is essential to promote progenitor cell recruitment and 
initiate healing mechanisms(1). The requirement of fine-tuning inflammation for a beneficial 
regenerative outcome prompted the design of “immuno-informed” biomaterials to control 
the host response(2). The great majority of regenerative medicine strategies aim for spatial 
and temporal control of stem cell differentiation. But for effective tissue repair, it is also 
necessary to tightly control the coordinated movement of different cell types to the injury 
site. Thus, strategies that modulate the immune response to attract endogenous stem 
cells are appealing, as we start to understand that recruitment, and not only proliferation 
and differentiation of progenitor cells is important for effective regeneration.  
Mesenchymal stem/stromal cells (MSC) have a pivotal role in supporting the regenerative 
process due to their ability to migrate to inflamed tissues, to differentiate in different 
lineages and to their paracrine and immunomodulation properties(3). Importantly, it was 
shown in a murine model that upon biomaterial subcutaneous implantation there is first 
recruitment of inflammatory cells, which is then correlated with recruitment of MSC(4-7). 
MSC recruitment can then lead to subsequent modulation of inflammation and is essential 
to promote the constructive remodelling of the tissue(8,9). Nevertheless, the specific 
contribution of different immune cell populations interacting with implanted biomaterials for 
MSC recruitment remains unexplored. 
In the first 48 hrs upon implantation, Natural Killer (NK) cells and polymorphonuclear 
neutrophils become the predominant cells at the tissue-implant interface(10,11). NK cells are 
lymphocytes crucial for remodelling of the endometrium during pregnancy, and which can 
promote MSC recruitment, possibly through secretion of different chemokines(12). 
Monocyte recruitment from the blood to the implant site thrives under its inflammatory 
environment, where they gradually differentiate into macrophages that replace the short-
lived neutrophils and NK cells. Macrophages are master regulators of the foreign body 
response and tissue regeneration through secretion of bioactive molecules which can 
impact inflammation, angiogenesis, extracellular matrix remodelling and stem cell 
recruitment and differentiation(2). And indeed, Macrophages are potent inducers of MSC 
recruitment, mainly through the production of the chemokine RANTES(12,13). The 
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remarkable plasticity of macrophages allows them to adopt a dynamic profile between M1 
pro-inflammatory and M2 pro-regenerative functional programmes which can shift the 
regenerative outcome. Essentially, these over-simplistic functional phenotypes are not 
exclusive and the overall response is the net result of a combination of distinct 
macrophage phenotypes dictated by the specific microenvironment, cell-cell interaction 
and biomaterial properties(14,15).  
Even though biomaterials impact on immune cells, few studies compared the response of 
different populations to 3D matrices. But more importantly, its consequence on the 
dynamical behaviour of stem cells is not understood. Here, we analysed the ability of 
human immune cells interacting with different scaffolds to promote human stem cells 
recruitment. Thus, two different types of materials were used as models for biomaterials 
with distinct physic-chemical properties: Poly-Lactic Acid (PLA), an FDA approved 
synthetic polymer used for bone repair or as internal fracture fixation device (16); and 
chitosan which is a natural polysaccharide, currently explored for many applications, 
including wound dressings and bone regeneration(17,18). Firstly, the effect of PLA and 
chitosan scaffolds on the behaviour of primary human PBMC, NK cells, monocytes and 
macrophages isolated from peripheral blood of healthy donors was characterized. Then, it 
was determined how the responses of these immune cell populations affected human 
bone marrow MSC recruitment and motility within 3D matrices (Figure 1). 
 
Figure 1 - Schematic representation of the study performed. Experiments were 
performed with 3D PLA or chitosan scaffolds on a well of a 24 well plate, and, for invasion 
assays, a Matrigel-coated transwell chamber on top of it, with a spacer to compensate for 
scaffolds height. Different immune cell populations, namely, PBMC, NK cells, monocytes 
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and macrophages were seeded on the scaffolds to analyse cell number, metabolic 
activity, cell morphology, secretory profile and MSC recruitment. Furthermore, motility of 
MSC seeded on scaffolds was also analysed. 
 
3.3 Results 
3.3.1 Scaffold characterization 
To compare the behaviour of immune cell populations incubated with materials with a 
different chemistry, we prepared PLA and chitosan scaffolds with approximately the same 
pore size (Supplementary Figure S1), which can be instrumental in defining the 
inflammatory response towards biomaterials. Both types of scaffolds showed a 
homogeneous porosity with the large pores having an average diameter of 141±44 μm for 
PLA and 125±25 μm for chitosan, in agreement with previous reports(19,20). PLA had a 
rougher surface compared to chitosan and displayed micropores with a mean diameter of 
25±10 μm against 42±24 μm for chitosan. Both types of scaffold had endotoxin levels 
lower than 0.2 EU/ml, which are below the recommended FDA limit for implanted 
biomaterials. 
3.3.2 Metabolism, cell number and morphology  
Upon biomaterial implantation, distinct immune cell populations are recruited and 
activated in a highly regulated manner over the acute and chronic phases of inflammation. 
Here, the behaviour of PBMC, NK cells and monocytes was evaluated after 2 days in 
contact with the materials while macrophages were analyzed after differentiation through 
9 days of contact with the scaffolds. Although not statistically significant, there was a 
tendency for the metabolic activity of macrophages, but not monocytes, to increase in 
contact with PLA and chitosan scaffolds as opposed to 2D TCPS. In contrast, PBMC and 
NK cells metabolism was significantly reduced upon interaction with PLA or chitosan 
scaffolds (Figure 2a).  
Immune cells metabolism was not correlated with cell number as DNA quantification 
suggests that NK cells showed a significantly higher number of cells when incubated with 
PLA. This indicates that there was cell proliferation even in the absence of any exogenous 
stimulus apart from the scaffold, but that the metabolic activity per cell is diminished 
(Figure 2b). The number of macrophages was maintained in both types of 3D scaffolds 
but the cells disappeared on TCPS. Therefore, caution must be taken when comparing 
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data from macrophages differentiated on TCPS with cells in biomaterials. No major 
differences were observed with monocytes.  
 
Figure 2 - Modulation of immune cell behaviour by distinct materials. (a) Metabolic 
activity, (b) cell number and (c) morphology were determined for immune cells incubated 
for 48 hrs or 9 days (Macrophages) on 2D TCPS or in 3D scaffolds of chitosan or PLA. 
n=3 (a) Metabolic activity was estimated with a resazurin assay. The background 
fluorescence intensity obtained in the presence of each material was subtracted to 
experimental values. (b) Cell number was estimated by quantifying the amount of DNA 
with Quant-IT Picogreen. The dashed line indicates the number of cells initially seeded. 
(c) To visualize cells, scaffolds were fixed and stained for actin (green) and the nuclei 
(red) before being visualized by laser scanning confocal microscopy. Chitosan scaffolds 
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can be observed in green due to their autofluorescence. Scale Bar, 12.5 µm. Data is 
represented as floating bars with line at the mean ± maximum to minimum value. 
 
Visualization of the cells upon actin staining revealed that in all cases cells were 
distributed throughout the scaffolds (Supplementary Figure S2). A more detailed 
observation suggests that NK cells adopted a more elongated morphology, with polarized 
actin, when in chitosan scaffolds than in PLA (Figure 2c). Furthermore, an irregular 
morphology with extensive actin protrusions was frequently observed for macrophages in 
PLA but not in chitosan. Some cell fragmentation was noticed, consistent with minor cell 
death within the scaffolds, as anticipated from the results obtained when estimating the 
number of cells by DNA quantification (Figure 2b). Very few giant cells were observed for 
either PLA or chitosan scaffolds. 
3.3.3 Cytokine secretion 
Since macrophages showed the highest metabolic activity in the presence of 3D 
biomaterials their supernatants were analyzed for the presence of 40 inflammatory 
mediators with antibody arrays. Importantly, materials had a profound effect on the 
secretion profile of these macrophages (Figure 3a). ELISA was performed to quantify the 
inflammatory mediators that achieved quotients of signal intensity higher than 0.3: IL-6, IL-
8, MIP-1α, MIP-1β, MCP-1 and RANTES (Figure 3b).  
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Figure 3 - Protein array of macrophage-secreted cytokines upon culture on distinct 
materials. Macrophages were allowed to differentiate in the materials for 7 days, washed 
and cultured in serum free medium for another 48 hrs. Media was collected and analysed 
by protein arrays. (a) Developed membranes of a protein array used to analyse 
supernatants from macrophages cultured in different materials. (b) The average intensity 
of signal detected for each molecule in the protein arrays was divided by the average 
intensity of signal detected for the positive controls. Cytokines reaching a quotient of 
signal intensity (Q.S.I.) higher than 0.3 (dashed line) were selected for ELISA 
quantification (box). 
 
Distinct immune populations were cultured in the different materials (Figure 4) and it was 
found that PBMC secreted low amounts of IL-6, MIP-1α and MCP-1 and expressed high 
levels of IL-8 with no statistical differences when incubating with the different materials. 
NK cells secreted more RANTES when cultured on 2D TCPS than in 3D chitosan or PLA 
scaffolds. Monocytes showed a trend to express more IL-6 and MIP-1α when in chitosan 
and PLA scaffolds than when with TCPS while their culture in PLA induced a significantly 
higher expression of IL-8 than on 2D TCPS or in 3D chitosan scaffolds. No differences 
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were found for MCP-1 between materials and MIP-1β was not detected in monocyte 
supernatants. Most interestingly, when these cells were allowed to differentiate into 
mature macrophages there was secretion of IL-6, IL-8 and MCP-1 for PLA while the 
interaction with chitosan scaffolds lead to secretion of IL-8, MIP-1α, MIP-1β, MCP-1 and 
RANTES. There was no correlation between the purity of the immune cell populations and 
the concentration of secreted cytokines (Supplementary Figure S3). 
 
Figure 4 - Cytokine secretion profile of PBMC, NK cells, monocytes and 
macrophages cultured on distinct materials. PBMC, NK cells and monocytes were 
cultured for 48 hrs on 2D TCPS or in 3D chitosan and PLA scaffolds. Macrophages were 
allowed to differentiate in the materials for 7 days, washed and cultured in serum free 
medium for another 48 hrs. Media was collected and analysed by ELISA. The amounts of 
IL-6, IL-8, MIP-1α, MIP-1β, MCP-1 and RANTES present in the supernatants from 
immune cells from 5 donors were quantified by ELISA. p < 0.05 (*) and p < 0.001 (***). 
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Thus, the secretion profile of PBMC was not affected by the material while NK cells 
showed decreased production of RANTES in the 3D biomaterials. And of significant 
importance, differentiation of monocyte-derived macrophages on PLA and chitosan 
scaffolds led to secretion of inflammatory mediators known to stimulate MSC recruitment.  
 
3.3.4 MSC recruitment and motility in 3D microenvironments  
Different materials impacted on different immune cells, with PLA and even more strongly 
chitosan stimulating macrophage activity and chemokine secretion. Therefore, we sought 
to understand the functional consequences of this material-cell interaction on human stem 
cell recruitment. To investigate this, a modified Boyden chamber invasion assay was 
performed. PLA or chitosan scaffolds were placed on a well of a 24 well plate, and a 
Matrigel-coated transwell chamber was inserted on top of it. Then, human MSC were 
allowed to migrate for 24 hrs towards the bottom well with the scaffolds seeded with 
different immune populations (PBMC, NK cells, monocytes or macrophages). To ensure 
that immune cells had time to produce paracrine factors, immune cells were cultured in 
DMEM without serum for 24 hrs and only then was the invasion assay performed. To 
analyse the role of macrophages, monocytes were allowed to differentiate in the different 
materials for 7 days. 
Chitosan scaffolds by itself showed a trend to recruit more MSC compared with TCPS and 
PLA negative controls (Figure 5). PBMC were not capable of relevant MSC recruitment 
independently of the substrate, with the number of recruited MSC being very similar to the 
negative controls. On the other hand, NK cells on 2D TCPS were able to recruit 4.5 times 
more MSC than in the control. This value decreased to 1.9 and 2.1 times in chitosan and 
PLA 3D scaffolds, respectively. Monocytes on 2D TCPS showed a 5.8 fold increase in 
MSC recruitment compared with the negative control. However, monocyte interaction with 
chitosan and PLA scaffolds hindered this increase to 1.2 and 1.5 fold, respectively. 
Importantly, when these cells were differentiated into macrophages the number of 
recruited MSC was decreased on 2D TCPS but was markedly higher when in contact with 
chitosan and PLA scaffolds. Indeed, macrophages were able to recruit 3 and 2.1 times 
more MSC for chitosan and PLA against 1.9 fold observed for TCPS. Thus, NK cells and 
monocytes on 2D TCPS led to a high number of recruited MSC but when differentiated in 
the presence of either chitosan or PLA scaffolds macrophages were the most effective in 
recruiting MSC (Figure 5), in agreement with the secretion profile found for these cells.  
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Figure 5 - MSC recruitment promoted by immune cells in different materials. 
Invasion assays were performed in the presence of the indicated immune cells that were 
pre-incubated for 24 hrs on 2D TCPS or in chitosan (Ch) or PLA 3D scaffolds. MSC were 
placed on the top chamber and allowed to migrate for 24 hrs. Graphs are box and 
whiskers plots with median ± maximum to minimum value. n=6-8, p < 0.05 (*) and p < 
0.001 (***). 
 
To understand whether the presence of macrophages would encourage not only MSC 
recruitment but also MSC motility within the 3D scaffolds, the dynamical behaviour of the 
cells was imaged throughout 7 days as previously described(21). Tracking Dendra2 
labelled and photo-marked MSC revealed that 3D MSC motility in the absence of immune 
cells was similar for PLA and chitosan scaffolds. But interestingly, there was a 44% 
increase in the cells motility within chitosan scaffolds at day 7 when MSC were co-cultured 
with macrophages (Figure 6a and b). The same co-culture led to a 17% decrease in cells 
motility in PLA scaffolds (Figure 6c). Thus, interactions between macrophages and 
chitosan scaffolds led to the highest increase in both MSC recruitment and motility. 
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Figure 6 - MSC motility is stimulated by macrophages in chitosan but not in PLA 
scaffolds. (a) Processed images of MSC in chitosan and PLA 3D matrices alone or co-
cultured with macrophages (1:3 ratio) over a period of 7 days obtained by a customized 
Matlab® plugin. The infiltration area increase over time in a 3D image stack was 
estimated using Dendra2imaging Matlab® plugin. White squares represent the 
photomarked cells position. The outer circle represents convex hull contour while internal 
radial dotted line represents the area occupied by photo-marked cells automatically 
quantified over distinct time-points. Scale bar, 250 μm. The infiltration area at time-points 
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1, 4 and 7 days was calculated and normalized to time-point zero, for cells in (b) chitosan 
and (c) PLA scaffolds. p < 0.001 (***), n=5 donors. 
 
3.4 Discussion 
Here, we investigated which immune cells are activated by PLA and chitosan scaffolds in 
such a way that promotes stem cell recruitment and motility. While the type of scaffold 
influenced the extent and type of immune cell responses, it was the cell type that led to 
major differences in promoting MSC recruitment.  
In this study, to avoid interference of unknown molecules in the secretion profile and cell 
recruitment assays, experiments were performed after washing and in the absence of 
serum. However, immune responses can depend on the proteins adsorbed to the 
materials surface and this should be addressed in future studies. Also, provisional matrix 
formation includes dynamic adsorption and desorption of several serum proteins, the 
Vroman effect, and this can lead to another level of complexity: activation of complement 
and coagulation systems, which are difficult to mimic.   
Here, the number of NK cells increased when cultured on 3D materials for 48 hrs without 
any other stimuli, especially on PLA, suggesting that these biomaterials can trigger NK 
cell proliferation. Indeed, cell culture in a 3D spatial arrangement has been reported to 
affect a range of cellular functions, including cell proliferative index and gene expression, 
compared with 2D substrates (22,23). Moreover, similar observations were found between 
3D matrices with distinct properties(24). Nevertheless, the cells metabolism was reduced 
when in contact with the scaffolds, indicating that individual cells are less active. Since 
resazurin conversion rate depends on the cells metabolic pathway, which is modulated by 
oxygen availability(25), the decreased metabolic activity in the scaffolds could be related to 
hypoxic gradients created by the matrix architecture and culture density in these 3D 
biomaterials(26,27). Similarly to other studies, NK cells on 2D TCPS secreted high levels of 
RANTES and IL-8 and low amounts of MIP-1α and MIP-1β(28). It has also been recently 
shown that NK cells secrete NAP-2 when on TCPS but its production in the presence of 
biomaterials remains unknown(29). However, secretion of MIP-1α, MIP-1β and RANTES 
which can stimulate MSC recruitment was abrogated when NK cells were cultured with 
chitosan or PLA scaffolds. In agreement with this, NK cells were able to recruit MSC when 
on TCPS but not in the 3D biomaterials. Thus, the role of these cells as promoters of stem 
cell recruitment may be hindered during the acute response to biomaterials.  
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As for monocytes, their number and metabolic activity was maintained upon incubation 
with the different materials. However, monocytes secreted higher levels of IL-8 in PLA 
while RANTES was expressed on TCPS but absent in the biomaterials. Similar to NK 
cells, monocytes had an improved capacity to promote MSC recruitment on TCPS but lost 
this ability in the presence of the 3D biomaterials. RANTES can impact on MSC 
chemotaxis and also on other key functions linked with their regenerative potential. 
Indeed, it was recently shown that the immunosuppressive ability of MSC relies on STAT-
1 signalling (30), which in these cells can be specifically activated by RANTES (31,32). 
Therefore, interactions of monocytes and NK cells with biomaterials hamper expression of 
key chemokines and, as a consequence, MSC recruitment.  It will be of interest to find 
strategies to modify biomaterials to stimulate NK cells and monocyte-mediated MSC 
recruitment. 
The purity of the enriched population is an important issue to consider when interpreting 
the results of secreted inflammatory mediators. The percentage of NK cells and 
monocytes used specifically for the ELISA measurements was higher than 81%, being on 
average 89% and 90%, respectively. The contaminant population was CD3- and thus 
probably includes B cells, dendritic cells and monocytes or NK cells, respectively. It is 
unlikely that these contaminant cells are the contributors to the cytokine levels since there 
was no correlation between the percentage of cells of each population and the levels of 
secreted mediators (Supplementary Figure S3).  
Contrary to the other immune cell populations analysed, macrophages differentiated in the 
presence of PLA or chitosan scaffolds showed high levels of metabolic activity. This 
difference was not perceived for their precursor cell, suggesting that monocyte to 
macrophage differentiation is needed to yield this response. There was probably an 
increased conversion of resazurin to resorufin due to abundant mitochondrial ROS 
production by macrophages interacting with the scaffolds. Indeed, we noticed that 
macrophage culture in 3D biomaterials lowered the pH of culture medium to levels below 
3.8, particularly with chitosan, suggesting a more intense reaction in the presence of this 
material. Although monocytes could be cultured for 48 hrs on 2D TCPS surfaces, their 
prolonged incubation on this surface led to poor cell survival. This suggests that 
monocytes failed to remain attached on TCPS for a 7 day period, which led to a decrease 
in the number of monocyte-derived macrophages probably due to anoikis(33,34). 
Interestingly, the same outcome was not verified for macrophages incubated in the 3D 
biomaterials, indicating that the 3D scaffold microenvironment stimulated macrophage 
metabolism and survival. This will have an impact on the levels of cytokines being 
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produced by monocyte-derived macrophages on 2D TCPS, which thus cannot be 
compared with the levels found for cells incubated with the 3D biomaterials.  
It has previously been shown that 3D PLA and chitosan scaffolds lead to production of a 
mixture of cytokines characteristic of both M1 and M2 macrophages(14). However, the over 
simplistic M1 or M2 classification remains controversial and analysis of the functional 
outcome of macrophage behaviour induced by biomaterials on MSC behaviour 
recruitment might be more useful(35). Distinct biomaterials had a profound effect on 
macrophages secretion profile, with PLA stimulating secretion of IL-6 and IL-8 while 
chitosan led to increased IL-8, MCP-1, MIP-1α and MIP-1β and RANTES production. IL-6, 
IL-8, MIP-1α, MIP-1β, MCP-1 and RANTES have all been implicated as potent 
chemotactic agents for MSC recruitment(32,36-39).  Also, upon biomaterial interaction 
macrophages can produce an array of pro-inflammatory cytokines and chemokines that 
have been reported to exacerbate the expression of CCR2, CCR3 and CCR4 receptors 
on MSC(31,32). Thus, this synergism could be the basis for the ability of monocyte-derived 
macrophages to recruit MSC when interacting with the 3D materials.  Interestingly, 
analysis of the cells motility within 3D matrices has revealed that MSC motility within PLA 
and chitosan is very similar but that macrophages stimulated MSC movement when in 
chitosan but not in PLA. MSC movement in 3D microenvironments might be favoured by 
increased local concentrations of collagenases and gelatinases, which is promoted by 
pro-inflammatory environments. In fact, a strong increase in expression of MMP-1, -3, -9 
and MMP-13 has been reported for MSC upon treatment with inflammatory cytokines(32,40). 
Moreover, it has been previously demonstrated that chitosan leads to enhanced activity of 
MMP-9 produced by macrophages(41). Therefore, differences in the inflammatory milieu 
could explain why macrophages encouraged MSC motility within chitosan scaffolds but 
not for PLA.  
PBMC consist of a heterogeneous population that includes mostly monocytes and T 
lymphocytes but also B, NK and NKT lymphocytes, thus allowing immune cell crosstalk to 
occur. PBMC showed no significant differences in their cell number when in the presence 
of scaffolds. Moreover, metabolism did not correlate with the cell number as there was a 
significant decrease of cells metabolic activity when cultured in 3D materials, similarly to 
what was observed with NK cells. Additionally, PBMC secreted low amounts of IL-6, MCP-
1 and MIP-1α with a reasonable expression of IL-8 that was material-independent. 
Concomitantly, PBMC did not stimulate MSC recruitment, independently of the material, 
suggesting that either the total number of monocytes/macrophages or NK cells found in 
PBMC was not sufficiently high to stimulate MSC recruitment or that interactions between 
the different immune cell populations might inhibit production of important chemokines.  
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3.5 Conclusion 
In summary, this work provides a comprehensive analysis of primary human responses 
triggered by different 3D biomaterials and the functional consequence of those responses 
on recruitment and motility of primary human MSC (Figure 7). PBMC and NK cells 
showed an increased cell number in PLA and expressed an unfavourable secretion profile 
when interacting with chitosan or PLA scaffolds, and did not stimulate MSC recruitment. 
Importantly, monocyte-derived macrophages but not monocytes yielded the highest MSC 
recruitment when interacting with these biomaterials. This may imply that stem cell 
recruitment is only signalled at later stages of host response and that it is promoted by 
mature macrophages. Moreover, the impact of macrophages on MSC motility was 
biomaterial-dependent. This stem cell dynamical behaviour can be essential for the 
regenerative switch from detrimental inflammatory response to constructive remodelling.  
 
Figure 7 - Summary of PBMC, NK cell, monocyte and macrophage behaviour when 
in contact with 2D TCPS or 3D chitosan and PLA scaffolds and their impact on MSC 
recruitment. Cell number (#) is compared with the initial number of seeded cells. 
Metabolic activity of cells in 2D TCPS was considered baseline (-) for comparisons with 
chitosan and PLA scaffolds. Recruitment of MSC in relation to each negative control is 
indicated. 
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3.6 Material & Methods 
3.6.1 Scaffold Fabrication  
PLA scaffolds: Poly-96L/4DL-lactic acid (from PURAC, Netherlands) was used. PLA 
scaffolds were fabricated by solvent casting and particle leaching as previously 
described(42). A 5% (w/v%) PLA solution in chloroform was mixed with sieved sodium 
chloride (NaCl) measuring between 75 and 150 µm. The slurry was cast into 24 well 
Teflon moulds until complete chloroform evaporation. NaCl particles were dissolved by 
immersing the cylinders in distilled water.  
Chitosan scaffolds: Chitosan (France-Chitine) was purified as described(43). Chitosan 
sponges were prepared by freeze-drying using a 2% solution of chitosan (degree of 
acetylation: 12.00 ± 2.35%, molecular weight: 324 ± 27 x 103) as in (19,43). Briefly, chitosan 
was hydrated overnight at 4 ºC and dissolved by adding acetic acid (Panreac) to a final 
concentration of 0.2 M under strong vortex agitation. The chitosan solution was incubated 
for 24 hrs at 4 ºC, was centrifuged at 4165 g for 5 min and then 800 μl was added to each 
well of a 48-well plate. Plates were placed at -20 ºC and freeze-dried at -80 ºC for 48 hrs 
to produce scaffolds.  
Both PLA and chitosan scaffolds were cut into a cylinder shape of 11 mm diameter and 2 
mm height (20.2 ± 0.5 mg and 5.8 ± 0.5 mg average weight for PLA and chitosan, 
respectively) and disinfected as in (19).  
3.6.2 Scanning electron microscopy characterization of 3D scaffolds 
Cross-sections of 2 mm thickness were cut in liquid nitrogen and mounted with carbon 
tape for scanning electron microscopy (SEM) analysis. Samples were sputter-coated with 
gold and observed with a JEOL JSM-6301F SEM, at 1 kV and amplifications of 1000X or 
250X. Pore diameter was measured with ImageJ software.  
3.6.3 Measurement of endotoxin levels 
PLA and chitosan extracts were prepared by cutting the scaffolds into small pieces that 
were suspended in 40 ml endotoxin-free water per gram of dry polymer, and incubated for 
24 h at 50 ºC under continuous shaking (250 rpm), as described elsewhere(44). Endotoxin 
detection was performed by Analytical Services Unit of iBET, Oeiras, Portugal using a 
Charles River endotoxin detection kit.  
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3.6.4 Cells 
Human bone marrow MSC (Lonza) were cultured in MSC growth medium (DMEM with 
low glucose supplemented with Glutamax plus 10% MSC selected inactivated FBS and 
1% penicillin/streptomycin (all from Invitrogen)). Cells were incubated at 37ºC/5% (V/V) 
CO2 and medium was changed twice per week until cells reached approximately 80% 
confluence. For expansion, cells were detached by treatment with 0.05% trypsin/EDTA 
(Invitrogen) and replaced in 150 cm2 tissue culture flasks (BD Falcon). MSC were used at 
passages 5-8. PBMC, NK cells and monocytes were obtained from buffy coats of healthy 
human donors, kindly provided by Centro Hospitalar de São João after patients informed 
consent and ethics committee approval. Briefly, a PBMC suspension was prepared by 
density gradient centrifugation and NK cells were purified by negative selection using the 
EasySep human NK cell enrichment kit (StemCell Technologies), as detailed 
elsewhere(12). Human monocytes were isolated by negative selection using a RosetteSep 
human monocyte enrichment cocktail (StemCell Technologies), as previously 
described(14). PBMC, NK cells and monocytes used in the following experiments were 
isolated from the same donor. The percentages of CD56+CD3- cells for the isolated NK 
cells and CD14+CD3- for monocytes were on average 89±6% and 87±8%, respectively, 
as confirmed by flow cytometry. Macrophages were differentiated from monocyte-enriched 
populations by culturing directly on 2D TCPS (Tissue Culture Polystyrene) surfaces or in 
PLA and chitosan 3D scaffolds for 7 days in RPMI medium supplemented with 1% 
penicillin/streptomycin and 10% inactivated FBS. Cells were cultured in the absence of 
any additional growth factors/cytokines such as M-CSF or GM-CSF. 
3.6.5 Cell seeding 
To understand how distinct materials affected immune cells, PBMC, NK cells or 
monocytes isolated from the same donor were ressuspended in DMEM without serum and 
seeded on 2D TCPS or in PLA or chitosan 3D scaffolds. For that, 25 µl of cell suspension 
was added to each side of the scaffold with a total of 6×105 immune cells per scaffold. 
Then, the seeded scaffolds were incubated for 4 hrs at 37ºC/5% (V/V) CO2 to promote cell 
adhesion before adding 750 µl of DMEM without serum. Cell culture proceeded for 48 hrs. 
For macrophages, 6×105 monocytes were seeded as described and allowed to 
differentiate in the materials for 7 days in 750 µl of RPMI medium supplemented with 1% 
penicillin/streptomycin and 10% inactivated FBS. Then, this culture medium was carefully 
removed and washed with PBS before adding 750 µl DMEM medium without serum and 
culturing for another 48 hrs.  
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3.6.6 Metabolic activity 
The metabolic activity of PBMC, NK cells and monocytes that had interacted for 48 hrs 
with the materials, or macrophages that had been in culture for 9 days with the scaffolds 
was assessed with a resazurin assay as described elsewhere(45). Values obtained with 
scaffolds incubated in the absence of cells were subtracted in the final analysis.  
3.6.7 DNA quantification 
PLA and chitosan scaffolds were washed in PBS, thinly cut and incubated in 1% triton X-
100 (Sigma) at 4°C under agitation for 1 hr. To reduce the effects of triton X-100 (Sigma) 
in DNA quantification, the solutions were diluted in PBS for a final concentration of 0.1% 
triton X-100. Then, scaffolds were vortexed and Quant-iT™ PicoGreen dsDNA Reagent 
(Invitrogen) was used according to the manufacturer’s protocol to quantify DNA content. 
To estimate the number of cells on the scaffolds, a standard curve was prepared using 
samples with a known number of PBMC, NK cells and monocytes. 
3.6.8 Nuclei and actin staining 
For analysis of cellular morphology, cells were stained for actin and nuclei. After 48 hrs 
(for PBMC, NK cells and monocytes) or 9 days (for macrophages) of culture in the 
scaffolds, cells were washed with PBS and fixed with 4% paraformaldehyde for 30 min at 
4ºC and washed with PBS. Cells were incubated with phalloidin–AlexaFluor633 (50 µl, 
Invitrogen) in PBS (1:40) for 1 hr on ice and washed with PBS. Nuclei were then 
counterstained with propidium iodide (20 µg/ml) for 10 min followed by washing with PBS. 
Scaffolds were imaged on a laser scanning confocal microscope (Leica TCS SP5 II, 
model DMI6000B-CS, Bioimaging Center for Biomaterials and Regenerative Therapies, 
b.IMAGE, Porto).  
3.6.9 Protein arrays 
Monocyte-derived macrophages were cultured for 7 days on 2D TCPS or in 3D chitosan 
or PLA scaffolds in RPMI medium supplemented with 1% penicillin/streptomycin and 10% 
inactivated FBS. Then, culture medium was carefully removed and wells washed with 
PBS, before adding fresh 750 µl of DMEM without serum. Supernatants were then 
collected after 48 hrs of cell culture in the designated materials, centrifuged and kept at -
80ºC until analysis. A membrane-based Inflammation Array III (Raybiotech) was used to 
analyse secretion of 40 cytokines according to manufacturer’s instructions. Supernatants 
from chitosan scaffolds incubated without cells were used as a control. 
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3.6.10 ELISA assays 
ELISA assays were performed to quantify secreted cytokines. Supernatants were 
collected after 48 hrs of immune cell – material interaction, centrifuged and kept at -80ºC 
until analysis. IL-6, IL-8, MIP-1α, MIP-1β, MCP-1 and RANTES levels were quantified 
according to manufacturer’s instructions (Mini ELISA Development Kits, PeproTech). 
Concentrations were determined for five donors per condition and values were corrected 
with the amount determined for materials incubated in the absence of cells.  
3.6.11 Invasion assay 
Studies on invasion of MSC were performed using a modified transwell chamber system. 
Membrane filters with a pore size of 8 µm that had been coated with Matrigel (BD 
Biosciences) were used for the top compartment. Matrigel mimics the extracellular matrix 
that cells need to invade through in order to arrive to the implant site. The lower 
compartments of the invasion chamber contained 750 µl of DMEM medium, as a negative 
control, or immune cells (PBMC, NK cells, monocytes and macrophages) seeded on 2D 
TCPS or PLA and chitosan 3D scaffolds as already described. Custom spacer rings with 2 
mm height were used to maintain the distance between the seeded scaffolds and the 
transwell insert. Matrigel-coated inserts were pre-incubated for 1 hr with serum-free 
DMEM before adding MSC at 4x104 cells in 500 µl serum-free DMEM medium. The 
invasion chambers were incubated for 24 hrs at 37ºC/5% CO2. After incubation, inserts 
were washed with PBS and cells were fixed in 4% paraformaldehyde for 20 min at room 
temperature (RT). Inserts were washed with PBS and kept at 4ºC until analysis. Cells on 
the top surfaces of filters were wiped off with cotton swabs and the membrane was 
carefully cut and mounted on a slide with Vectashield and DAPI. Cells that had migrated 
into the lower compartment and attached to the lower surface of the filter were counted in 
an inverted fluorescence microscope (ZeissAxiovert). Cell nuclei were counted in ten 
200X fields of view for each membrane. The number of migrated cells was estimated by 
taking into account the area of a field of view and the total area of the membrane. 
3.6.12 Photoswitching and imaging Dendra2+ MSC to measure cells motility 
MSC motility was estimated by following the behaviour of photo-switched Dendra2+ MSC 
for up to 7 days, as previously described(21). Dendra2+ MSC can be converted from green 
to red fluorescence in defined regions, being then easier to track the cells over long 
incubation periods that require placing the cells in the incubator between time points. 
Briefly, cells were transfected by electroporation with Dendra2 plasmid DNA (pDendra2, 
Clontech) using a X-Cell Gene Pulser (BioRad), with 80% efficiency, as described in (21). 
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MSC were then seeded on PLA or chitosan scaffolds with a square shape of 4x4 mm and 
2 mm height. When mentioned, scaffolds had been previously seeded with 6×105 human 
monocytes which were allowed to differentiate into macrophages for 7 days. Then, 2 x105 
MSC in 25 μL of DMEM medium were added to each side (top and bottom) of a scaffold in 
non-treated 24 well tissue culture plates. Cells were allowed to adhere to the scaffold for 4 
hrs at 37ºC/5% CO2 and then 400 μL of medium was added. MSC to macrophage ratio 
was 1:3. Green-to-red Photoconversion was performed with a laser scanning confocal 
microscope (Leica TCS SP5 II, model DMI6000B-CS, Bioimaging Center for Biomaterials 
and Regenerative Therapies, b.IMAGE, Porto). The reference red cell population was 
then used to centre the scaffold, which was imaged 1, 4 and 7 days after conversion (3-5 
spots per scaffolds in each individual experiment). After imaging, cells were returned to 
the incubator and cultured at 37ºC/5%CO2, until the next imaging time-point. 
3.6.13 Dendra2 imaging data analysis - MatLab Plugin 
MatLab Plugin: An automatic tool named Dendra2imaging was implemented in 
MATLABTM. This tool enabled analysis of the infiltrated area covered by photo-marked 
cells in microscopy images acquired in different days. The algorithm defines a threshold 
value used to bin the input image in order to extract the objects (cells) from their 
background(46). For standardization purposes, the same threshold value was applied to 
images of the same series in distinct experimental conditions, allowing unbiased 
comparison of cell motility. Based on the segmented image the algorithm automatically 
estimates the region occupied by cells as well as the convex hull contour of that same 
region. The region occupied by photo-marked cells was then normalized to the area 
measured at time-point 0. 
3.6.14 Statistical analysis 
Statistical analysis was performed using Prism5 software, v5.01. Friedman matched 
paired test followed by Dunns comparison test was used to compare more than two 
samples. For grouped samples, two-way ANOVA test was used followed by Bonferroni 
post-test. Data are mean ± Standard Error of the Mean (SEM) unless stated otherwise. 
Values of p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***) were considered statistically 
significant. 
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3.9 Supplementary Data 
 
Supplementary Figure S1 - Structure of (a) PLA and (b) chitosan (Ch) scaffolds. 
Photographs and SEM (Scanning Electron Microscopy) images show the macroscopic 
and microscopic structure of the scaffolds. The presence of large (#) and small (arrows) 
interconnecting pores is visible. 
 
Supplementary Figure S2 - Immune cells are homogenously distributed throughout 
the scaffolds. Nuclei of cells within (Ch) chitosan (top) and PLA (bottom) scaffolds. Upon 
cell culture for 2 days (or 9 days for macrophages) in the indicated scaffolds, cells were 
fixed and stained for nuclei with propidium iodide before being visualized by laser 
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scanning confocal microscopy. The chitosan scaffolds can be observed due to their 
autofluorescence. Scale Bar, 100 µm. n=3 
 
Supplementary Figure S3 - NK cell (top) and monocyte (bottom) purity impact on 
the production of selected cytokines. No correlation between cell purity and the 
concentration of cytokines has been found. RANTES: black circles; IL-8: red squares; 
MCP-1: black diamonds. n = 5 donors.   
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“DO FUNDO DO FIM DO MUNDO 
 
Do fundo do fim do mundo 
Vieram me perguntar 
Qual era o anseio fundo 
Que me fazia chorar. 
E eu disse: «É esse que os poetas 
Têm tentado dizer 
Em obras sempre incompletas 
Em que puseram seu ser.» 
E assim com um gesto nobre 
Respondi a quem não sei 
Se me houve por rico ou pobre.” 
 
14-7-1934 
Poesias Inéditas (1930-1935). Fernando Pessoa. Lisboa: Ática, 1955 (imp. 1990) -153. 
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4.1 Abstract 
The biological response to implanted biomaterials is a complex and highly coordinated 
phenomenon involving many different cell types that interact within 3D 
microenvironments. Here, we increased the complexity of a 3D platform to include at least 
three cell types that play a role in the host response upon scaffold implantation. With this 
system it was possible to address how immune responses triggered by 3D biomaterials 
mediate recruitment of cells that promote tissue regeneration, MSC, or a foreign body 
response, fibroblasts. Primary human macrophages yielded the highest fibroblast 
recruitment when interacting with chitosan scaffolds but not PLA. Interestingly, when there 
were MSC and fibroblasts in the same environment, macrophages differentiated in 
chitosan scaffolds again promoted a significant increase on fibroblast recruitment, but not 
of MSC. However, macrophages that were firstly allowed to interact with MSC within the 
scaffolds were no longer able to recruit fibroblasts. Overall, this study strength the idea 
that ex vivo predictive systems need to consider the different players involved in the 
biological response to biomaterials and that timing of arrival of specific cell types will affect 
the outcome. This 3-cell-3D platform might be used as tool to predict the impact of novel 
immunomodulatory materials for tissue regeneration.  
 
KEYWORDS: Inflammation; 3D Biomaterials; Macrophage; Fibroblasts; 
Mesenchymal stem cell; Recruitment; Primary Human Cells 
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4.2 Introduction 
Implantation of regenerative biomaterials triggers two opposing types of host responses: 
an immune reaction against the foreign body material(1,2) and tissue 
repair/regeneration(3,4). While the beneficial aspects of this immune reaction, such as 
debris clearance and progenitor cell recruitment, initiate healing(5), their potentially 
damaging effects, such as excessive inflammation followed by fibrotic encapsulation of a 
biomaterial should be minimized for scaffold-guided regeneration to succeed(6).  
MSC display the ability to migrate to inflamed tissues, can secrete a plethora of bioactive 
molecules with immunomodulatory and pro-regenerative action, and can differentiate in 
different lineages to directly replace damaged cells(7). Thus, MSC have become an 
attractive target in many regenerative strategies, including stem cell therapy, implantation 
of classically engineered cell-scaffold tissue constructs and lately for in situ tissue 
engineering(8). While MSC have a pivotal role in supporting the regenerative process, 
fibroblasts are perceived as critical effector cells in foreign body response (FBR) through 
exacerbated production of extracellular matrix (ECM) components(9) and secretion of pro-
inflammatory cytokines(10,11). Importantly, colonization of an implanted scaffold by blood-
derived immune cells is the main driver of the inflammatory response, which in turn can 
mediate recruitment of MSC and/or fibroblasts and heavily influence the healing outcome. 
Thus, in in vivo microenvironments the interactions between different cell types will dictate 
the regenerative outcome.  
In the first 48 hrs upon biomaterial implantation, neutrophils , monocytes  and Natural 
Killer (NK) cells are sequentially recruited to cleanse and coordinate the repair of the 
injured area but also to degrade the foreign material(15). The recruited monocytes 
gradually differentiate into macrophages, which replace the exhausted neutrophils and NK 
cells(6). Thereafter, macrophages become the dominant infiltrating cells that respond 
according to the biomaterial properties by secreting large amounts of bioactive mediators 
that can drive inflammation and tissue repair . Mediators produced by immune cells 
can promote recruitment of MSC(19) or other cells such as fibroblasts(11). Thus, biomaterial-
evoked immune responses might control the type of stromal cells recruited and 
consequently the regenerative outcome.  
Previous studies have been performed with co-cultures with only two cell types, 
investigating the outcome of immune cell – MSC interactions or immune cell – fibroblasts 
interactions(20-23). However, there is an increasing demand for ex vivo strategies that 
predict the effect of biomaterials in more complex settings, closer to a physiological 
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scenario. Here we developed an in vitro platform to analyse the interactions between 
materials and three different types of primary human cells: immune cells, fibroblasts and 
MSC. As models for biomaterials with distinct physico-chemical properties, we used Poly-
Lactic Acid (PLA), an FDA approved synthetic polymer used for bone repair or as internal 
fracture fixation device(24,25), and chitosan, which is a natural polysaccharide, currently 
explored for many applications, including wound dressings and bone regeneration(26-28). 
Here, we characterized the ability of different human immune cell populations reacting to 
the different 3D scaffold models to promote fibroblast recruitment and explored how MSC 
impact on this mobilization. 
 
4.3 Results 
4.3.1 MSC-mediated fibroblast recruitment is highly dependent on the biomaterial 
properties 
Many implanted engineered tissue-constructs rely on MSC as a cell source that 
decreases fibrous capsule thickness and consequently improves tissue integration(29-31). 
Fibroblasts are major contributors for the fibrous capsule formation following host 
response to implanted biomaterials(6). Thus, we firstly investigated whether MSC seeded 
within two different model scaffolds modulated recruitment of fibroblasts. For those 
experiments, a modified Boyden chamber model was used. Briefly, 3D PLA or chitosan 
scaffolds were placed on 24 well plates and primary human bone marrow MSC were 
seeded and cultured in DMEM without serum for 24 hrs to ensure production of paracrine 
factors. Then, primary human dermal fibroblasts (HDF) were added to Matrigel-coated 
transwells were inserted on top of the chamber and were allowed to migrate for 24 hrs. It 
was found that MSC seeded in chitosan scaffolds did not promote HDF recruitment 
(Figure 1a) while MSC in PLA induced a 1.6 fold increase in the number of recruited HDF 
(Figure 1b).  
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Figure 1 - Human dermal fibroblast (HDF) invasion is promoted by MSC seeded in 
3D chitosan or PLA scaffolds. Invasion assays were performed with HDF placed on the 
top chamber of transwell system and allowed to invade for 24 hrs stimulated by MSC in 
(a) chitosan or (b) PLA scaffolds in the bottom chamber. Graph bars show mean ± SEM. 
n=5, p < 0.01 (**). 
4.3.2 Fibroblast recruitment mediated by immune cells in distinct materials 
Invasion assays were performed to clarify which type of immune responses, evoked by 
different immune cells interaction with PLA or chitosan 3D scaffolds or 2D TCPS, 
promoted the highest fibroblast recruitment. For that, the materials were seeded with 
different immune populations (peripheral blood mononuclear cells (PBMC), NK cells, 
monocytes or macrophages) and incubated in DMEM without serum for 24 hrs to ensure 
production of paracrine factors. To analyse the role of macrophages, monocytes were 
allowed to differentiate in the different materials for 7 days, before washing and also 
incubating in DMEM with no serum for 24 hrs. Then, invasion of HDF through Matrigel-
coated transwells was analysed.  
No statistical significance was achieved for HDF recruitment mediated by PBMC, NK cells 
and monocytes. However, when monocytes differentiated into macrophages the number 
of recruited HDF was markedly higher when in contact with chitosan scaffolds but not on 
2D TCPS or in 3D PLA (Figure 2). Indeed, macrophages were able to recruit 2.7 times 
more HDF in chitosan matrices against 0.8 and 1.5 fold observed for 2D TCPS and PLA 
scaffolds, respectively.  
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Figure 2 – Human dermal fibroblast (HDF) recruitment promoted by immune cells in 
different materials. Invasion assays were performed with HDF placed on the top 
chamber of a Matrigel-coated transwell system and allowed to invade for 24 hrs towards 
PBMCs, NK cells, monocytes or macrophages on 2D TCPS, or in chitosan or PLA 
scaffolds as stimuli. Graphs are box and whiskers plots with median ± maximum to 
minimum value. n=4-7, p < 0.05 (*). 
4.3.3 Macrophages in chitosan scaffolds recruit more HDF in competition with 
MSC    
In vivo it is expected that both fibroblasts and MSC will be present around an 
injury/implant area. Therefore, we investigated how the immune response triggered by 
macrophage-biomaterial interactions affects recruitment of these two stromal cell types in 
competition. To explore this, a modified Boyden chamber invasion assay was performed 
where HDF and MSC at a 1:1 ratio were allowed to migrate towards chitosan or PLA 
scaffolds seeded with macrophages. MSC vs HDF could be distinguished by staining for 
CD146(32) (Figure 3a). 
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It was found that Macrophages differentiated in the presence of chitosan induced a 
significant recruitment of fibroblasts in detriment of MSC towards the 3D scaffold (Figure 
3b). However, the same outcome was not observed when macrophages were cultured in 
3D PLA scaffolds or on 2D TCPS. 
 
Figure 3 - MSC and HDF competitive recruitment promoted by macrophages in 
different materials. Invasion assays were performed in the presence of macrophages 
differentiated on 2D TCPS or in chitosan and PLA scaffolds for 7 days that were washed 
and pre-incubated for 24 hrs in DMEM serum free media before adding MSC and HDF 
(mixed at 1:1 ratio) to the top chamber. (a) Representative images upon CD90 (green) 
and CD146 (red) staining of migrated cells when only HDF (left), only MSC (middle) or 
HDF mixed with MSC (right) were allowed to invade. Differential cell identification was 
performed based on CD146 positive expression by MSC but not HDF (arrows). (b) 
Number of recruited MSC (red bar) and HDF (green bar) by macrophages differentiated in 
different materials. Graphs bars represent mean ± SEM. n=3 donors, p < 0.01 (**). 
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4.3.4 MSC interaction with macrophages within 3D scaffolds blocks fibroblast 
recruitment 
From an in situ tissue engineering perspective, the arrival of endogenous MSC to the 
implant site is a key event for reduced FBR and improved regeneration(8,29). Thus, we 
sought to understand whether MSC interaction with macrophages could regulate the 
subsequent mobilization of fibroblasts. For that, macrophages were allowed to 
differentiate in the scaffolds before adding the MSC. Then, cells were cultured in DMEM 
without serum for 24 hrs and invasion assays where then performed with HDF in the 
upper chamber.  Macrophages alone in chitosan or PLA scaffolds were able to recruit 2.5 
times more HDF compared with the negative controls but importantly, interaction with 
MSC either in chitosan or PLA scaffolds did not promote any fibroblast recruitment (Figure 
4a, b). This was not due to a reduction in macrophages activity as resazurin assays 
suggest that MSC and macrophages remained metabolically active upon interaction 
(Supplementary Figure 1).   
 
Figure 4 - HDF recruitment promoted in chitosan or PLA scaffolds by macrophages 
alone or co-cultured with MSC. Invasion assays were performed with HDF placed on 
the top chamber of transwell system and allowed to invade for 24 hrs stimulated by 
macrophages alone or co-cultured with MSC in (a) chitosan or (b) PLA scaffolds in the 
bottom chamber. Graphs are box and whiskers plots with median ± maximum to minimum 
value. n=5, p < 0.001 (***).  
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4.4 Discussion 
Here, we report on a 3-cell platform to screen how the responses of different immune cell 
populations reacting with model 3D biomaterials affect recruitment of stromal cell types 
that can be found at an implant site. This system allowed us to investigate whether 
activation of immune cells by PLA or chitosan scaffolds would promote recruitment of 
fibroblasts and also whether MSC could regulate this process.  
Macrophages differentiated in the presence of chitosan scaffolds were the most effective 
cells in recruiting fibroblasts. This correlates with the idea that macrophages are pivotal for 
the foreign body response through recruitment and activation of fibroblasts(33,34). Most 
interestingly, using a competitive assay it was found that when MSC and HDF co-habited 
within the same environment (upper chamber) there are differences on preferential 
stromal cell type recruitment by macrophages. This implies that heterotypic cross-talk 
between these cells influence the cell dynamics towards the implant site. Under this 
environment, only the macrophages differentiated in chitosan scaffolds were able to 
promote a significant increase of fibroblast recruitment in detriment of MSC. This event 
could increase the likelihood of fibrotic ECM formation at the implant site for chitosan 
scaffolds. Indeed, higher numbers of fibroblasts near the implanted scaffold have been 
correlated with increased inflammation and fibrous capsule thickness(11). The ratio of 
fibroblasts:MSC being recruited may play a role in determining the degree and extent of 
fibrosis since the presence of MSC has been associated with decreased thickness of the 
fibrous capsule that circumvents the implant(11,29). Considering this, we sought to 
understand whether the arrival of MSC at the implant site and consequent interaction with 
the macrophages would interfere with the subsequent fibroblast recruitment profile. For 
that, macrophages were allowed to differentiate in the scaffolds before adding MSC to 
understand whether this interaction could regulate the recruitment of HDF. Interestingly, 
MSC interaction with differentiated macrophages resulted in impairment of fibroblast 
recruitment. Cells were metabolically active upon interaction, which excludes 
macrophage-mediated MSC apoptosis due to allogenic reaction as an explanation for this 
finding. This suggests the existence of an immunomodulatory mechanism to halts both 
macrophage and MSC ability to recruit fibroblasts towards the implant site.  
In summary, this work provides a comprehensive analysis of the consequence of primary 
human responses triggered by different 3D biomaterials on recruitment of HDF. Moreover, 
it was found that interaction of MSC and HDF within the same environment can alter 
recruitment of each cell type by macrophages depending of the scaffold properties. 
Surprisingly, the macrophage-MSC interaction at both biomaterials interface did not 
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promote fibroblast recruitment. This finding suggests that stem cell arrival to the implanted 
scaffolds could provide the needed switch from inflammation and fibrosis towards 
constructive remodelling.     
4.5 Materials & Methods 
4.5.1 Scaffold Fabrication 
PLA scaffolds: Poly-96L/4DL-lactic acid (from PURAC, Netherlands) was used. PLA 
scaffolds were fabricated by solvent casting and particle leaching as previously 
described(35). A 5% (w/v%) PLA solution in chloroform was mixed with sieved sodium 
chloride (NaCl) measuring between 75 and 150 µm. The slurry was cast into 24 well 
Teflon moulds until complete chloroform evaporation. NaCl particles were dissolved by 
immersing the cylinders in distilled water.  
Chitosan scaffolds: Chitosan (France-Chitine) was purified as described(36). Chitosan 
sponges were prepared by freeze-drying using a 2% solution of chitosan (degree of 
acetylation: 12.00 ± 2.35%, molecular weight: 324 ± 27 x 103). Both PLA and chitosan 
scaffolds were cut into a cylinder shape of 11 mm diameter and 2 mm height (20.2 ± 0.5 
mg and 5.8 ± 0.5 mg average weight for PLA and chitosan, respectively) and disinfected 
as previously described(28).  
4.5.2 Measurement of endotoxin levels 
PLA and chitosan extracts were prepared by chopping the scaffolds into small pieces that 
were suspended in 40 ml endotoxin-free water per gram of dry polymer, and incubated for 
24 h at 50 ºC under continuous shaking (250 rpm), as described elsewhere(37). Endotoxin 
detection was performed by Analytical Services Unit of iBET, Oeiras, Portugal using a 
Charles River endotoxin detection kit.  
4.5.3 Cells 
Human bone marrow MSC (Lonza) were cultured in MSC growth medium (DMEM with 
low glucose supplemented with Glutamax plus 10% MSC selected inactivated FBS and 
1% penicillin/streptomycin (all from Invitrogen)). Adult human dermal fibroblasts 
(Invitrogen) were cultured in DMEM with high glucose supplemented with glutamine plus 
10% inactivated FBS (all from Biowest) and 1% penicillin/streptomycin (Invitrogen). Cells 
were incubated at 37ºC/5% (V/V) CO2 and medium was changed twice per week until 
cells reached approximately 80% confluence. For expansion, cells were detached by 
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treatment with 0.05% trypsin/EDTA (Invitrogen) and replaced in 150 cm2 tissue culture 
flasks (BD Falcon). MSC and HDF were used at passages 5-8 and 3-7, respectively. 
Peripheral blood mononuclear cells (PBMC), Natural Killer (NK) cells and monocytes were 
obtained from buffy coats of healthy human donors, kindly provided by Centro Hospitalar 
de São João. Briefly, a PBMC suspension was prepared by density gradient centrifugation 
and NK cells were purified by negative selection using the EasySep human NK cell 
enrichment kit (StemCell Technologies), as detailed elsewhere(38). Human monocytes 
were isolated by negative selection using a RosetteSep human monocyte enrichment 
cocktail (StemCell Technologies), as previously described(39). PBMC, NK cells and 
monocytes used in the following experiments were isolated from the same donor. The 
percentages of CD56+CD3- cells for the isolated NK cells and CD14+CD3- for monocytes 
were on average 89±6% and 87±8%, respectively, as confirmed by flow cytometry. 
Macrophages were differentiated from monocyte-enriched populations by culturing directly 
on 2D TCPS (Tissue Culture Polystyrene), in PLA or chitosan 3D scaffolds for 7 days in 
RPMI medium supplemented with 1% penicillin/streptomycin and 10% inactivated FBS. 
4.5.4 Cell seeding 
To understand how distinct materials affected immune cells, PBMC, NK cells or 
monocytes isolated from the same donor were seeded on 2D TCPS, in PLA or chitosan 
3D scaffolds. For that, 25 µl of cell suspension was added to each side of the scaffold with 
a total of 6x104 immune cells per scaffold. Then, the seeded scaffolds were incubated for 
4 hrs at 37ºC/5% (V/V) CO2 to promote cell adhesion before adding 750 µl of DMEM 
without serum. Cell culture proceeded for more 48 hrs. For macrophages, 6x104 
monocytes were seeded as described and allowed to differentiate in the materials for 7 
days. 
For invasion assays, immune cells were pre-cultured in DMEM without serum for 24 hrs. 
Then, the invasion assay was incubated for another 24 hrs. The total time of cell-material 
interaction was 48 hrs corresponding to the amount of time through which the initial acute 
inflammatory response is mounted upon biomaterial implantation. For macrophages, 
monocytes were allowed to differentiate in the materials for 7 days before washing and 
incubating the cells for 24 hrs with or without 6x104 MSC in DMEM before performing the 
24 hrs invasion assay. 
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4.5.5 Invasion assay 
Studies on invasion of HDF were performed using a modified transwell chamber system. 
For the top compartment, membrane filters with a pore size of 8 µm that had been coated 
with Matrigel (BD Biosciences) were used. Matrigel mimics the extracellular matrix that 
cells need to invade through in order to arrive to the implant site. The lower compartments 
of the invasion chamber were filled with 750 µl DMEM medium, as a negative control, or 
serum-free DMEM with immune cells and/or MSC previously seeded on 2D TCPS or in 
3D PLA and chitosan scaffolds. Custom spacer rings with 2 mm height were used to 
maintain the distance from the seeded scaffolds to the transwell insert. Then, Matrigel-
coated inserts that had been pre-incubated for 1 hr with serum-free DMEM were placed in 
the wells, forming the upper compartment. HDF at 4x104 cells in 500 µl serum-free DMEM 
medium were seeded into the upper compartment. The invasion chambers were 
incubated for 24 hrs at 37ºC/5% CO2. After incubation, inserts were washed with PBS and 
cells were fixed in 4% paraformaldehyde for 20 min at room temperature (RT). Inserts 
were washed with PBS and kept at 4ºC until analysis. Cells on the top surfaces of filters 
were wiped off with cotton swabs and the membrane was carefully cut and mounted in a 
slide with Vectashield and DAPI. Cells that had migrated into the lower compartment and 
attached to the lower surface of the filter were counted in an inverted fluorescence 
microscope (ZeissAxiovert). Cell nuclei were counted in ten 200X fields of view for each 
membrane. The number of migrated cells was estimated by taking into account the area 
of a field of view and the total area of the membrane. 
4.5.6 Competition assay 
Studies on the invasion of MSC mixed with HDF were performed using a modified 
transwell chamber system as previously described. Then, 4x104 MSC and HDF mixed at 
1:1 ratio in 500 µl serum-free DMEM medium were seeded into the upper compartment. 
The invasion chambers were incubated for 24 hrs at 37ºC/5% CO2. After incubation, 
inserts were washed with PBS and cells were stained with CD146 Alexa Fluor 647 (30 µl, 
AbD Serotec) in PBS (1:5) for 30 min. on ice and washed twice with PBS. Then cells were 
fixed in 4% paraformaldehyde for 30 min at 4ºC and counterstained with CD90 PE (30 µl, 
Immunotools) in PBS (1:5) for another 30 min. on ice and washed twice with PBS. Cells 
on the top surfaces of filters were wiped off with cotton swabs and the membrane was 
carefully cut and mounted in a slide with Vectashield and DAPI. Cells that had migrated 
into the lower compartment and attached to the lower surface of the filter were imaged 
and counted in a laser scanning confocal microscope (Leica TCS SP5 II, model 
DMI6000B-CS, Bioimaging Center for Biomaterials and Regenerative Therapies, 
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b.IMAGE, Porto). Cell nuclei with or without CD146 positive staining were counted in five 
200X fields of view for each membrane. Negative (with HDF only) and positive (with MSC 
only) controls were used to establish the criteria for positive CD146 staining. CD90 was 
used to delineate both MSC and HDF cell cytoplasm while CD146 was used to identify 
MSC. The number of migrated MSC and HDF was estimated by taking into account the 
area of a field of view and the total area of the membrane. 
4.5.7 Statistical analysis 
Statistical analysis was performed using Prism5 software, v5.01. D'Agostino & Pearson 
omnibus normality test was used together with the analysis of Q-Q plots to understand 
whether the fibroblast invasion process followed normality. Upon normality of the data was 
confirmed, two tailed paired t-test was used to compare two samples. Repeated measures 
ANOVA test followed by Bonferroni post-test was used to compare more than two 
samples. For grouped samples, two-way ANOVA test was used followed by Bonferroni 
post-test. Data are mean ± Standard Error of the Mean (SEM) unless stated otherwise. 
Values of p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***) were considered statistically 
significant. 
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4.9 Supplementary Data 
 
Supplementary Figure S1 - Metabolic activity of MSC and macrophages alone or co-
cultured in (a) chitosan or (b) PLA scaffolds following invasion assays with HDF 
seeded in the upper chamber. Relative fluorescence unit (RFU) as a measure of 
metabolic activity determined by resazurin assays upon 48 hrs of cell culture in serum free 
media. Graphs bars represent mean ± SEM. n=3 donors, p < 0.05 (*) and p < 0.001 (***). 
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“HÁ MUITO TEMPO QUE NÃO ESCREVO. 
  
Há muito tempo que não escrevo. Têm passado meses sem que viva, e vou durando, entre o 
escritório e a fisiologia, numa estagnação íntima de pensar e de sentir. Isto, infelizmente, não 
repousa: no apodrecimento há fermentação. 
Há muito tempo que não só não escrevo, mas nem sequer existo. Creio que mal sonho. As ruas 
são ruas para mim. Faço o trabalho do escritório com consciência só para ele, mas não direi bem 
sem me distrair: por detrás estou, em vez de meditando, dormindo, porém estou sempre outro por 
detrás do trabalho.  
Há muito tempo que não existo. Estou sossegadíssimo. Ninguém me distingue de quem sou. 
Senti-me agora respirar como se houvesse praticado uma coisa nova, ou atrasada. Começo a ter 
consciência de ter consciência. Talvez amanhã desperte para mim mesmo, e reate o curso da 
minha existência própria.  
Há muito tempo que não sou eu.” 
 
Livro do Desassossego por Bernardo Soares. Vol.I. Fernando Pessoa. Lisboa: Ática, 1982.  - 139. 
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5.1 Main findings 
Designing new biomaterials that can positively interact with the immune system instead of 
just attempting to avoid it constitutes a recent paradigm change in regenerative 
medicine(1). Although inflammation has been increasingly recognized as a key component 
of the regenerative process, the role of immune cells and inflammatory mediators in 
scaffold-guided regeneration remains poorly understood. Thus, this thesis aims to 
understand how the primary human immune responses, evoked by distinct 3D scaffold 
models, modulate recruitment of primary human BM-MSC and fibroblasts, instrumental 
cell types to determine the healing outcome. Our hypothesis focus on exploiting the 
regenerative cell mobilization upon immune responses to implanted materials. Thus, in 
Chapter 2 an imaging platform was developed to follow human MSC dynamical behaviour 
within complex 3D microenvironments. It was shown that Dendra2 photoconversion can 
be efficiently used to monitor and compare changes in MSC motility and morphology 
within distinct engineered matrices throughout 7 days. In Chapter 3 it was shown that 
distinct materials trigger specific immune cell responses which consequently had a major 
impact on MSC recruitment towards the implant. Additionally, in Chapter 4 it was 
demonstrated that distinct biomaterials can also modulate the immune cells ability to 
mobilize fibroblasts towards the implant site, but that in more complex systems, with the 
presence of a third cell type, MSC, this recruitment can be modified. Taken together, the 
gathered knowledge represents an important leap forward in the characterization of 
human immune cells ability to mediate stromal cell recruitment upon scaffold implantation. 
And importantly, these results illustrate scaffold’s potential to regulate the recruitment 
dynamics of pro-regenerative/fibrotic cell types through immune-modulation. This thesis 
work highlights a new concept for in situ tissue engineering scaffold development with 
potential for clinical translation.  
5.2 Concepts of in situ tissue engineering:                                                   
time for an integrated approach 
The finding that many adult tissues contain stem cells that function to maintain and 
regenerate tissues upon injury paved the way to the idea that we could recruit these 
endogenous stem cells to enhance tissue regeneration(2). Most excitingly, such strategies 
bypass the bottleneck issues of conventional tissue engineering and regenerative 
medicine related with ex-vivo expanded MSC. In line with this conceptual approach, 
Kitaori et al.(3) have shown that SDF-1 promotes bone regeneration by recruiting 
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systemically administered MSC to the fracture site. And importantly, inhibition of SDF-1 or 
blocking of its receptor, CXCR4, prevents MSC recruitment and results in impaired bone 
healing. The notion that stem cell recruitment by specific chemokine gradients is required 
for tissue regeneration, now supported by a number of in vivo studies(4-7), gave rise to in 
situ or scaffold-guided regenerative approaches. Such approaches aim to develop off-the-
shelf biodegradable scaffolds that can therapeutically augment our otherwise rather 
limited regenerative potential upon severe injuries. Landmark studies of Ji et al.(8), have 
shown that biomaterial-mediated SDF-1 delivery can be efficiently used to recruit MSC to 
a cranial defect resulting in an astonishing six-fold increase in bone formation compared 
to biomaterial alone. This promising approach based on scaffold-mediated chemokine 
delivery for stem cell recruitment has been successfully demonstrated in a number of in 
vivo studies(9-15). Nevertheless, several issues hamper the efficient usage of 
chemoattractants as a therapeutic approach. The most prominent ones include their high 
cost, short half-live, rapid diffusion, amenability to cleavage by proteases, controlled 
release under spatial defined gradients within a specific timeframe to promote chemotaxis 
of endogenous MSC and their largely uncharacterized inflammatory side effects(16). Here it 
was shown that specific biomaterials can induce immune cells to produce high and 
sustainable amounts of well-known stem cell chemoattractants. And importantly, this 
event was followed by the recruitment of high numbers of MSC towards the implanted 
material. Thus, our findings highlight a potential new approach in which scaffolds are 
specifically designed to modulate the immune system to produce the required stem cell 
chemoattractants instead of acting as delivery systems for exogenous chemokines. 
Interestingly, this novel approach would circumvent many of aforementioned concerns 
that plague the efficient usage of exogenous chemoattractants for enhanced stem cell 
recruitment.   
Despite the successful nature of such strategies, implantation of the so called 
“regenerative biomaterials” also triggers an opposing type of host response: an immune 
reaction against the implanted foreign material. This often culminates in biomaterials 
fibrotic encapsulation and it is one of the leading causes for implant failure. Therefore and 
as alternative, studies such as Lee et al.(17) attempt to improve scaffold-guided healing by 
targeting the biomaterial-induced FBR. These authors have shown that vanillin-
incorporated PLGA modulate macrophage activation and consequently led to a less 
severe FBR. The identification of the host inflammatory response as a critical component 
on scaffold-guided regeneration prompted the development of novel immunomodulatory 
strategies to decrease the FBR and improve the healing outcome(18-24). Here it was 
demonstrated that distinct biomaterials can also modulate the immune cells ability to 
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promote/avoid fibroblast recruitment. Importantly, our results suggested that although 
macrophages were a major player in mediating this recruitment other immune cells, as 
PBMC and monocytes, can also play a role depending on the biomaterial. Therefore, 
strategies to hamper these immune cells ability to promote fibroblast mobilization upon 
scaffold interaction could be of interest for ameliorating the FBR and their fibrotic 
encapsulation.  
Despite these two strategies have been successfully used to enhance endogenous tissue 
regeneration evidences suggest that biomaterial-evoked inflammation, endogenous MSC 
recruitment and FBR can be intimately related. Importantly, pioneer studies by Thevenot 
et al.(25) in a mice model have shown that SDF-1 incorporation in PLGA scaffolds 
enhances the recruitment of endogenous stem cells which in turn ameliorate the FBR to 
biomaterial implant through modifying immune cell responses. This and others studies(26-
30) highlight a complex interaction between the host immune response, stem cell 
recruitment and fibrotic encapsulation of implanted scaffolds with significant implications 
for the healing outcome. Within this context, our results suggested that immune cells can 
induce specific stromal cell recruitment profiles upon interaction with distinct biomaterials. 
And importantly, the preferential/premature mobilization of MSC by immune cell-
biomaterial interaction might influence the subsequent fibroblast dynamics towards the 
implant site. This could imply that an early boost on MSC recruitment instead of a 
continuous one might be a more efficient strategy to diminish the FBR and improve 
healing.  
In summary, most of these studies show that the scaffolds ability to promote progenitor 
cell recruitment and/or to modulate the immune response is pivotal to successfully 
augment endogenous tissue regeneration(25,31-39). Even though in situ tissue engineering 
has made tremendous progress with these two independent approaches, the field is still at 
its infancy in understanding the interplay between scaffold-mediated inflammation, tissue 
fibrosis and regeneration. Considering the experimental evidences so far, we anticipate 
that the next generation of regenerative scaffolds will most likely be designed to integrate 
both in situ engineering conceptual approaches. For instance such biomaterials could be 
designed to hijack the host immune response to recruit specific stromal cell types to 
potentiate regeneration instead of fibrotic encapsulation of the implant. Within this context, 
deeper insights on the complex interaction between biomaterials, host immune response 
and stromal cell recruitment are required to translate forward into design rules for the next 
generation of in situ tissue engineering scaffolds.  
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5.3 Translating forward:                                                      
deciphering host response in relevant models 
Mechanistic studies in physiologically relevant in vitro models are critical to systematically 
gather and translate the needed knowledge into future clinical applications. Such models 
provide an important tool to unravel the complexity of biological systems in order to 
understand mechanisms of biomaterial-immune cells-stromal cells interactions. For 
instance, Damanik and colleagues(40) have recently developed an in vitro model to study 
how biomaterials surface modifications modulate rat-derived macrophage and/or fibroblast 
behaviour. It was possible to correlate specific surface modifications with cell adhesion, 
proliferation, secretion profile and collagen/elastin production. This and other studies(41) 
with rat cells shed some light on some of the factors that can be used to modulate the 
host response. Nevertheless, Chamberlain et al.(42) demonstrated that primary human 
macrophage cytokine production, phenotype and intrinsic activation state have limited 
correlation to immortalized cell lines and/or macrophages derived from other species. 
Thus, and although the aforementioned reports are important proof-of-concept studies 
their immediate translation into a human scenario is rather limited.  
Considering this, McNally et al.(43) have recently developed a human model of IL-4-
induced macrophage fusion and FBGC formation to study the effects of different 2D 
material surfaces on phenotypic expression in primary human macrophages. Similarly, a 
number of other 2D models with primary human immune cells are available to 
study/predict the human host response to implanted biomaterials(43-48). Nevertheless, 
these models display two important intrinsic limitations if one wants to apply to in situ 
tissue engineering studies. Firstly, marked differences on immune cells responses when 
on 2D substrates versus their “native” 3D microenvironments have been reported(49-51). 
And secondly, such models clearly focus on the contribution of one immune cell type 
(mostly macrophages) upon interaction with 2D surfaces for the biomaterials fibrotic 
encapsulation. In a physiologic scenario, scaffold-guided regeneration involves the 
coordinated movement of distinct cell types in close interaction with several immune cells. 
Thus, if one aspires to create design rules for immune-modulatory scaffolds with clinical 
translation, more sophisticated in vitro systems will be required. Considering the need for 
a more physiologically relevant model, we developed a modified 3D Boyden invasion 
system using distinct primary human immune cells in co-culture with other primary human 
cell types and biomaterials in a three-dimensional environment. Importantly it allowed us 
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to study how human immune responses, triggered by different 3D scaffolds, guided the 
recruitment of other cells to assist in the healing process.  
In our quest to unveil the role of biomaterial-evoked immune responses on stromal cell 
recruitment we first sought to investigate whether the 3D scaffold models could distinctly 
modulate immune cell behaviour. To address this, PLA or chitosan 3D scaffolds were 
seeded with different immune populations from the same human blood donor (PBMC, NK 
cells, monocytes or macrophages) and cultured. The investigations carried out in this 3D 
model were performed in the absence of serum or with a pre-washing step to avoid 
interference of unknown molecules in the secretion profile and cell recruitment assays. 
This enabled a clearer analysis of the factors produced and their effect on cell recruitment. 
Arguably, this could also be a limitation of this work since immune responses can be 
influenced by the adsorbed proteins to the materials surface(52,53). Battiston and 
colleagues(54-56) have shown that the variation in protein adsorption, which was a function 
of surface chemistry, led to the varied cytokine release profile of adhered monocytes on 
different surfaces. Thus it would be interesting to study whether specific surface 
modifications/adsorbed protein coatings could modulate immune cells ability to promote 
recruitment of regenerative cell types towards the implant. This would be an elegant 
alternative to the expensive delivery of a limited number of chemokines to induce 
endogenous progenitor cell recruitment for in situ regeneration.  
Here it was shown that distinct materials induced specific secretion profiles by distinct 
immune cell populations. This was expected since PLA and chitosan scaffolds display 
many distinct features known to influence immune cell behaviour including surface 
chemistry(57), roughness(58) and stiffness(22). Importantly, we have observed that several 
chemokines known to induce MSC and/or fibroblast recruitment were highly expressed by 
macrophages, particularly upon differentiation in the presence of 3D biomaterials. Thus 
we sought to understand the functional role of the immune cells secretome on mediating 
the stromal cell recruitment towards the distinct biomaterials. For that, a Matrigel-coated 
transwell chamber seeded with stromal cells (MSC and/or fibroblasts) was inserted on top 
of the mentioned 3D culture system, to mimic the extracellular matrix basement 
membrane that these stromal cells need to invade to arrive to the implant site. With this 
model several aspects of stromal cell mobilization towards the implant site could be 
studied, from the type of immune responses evoked by distinct 3D materials, their effect 
on mediating invasion of stromal cells towards the implanted scaffolds, to the impact of 
immune cell interaction with the recruited MSC at the scaffold interface. Importantly, data 
derived from primary human cells from several donors, was obtained. Moreover, this 
primary human 3D model fulfils the missing gap between the over simplistic 2D culture 
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systems and the in vivo animal models that despite physiologically relevant may not fully 
represent the human responses due to inter-species immunological discrepancies(59). The 
development of such 3D models are not only instrumental to unveil mechanistic aspects of 
the human healing response upon scaffold implantation but can also have an important 
applicability in the field of personalized regenerative medicine as a predictive tool of hosts 
immune/healing response to a given implanted material.  
5.4 A new perspective from within: Dendra2 imaging platform   
For successful in situ tissue regeneration, endogenously recruited MSC must be able to 
colonize the engineered scaffold that gaps the wound limits. Colonization of the implanted 
scaffold by hosts cells, and therefore its in vivo performance, is highly dependent on the 
3D architectural features of the porous scaffold(60). Thus, there has been an increasing 
demand for imaging tools able to monitor and compare cell dynamics within 3D scaffolds 
with distinct properties. Indeed, the advance of live imaging methods is instrumental for 
tissue engineering scaffold development and has been identified as a strategic priority in 
the field(61).  
Several studies illustrate confocal microscopy potential to interrogate how specific 
engineered matrix features can be optimized to facilitate MSC ingrown(62-65). Nevertheless, 
most of these confocal imaging platforms fail to perform a longitudinal assessment of 
MSC dynamical behaviour within 3D scaffolds. This is important taking into account the 
physiologic timeframe and dynamics of the scaffold colonization process. As a result, 
other methods as photoacoustic(66,67) and optical coherence microscopy (OCT)(68-70) have 
been increasingly recognized as promising alternatives to characterize cell motility within 
tissue engineered constructs. Mostly because they far exceed the live cell imaging time 
allowed by confocal imaging techniques due to phototoxicity/photobleaching constrains, 
even that they do not match confocal spatial resolution. Longitudinal monitoring of MSC 
migration is possible with such alternative imaging modalities but intricate. Since cells 
would need to be permanently on the microscope over imaging time which usually is not 
feasible for long term experiments (e.g. more than one week). In addition, for OCT 
imaging the scaffold materials must be selected to have different scattering properties 
from the cells. Importantly, the ECM components that are gradually secreted by cultured 
cells has been reported to obscure the cell signal over time(69).  
Within this framework, we have developed an efficient confocal imaging method for tissue 
engineering applications that takes advantage of the photoswitchable Dendra2 fluorescent 
protein. And importantly, a direct comparison of MSC migration within distinct 3D 
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engineered matrices with a longitudinal perspective is now possible using a confocal 
microscope. Apart from surpassing current long term imaging limitations, this Dendra2 
imaging strategy could be used to simultaneously investigate intracellular protein 
dynamics during the 3D migration process by Dendra2 tagging or be even used as a 
reporter gene for MSC differentiation(71-73). Moreover, our Dendra2 imaging principle could 
also be applied in wide-field mercury lamp fluorescence microscopes widely available in 
research institutions(72).  
Despite the imaging functionality, our results suggest that the transfection process, but not 
the Dendra2 protein expression, hinders MSC proliferation. Nevertheless, others have 
reported that electroporation has no influence on MSC differentiation and proliferation(74). 
Thus, several strategies could be employed to overcome this issue, including 
electroporation with different settings and MSC donors or even by using alternative 
transfection techniques such as viral transduction or lipofection(75-77).  
Although this technique can be used to compare cell motility within distinct matrices we 
found that Dendra2 expression seems to slowdown MSC migration velocity by 43% on 
2D. Therefore, no absolute measurements of cells velocity could be provided. However, it 
would be important to confirm whether this observation is maintained in a 3D environment 
where cells can rely on different migration processes. Alternatively, other photoconvertible 
proteins could be used to overcome these limitations(78). Thus it would be possible to 
calculate the absolute values for Euclidean distance using the current imaging framework. 
This could be achieved by combining the centre-of-mass position of photoconverted 
population with specific landmarks on the scaffold itself to triangulate cells positions over 
the distinct time-points(79).     
Importantly, MSC dynamical behaviour was characterized in matrices with distinct optical 
densities and properties. These included a Matrigel matrix that mimicked the basement 
membrane in the invasion assays. The slower migration in Matrigel compared with porous 
scaffolds could be explained by the increased steric hindrance of the matrix, due to a 
tighter mesh size combined moderate gel stiffness, which can limit cell spreading(80-83). In 
such scenario MSC would need to use alternative migration modes to invade the matrix. 
Moreover, MSC invasion would be assisted by their proteolytic activity which is reported to 
be augmented under inflammatory settings(81,84-87).  
Taken together, Dendra2 imaging it is a highly flexible and adaptable platform that allows 
coupling 3D cell morphology analysis and quantification of cell migration in real-time, 
studies on cell-ECM interactions in a range of bioengineered matrices with distinct optical 
properties, and reliable imaging for more than 7 days. 
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5.5 Biomaterial immune-modulation:                                                       
Aiming for the strategic control of stromal cell recruitment 
Biomaterial implantation unavoidably leads to tissue damage, immune cell recruitment, 
adhesion at the scaffolds interface and cell activation. This ultimately drives the 
inflammatory process whose role has been increasingly recognized as a key component 
of tissue repair and regeneration. Importantly, the scaffold features can influence many 
aspects of immune cells behaviour. These features are largely responsible for the type of 
infiltrating immune cells, activation state and secretion profile that mediate subsequent 
steps of the healing cascade, including the mobilization of distinct stromal cell types(29,39). 
Here it was showed that marked differences on immune cells proliferation, metabolism 
and actin cytoskeleton morphology are induced by distinct 3D materials. Additionally, the 
responses of immune cells known to participate on early (NK cells, monocytes and 
PBMC) and/or late (predominantly macrophages but also PBMC at some extent) phases 
of host response to the implanted scaffolds were investigated to trace a putative profile of 
MSC and fibroblast recruitment over the inflammatory process.  
Our results suggest that NK cells and PBMC proliferate at different extents depending on 
the biomaterial. Thus the proportion of each immune population at the implant site may be 
partially regulated by their selective recruitment from circulation but also by the 
biomaterial-induced proliferative state. Importantly, this could be targeted to enhance the 
number of specific “pro-regenerative” immune cells at the biomaterial interface. Despite 
the increased cell number of PBMC and NK cells in some materials both populations 
exhibited rather similar secretion amounts of key inflammatory mediators regardless of the 
3D scaffold, suggesting a self-regulatory mechanism. This translated into a comparably 
low ability to mobilize MSC or fibroblasts which suggests that these cells role in host 
response is probably more related with avoiding biomaterial-derived infections and not 
mediating stromal cell recruitment. Nevertheless, we have recently shown that NK cells 
have the ability to induce MSC migration through production of RANTES and NAP-2 
chemokines(88). Moreover, blocking CXCR2 receptor, a receptor that recognizes both 
chemokines, abolished NK cell-mediated MSC recruitment. Although a similar outcome 
was observed here for NK cells on TCPS, RANTES expression was significantly down-
regulated when NK cells interacted with the 3D biomaterials. Therefore it would be 
interesting to find immune-modulatory strategies to restore these early cells ability to 
mobilize endogenous MSC upon interaction with implanted biomaterials.  
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In our model, monocytes (whose accumulation in vivo peaks at around 72 hrs) do not 
seem to proliferate upon biomaterial interaction. Several reports state that distinct 
monocyte subsets are continuously recruited from the blood stream to the inflammation 
site throughout the healing process(89). Contrary to the other immune cells, monocytes 
seem to slightly adjust the secreted cytokine levels depending on the biomaterial, at least 
for the analyzed markers. Thus, PLA scaffolds encouraged a significantly higher 
production of IL-8 compared to chitosan. Interestingly, this was followed by a trend for 
monocytes to recruit more fibroblasts (but not MSC) in PLA matrices which suggests 
some degree of decision making over the type of recruited stromal cell early on in the 
inflammatory phase.     
Upon arrival to the implant site, monocytes gradually differentiate into macrophages 
representing the dominant immune cell type at later stages (days to weeks) of the host’s 
healing response(90,91). Macrophages differentiation is perceived as pivotal in orchestration 
of either tissue regeneration or foreign body response(92). Indeed, their remarkable 
plasticity enables them to assume diverse and context-dependent polarization states 
which influence the healing outcome(93). These are broadly categorized by their functional 
properties and patterns of cytokine secretion into M1 (pro-inflammatory), M2wound healing 
which are more amiable to promote fibrosis and M2regulatory which suppresses the immune 
responses to resolve inflammation and encourage functional tissue restoration. 
Nevertheless, Madden et al.(94) have shown that many macrophages that stained in vivo 
for specific cell surface markers of M1 also stained for M2, that is, in what appears to be a 
mixed M1–M2 phenotype. This was corroborated by Van Putten et al.(41) that also 
suggested that many macrophages in the FBR induced by hexamethylenediisocyanate 
cross-linked dermal sheep collagen (HDSC) did not fit into the classical M1 or M2 
dichotomy. Thus, although the aforementioned classification system constitutes a practical 
framework, in reality a continuum of phenotypes with overlapping functions co-exist(95). 
Regarding to the biomaterial models used in this thesis, our group has previously 
demonstrated that PLA and chitosan lead to production of a mixture of cytokines 
characteristic of both M1 and M2 macrophages(57). Here, these 3D biomaterials also had a 
profound effect on macrophages secretion profile. Similarly to their precursor cells, 
macrophages tuned their secretion profile according to the type of biomaterial 
encountered. Interestingly, among the inflammatory mediators distinctly expressed were 
IL-6, IL-8, MIP-1α, MIP-1β, MCP-1 and RANTES. All these mediators have been 
implicated as potent chemoattractants for MSC and/or fibroblast recruitment(86,96-100). 
Therefore, instead of classifying macrophage biomaterial-induced polarization markers for 
M1 or M2 we found it more meaningful to investigate their functional outcome on 
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mediating the late stromal cell mobilization(101). Here we found that macrophages were the 
immune cell type specifically activated by 3D biomaterials to secrete large amounts of 
bioactive molecules that could strongly encourage MSC and fibroblast recruitment 
towards the implant site. Most interestingly, it was demonstrated that when these stromal 
cells co-exist within the same environment differences on preferential cell recruitment by 
macrophages arose and notably were scaffold-dependent: macrophages in chitosan 
scaffolds promoted a significant increase of fibroblast recruitment in detriment of MSC, 
contrarily to what was observed with PLA. Since higher numbers of fibroblasts near the 
implanted scaffold have been correlated with increased inflammation and fibrous capsule 
thickness(29) our results could suggest an increased likelihood that chitosan leads to a 
stronger FBR comparably to PLA scaffolds upon implantation. Nevertheless, additional in 
vivo studies comparing the host response to implanted PLA and chitosan scaffolds are 
required to further validate our 3D model and substantiate this claim. Considering our 
findings, chitosan scaffolds modified to ameliorate/modulate immune cell 
activation(23,24,102,103) or designed to recruit higher numbers of endogenous MSC to down-
regulate excessive fibrosis(30,104) could greatly benefit their biocompatibility. 
 
 
Figure 1 - Blueprint of primary human immune cells impact on stromal cell 
recruitment towards chitosan (right) or PLA (left) 3D scaffolds. Chitosan scaffolds: 
Upon implantation, PBMC, NK cells and monocytes are recruited to and activated at the 
implant interface to secrete several mediators including IL-6, IL-8 and MCP-1. PBMC and 
NK cells can proliferate upon contact with chitosan. In an early phase NK cells are 
GENERAL DISCUSSION 
167 
responsible for mobilization of MSC with few MSC and fibroblasts being recruited by 
monocytes. Upon monocyte-to-macrophage differentiation these cells secrete huge 
amounts of inflammatory mediators such as MCP-1, MIP-1α/β, and RANTES, and 
promotes preferential recruitment of fibroblast in detriment of MSC to the implant 
surroundings. Nevertheless, recruited MSC accumulate at the injury site and their 
interaction with macrophages at the scaffolds interface strongly accelerates the 
colonization rate. In turn, MSC interaction with macrophages at the scaffolds interface 
terminates subsequent fibroblast which can be a key event in shifting from fibrotic 
encapsulation towards tissue regeneration. PLA scaffolds: Upon interaction with PLA 
scaffolds, PBMC, NK cells and monocytes can secrete cytokines such as IL-6, IL-8 or 
MCP-1. NK cells greatly increase their numbers within the PLA scaffolds. During the early 
inflammatory phase, PBMC and monocytes are responsible for a higher fibroblast 
mobilization towards implanted PLA matrix. However, monocytes differentiation into 
mature macrophages is followed by the secretion of high amounts of inflammatory 
mediators as IL-6, IL-8 and MCP-1 which ultimately drives a preferential recruitment of 
MSC over fibroblast towards the implant. This environment has no effect of the scaffold 
repopulation rate by mobilized MSC. Similar to chitosan scaffolds, MSC interaction with 
macrophages at the implant interface represses further fibroblast recruitment towards the 
scaffold. PBMC: peripheral blood mononuclear cells; NK cells: natural killer cells; MSC: 
mesenchymal stromal/stem cells; Stromal green cells (MSC); Stromal red cells 
(Fibroblasts). 
 
In order to validate our 3D model, the in vivo host response to implanted materials could 
be evaluated through several parameters at days 0, 1, 4 and 7 post-implantation in an air 
pouch model(24). These would include the number of NK cells (CD3-/CD56+), 
monocytes/macrophages (CD14+/CD68+), cytotoxic T cells (CD3+/CD8+), regulatory T 
cells (CD3+/CD25+) and B cells (B220+). To compare the obtained results with the 
literature it would be also interesting to profile M1 (CCR7+/CD80+) and M2 
(CD163+/CD206+) macrophage marker expression to trace a putative M2/M1 ratio. 
Additionally, it would be important to quantify the presence of inflammatory 
cytokines/chemokines in tissue exudates (IL-6, MIP-1, RANTES, MCP-1, TGF-β, IL-10, 
PGE2, etc.) by ELISA at the different time-points. To finalize, the number of recruited 
MSC (CD106+/CD146+) and fibroblasts (SMA-α) should be correlated with the scoring of 
histological images to include fibrous encapsulation thickness, number of blood vessels 
and extent of scaffold biodegradation. If a correlation were observed between ratio of 
fibrotic-to-progenitor cells mobilized to implant site and in vivo foreign body response 
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endpoint markers, our 3D in vitro model would be a valuable tool in scaffold 
biocompatibility testing for biomedical industry.  
5.6 Beyond MSC mobilization:                                                                       
Can macrophages modulate the scaffold colonization process?     
Adding to the scaffolds features on defining MSC motility within 3D biomaterials, another 
equally important (yet often neglected) complexity factor emerges: the inflammatory milieu 
/ immune cells already present at the scaffold interface. Shockingly, studies that address 
the inflammatory component on scaffold colonization rate by endogenous MSC are scarce 
to nonexistent. It was shown that the presence of macrophages in 3D scaffolds was 
pivotal to promote MSC recruitment. Thus we evaluated whether their interaction with 
these cells at the scaffold interface could also modulate the MSC migration within the 3D 
scaffolds and consequently the scaffolds colonization rate. Most interestingly, we 
demonstrate that although stem cell motility within PLA and chitosan 3D matrices was 
similar in the absence of immune cells their motility could be significantly altered by the 
presence of macrophages. Indeed, a significant increase in MSC motility within chitosan 
was observed with no effect on cells motility in PLA. This implies that macrophages 
promote a faster colonization of chitosan scaffolds by the recruited progenitor cells but not 
in PLA scaffolds. This detailed analysis of MSC motility within distinct 3D 
microenvironments and inflammatory settings revealed itself as an important leap forward 
for the longitudinal characterization of MSC dynamical behaviour under physiologically 
relevant inflammatory conditions. It would be interesting to investigate whether 
macrophages could selectively facilitate or hamper scaffold colonization by distinct cell 
types. To test this, analogous studies with macrophages and fibroblasts from the same 
donor could be performed in Dendra2 imaging platform. If a correlation were observed 
biomaterials designed to modulate this macrophage ability could be pursued as a novel 
strategy to improve healing outcome.    
Thus, an improved understanding on how biomaterial physico-chemical features modulate 
immune cells to improve not only the recruitment but also scaffold’s repopulation by the 
endogenous MSC is warranted for an integrated and smarter in situ engineering scaffold 
design.  
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5.7 MSC on the spot: resolving inflammation and fibrosis? 
Upon arrival to the implant site, MSC are primed by high levels of TNF-α, IL-1β and IFN-γ 
already present in the pro-inflammatory environment. This drives MSC to secrete 
immunomodulatory and trophic factors, which suppress inflammation and fibrosis. 
Similarly, MSC secrete TNF-stimulated gene/protein-6 (TSG-6) which disrupts IL-8 
binding site, downregulating the expression of adhesion molecules at the inflamed 
endothelium surface thus inhibit rolling and transendothelial migration of neutrophils. This 
strategy impairs neutrophils influx and ROS respiratory burst avoiding further tissue 
damage and inflammation(105). IL-10 which can also be secreted by MSC have been 
reported to inhibit neutrophils recruitment(106). 
MSC have been reported to mediate M1-to-M2 macrophage polarization by two main 
negative feedback loops: PGE2 and TSG-6(107-109). Indeed, MSC seem to “educate” 
macrophages with a rather characteristic anti-inflammatory polarization profile (called 
M2m) which renders them to secrete high levels of IL-10 and IL-6 and low IL-12 and TNF-
α(107,110). Interestingly, Swartzlander el al.(30) reported that MSC encapsulated within 
poly(ethylene glycol) (PEG) hydrogels diminish the fibrous capsule thickness formed 
around the implant, suggesting some degree of immunomodulation over the FBR process. 
Since this interaction seems critical to meditate pro-inflammatory-to-regulatory 
environmental transition we investigated whether this putative cross-talk would impact 
subsequent fibroblast recruitment. Notably, macrophage-MSC interaction resulted in 
repression of fibroblast mobilization regardless of the scaffold material. This suggests a 
mechanism that halts both macrophage and MSC ability to recruit fibroblasts (and 
eventually other cell types) towards the implant site once stem cell recruitment is 
achieved. To this regard, future studies should be conducted to elucidate whether MSC 
co-culture is able to induce a specific macrophage polarization to assist in this repressive 
effect. Moreover, additional mechanistic studies should be performed to understand 
whether this process activation relies on a certain MSC:Macrophage threshold ratio. 
Likewise, the specific factors involved in MSC-mediated fibroblast blocking mechanism 
should be unravelled. This could be achieved by proteomic analysis of the distinct cell 
supernatants followed by inhibition studies with possible candidates.   
Overall, these findings highlight the importance of the in-depth mechanistic understanding 
about interactions between macrophages, fibroblast and MSC to unravel new targets and 
strategies to regulate the endogenous stromal cell recruitment dynamics towards the 
implant site. 
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5.8 Healing response: more than stromal cell mobilization 
The severity of inflammation is closely linked to the features of subsequent processes of 
repair/regeneration of tissues(92,111). In this framework, mobilized fibroblasts have the 
ability to perpetuate the inflammatory response via expression of key chemokines(29,112). 
One of such examples is their interaction with macrophages. (myo)fibroblasts activated by 
pro-inflammatory macrophages can secrete MCP-1, RANTES and IP-10 that exacerbates 
inflammation through recruitment of additional monocytes and other leukocytes(113). 
Moreover, some of these cytokines, such as MCP-1 also act in an autocrine loop on 
fibroblasts through stimulation of collagen synthesis and up-regulation of TGF-β1, 
contributing to tissue fibrosis(114). In the inflammatory milieu, IL-6 is another cytokine that 
could enhance collagen and elastin secretion by fibroblasts(115,116). Interestingly, most of 
these cytokines were secreted in high amounts by the distinct immune cell upon 
interaction with 3D biomaterials. 
Here we demonstrate that macrophages can recruit MSC and fibroblasts, at later stages 
of inflammation, and that preferential recruitment of one cell type in detriment of the other 
is biomaterial-dependent. Despite both of these stromal cell types share many features in 
common, including the similar expression of surface markers and chemokine receptors, 
they display marked differences on their immunomodulatory properties and function(117-
120). During prolonged foreign body stimuli (e.g. due to slow scaffold degradation), 
fibroblasts and leucocytes which exert pro-inflammatory and pro-fibrotic effects, act in 
concerted manner to promote fibrotic encapsulation of the biomaterial walling it from the 
organism. This process may severely compromise the functional healing of in situ 
engineered scaffold by impeding its colonization by host’s cells. This stresses the need for 
tight regulatory mechanisms of immune cell/fibroblast pro-inflammatory and fibrotic 
phenotypes upon recruitment, which can be mediated by synchronized MSC 
mobilization(30). Proper functionality of these safeguard mechanisms can rely on the 
proportion of MSC:fibroblast mobilization towards the implant (which can be deregulated 
in aged individuals(121-123)). Additionally, the timely degradation of the scaffold can also be 
decisive to direct successful tissue regeneration instead of fibrosis. In contrast to 
fibroblasts and leucocytes, recruited MSC2 (meanwhile polarized by inflammatory 
milieu(124)) secrete a plethora of bioactive factors with a strong immunomodulatory and 
anti-fibrotic action over these cell types to ameliorate inflammation and fibrotic 
encapsulation of the implanted scaffold(118,125-128). Thus, timely regulation of the activation 
state of fibroblasts that were mobilized into the scaffold can also be pivotal to prevent 
excessive fibrosis.  
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5.9 Experimental pitfalls and other considerations 
Although this thesis work is exclusively derived from primary human cells, which facilitates 
data translation towards the clinics, some potential drawbacks should be noted. When 
using primary human cell sources, there is significant donor-to-donor variability, and thus 
samples from multiple donors were used for each experiment to achieve more meaningful 
results. Nevertheless, this study was performed in a relatively small-scale and it would be 
beneficial to increase the number of donors. More importantly, future studies should also 
characterize biomaterial-evoked immune responses in patients with associated co-
morbidities, who may be more likely to be the recipients of such in situ regenerative 
therapies. For instance, diabetic patients exhibit impaired/delayed wound healing 
responses as higher blood glucose levels affects leukocyte function(129). Moreover the 
concentration of progenitor cells in human blood is significantly decreased in aged 
individuals(130). Interestingly, both of the risk factors are associated with delayed or 
impaired wound healing through a reduced ability to shift from an M1 to an M2 
macrophage phenotype(131). Therefore, the development of such diseased 3D models 
would contribute to the understanding of the impact of classical risk factors for impaired 
healing, such as  age, diabetes or obesity, on these patients regenerative potential(132). 
Importantly, such knowledge would greatly benefit clinical decision between implantation 
of off-the-shelf regenerative scaffolds or traditionally engineered tissue constructs in those 
particular patient cohorts. 
Another potential drawback of our model is the restricted temporal assessment of distinct 
immune responses and stromal cell trafficking towards the implant site. To this regard, 
future studies could employ cell replenishment strategies in the distinct 
chambers/reservoirs to allow for a more prolonged in vitro culture. Interestingly, this 
approach would also allow studying how cellular changes over the 
inflammatory/regenerative process in bone-marrow/blood stream/implant site 
compartments (mimicked by cell replenishment in different reservoirs) could influence the 
healing response. This would enable the study of cell trafficking events extending beyond 
the initial inflammatory phase and would greatly increase the 3D model complexity. 
Despite MSC hypo-immunogenicity due to low expression levels of HLA class I, no 
expression of HLA class II and CD40, CD80, and CD86 co-stimulatory molecules, some 
clinical trials reported that allogeneic MSC can be recognized by the innate and adaptive 
immune system(133,134). To this regard several studies state that this recognition could be 
minimized by inflammatory MSC priming prior to cell infusion. Therefore, another potential 
limitation of this study lies on the use of contact co-cultures between MSC and 
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macrophages from different donors. Nevertheless, inflammatory environments, as the 
ones generated during macrophage-biomaterial interaction, have been demonstrated to 
change immunomudulatory gene expression in MSC or promote the cell–cell contact 
suppressive effect. Indeed, several reports on culture systems state that cell–cell contact 
is a key factor involved in the immunomodulatory effects of MSC(135-137). The net result is 
an enhanced immunosuppressive response by cultured MSC. Moreover, the 
concentration of MSC used in our co-culture experiments should be high enough to 
strongly influence the cell culture microenvironment and suppress an eventual 
macrophage-mediated allogeneic reaction. Consistent with this, we have observed that 
cells remained metabolically active upon interaction, which suggests that MSC 
immunosuppressive properties might prevail. Importantly, the obtained data can also 
provide important insights for tissue engineering and regenerative medicine therapies that 
rely on the use of allogeneic MSC.  
With this limitation in mind, future studies should be performed with contact co-cultures of 
the three cell types (immune cells, MSC and fibroblasts) from the same human donor to 
exclude eventual allogeneic reactions. With this setting it would be interesting to 
investigate the impact of biomaterial-evoked immune responses over co-cultured 
fibroblasts ECM production (e.g. elastin and collagen I) in the distinct scaffolds. Similarly, 
it would be important to analyze whether MSC can also play a regulatory role over this 
potentially detrimental macrophage-fibroblast interaction.    
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5.10 CONCLUSIONS & OUTLOOK 
The complexity of biomaterial-evoked immune responses poses a challenging 
environment for in situ tissue engineering strategies. Clearly, a better understanding of the 
underlying pathways that control the fate of implanted biomaterials is crucial to design 
novel immunomodulatory approaches that potentiate tissue regeneration and remodeling 
while preventing fibrosis.  
In line with this, this thesis provided a comprehensive analysis of the primary human 
responses triggered by different 3D biomaterials and their functional consequence on the 
preferential recruitment of primary human MSC or fibroblasts. Contrary to MSC, fibroblast 
recruitment can be signalled early on in the host response and can be promoted by 
several immune cells depending on the biomaterial properties. Moreover, macrophages 
were the most effective cells to mediate stromal cell recruitment to the implant which 
should predominate at later stages of the host response. Importantly, the scaffold 
properties strongly influence the macrophage-mediated preferential stromal cell type 
recruitment which can be instrumental to predict/determine the healing outcome. 
Strikingly, MSC arrival to the implant site and consequent interaction with macrophages 
can modulate their phenotype and block subsequent fibroblast recruitment to the vicinity 
of the scaffold. Future work should determine whether a certain MSC:macrophage ratio 
threshold is required  and which signalling molecules are involved in mediating this 
fibroblast influx blocking mechanism. Additionally, it would be interesting to characterize 
an eventual regulatory role by recruited MSC over the pro-fibrotic profile of the previously 
mobilized fibroblasts at the scaffold interface.    
Regarding the outreach of the presented work, the system here developed should be 
further validated in vivo to be applied in the clinics as a predictive 3D model to calculate 
the likelihood of a given scaffold material to promote endogenous tissue regeneration 
when implanted in a given patient. The same principle applies to the development of novel 
immunomodulatory scaffolds for in situ regeneration. Normal biological patient-to-patient 
variation, as well as comorbidities will result in dissimilarities in the immunological and 
regenerative competence between patients. Thus and most interestingly, mapping of 
specific immune cell populations responsible for stromal cell recruitment, as the one here 
established (Figure 1), may be instrumental to enable patient-tailored regenerative 
treatment. Additionally, such knowledge could be integrated in clinical management to 
provide personalized pre-operative boosting and/or depletion of specific circulating 
immune cell populations to synergistically augment the likelihood of scaffold-guided tissue 
regeneration for a given patient.  
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In conclusion, immunomodulatory scaffold development for in situ regeneration holds 
great promise for future application and commercialization. However, the mechanistic 
understanding on how the biomaterials and immune cells interact to yield the proper 
regenerative response remains a jigsaw puzzle. Taken together, the data presented in this 
thesis provides one of the first steps towards a novel integrative concept in in situ tissue 
engineering which can assist future scaffold development. 
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“PARA SER GRANDE, SÊ INTEIRO: NADA 
 
Para ser grande, sê inteiro: nada 
        Teu exagera ou exclui. 
Sê todo em cada coisa. Põe quanto és 
        No mínimo que fazes. 
Assim em cada lago a lua toda 
     Brilha, porque alta vive. 
 
14-2-1933 
Odes de Ricardo Reis . Fernando Pessoa. Lisboa: Ática, 1946 (imp.1994).  - 148. 
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